id	sid	tid	token	lemma	pos
dpc-4511	1	1	dermatology	dermatology	NOUN
dpc-4511	1	2	:	:	PUNCT
dpc-4511	1	3	practical	practical	ADJ
dpc-4511	1	4	and	and	CCONJ
dpc-4511	1	5	conceptual	conceptual	ADJ
dpc-4511	1	6	original	original	ADJ
dpc-4511	1	7	article	article	NOUN
dpc-4511	1	8	|	|	ADV
dpc-4511	1	9	dermatol	dermatol	ADJ
dpc-4511	1	10	pract	pract	NOUN
dpc-4511	1	11	concept	concept	NOUN
dpc-4511	1	12	.	.	PUNCT
dpc-4511	2	1	2025;15(1):4511	2025;15(1):4511	NUM
dpc-4511	2	2	1	1	NUM
dpc-4511	2	3	geriatric	geriatric	ADJ
dpc-4511	2	4	psoriasis	psoriasis	NOUN
dpc-4511	2	5	:	:	PUNCT
dpc-4511	2	6	evaluation	evaluation	NOUN
dpc-4511	2	7	of	of	ADP
dpc-4511	2	8	clinical	clinical	ADJ
dpc-4511	2	9	features	feature	NOUN
dpc-4511	2	10	,	,	PUNCT
dpc-4511	2	11	disease	disease	NOUN
dpc-4511	2	12	course	course	NOUN
dpc-4511	2	13	,	,	PUNCT
dpc-4511	2	14	and	and	CCONJ
dpc-4511	2	15	treatment	treatment	NOUN
dpc-4511	2	16	modalities	modality	NOUN
dpc-4511	2	17	of	of	ADP
dpc-4511	2	18	 	 	SPACE
dpc-4511	2	19	patients	patient	NOUN
dpc-4511	2	20	from	from	ADP
dpc-4511	2	21	a	a	DET
dpc-4511	2	22	tertiary	tertiary	ADJ
dpc-4511	2	23	care	care	NOUN
dpc-4511	2	24	hospital	hospital	NOUN
dpc-4511	2	25	elif	elif	NOUN
dpc-4511	2	26	çalışkan1	çalışkan1	PROPN
dpc-4511	2	27	,	,	PUNCT
dpc-4511	2	28	yusuf	yusuf	PROPN
dpc-4511	2	29	can	can	AUX
dpc-4511	2	30	edek1	edek1	PROPN
dpc-4511	2	31	,	,	PUNCT
dpc-4511	2	32	nuray	nuray	ADJ
dpc-4511	2	33	keskin2	keskin2	PROPN
dpc-4511	2	34	,	,	PUNCT
dpc-4511	2	35	petek	petek	X
dpc-4511	2	36	üstün1	üstün1	NOUN
dpc-4511	2	37	,	,	PUNCT
dpc-4511	2	38	esra	esra	PROPN
dpc-4511	2	39	adışen1	adışen1	PROPN
dpc-4511	2	40	1	1	NUM
dpc-4511	2	41	department	department	NOUN
dpc-4511	2	42	of	of	ADP
dpc-4511	2	43	dermatology	dermatology	NOUN
dpc-4511	2	44	,	,	PUNCT
dpc-4511	2	45	gazi	gazi	PROPN
dpc-4511	2	46	university	university	PROPN
dpc-4511	2	47	faculty	faculty	NOUN
dpc-4511	2	48	of	of	ADP
dpc-4511	2	49	medicine	medicine	NOUN
dpc-4511	2	50	,	,	PUNCT
dpc-4511	2	51	ankara	ankara	PROPN
dpc-4511	2	52	,	,	PUNCT
dpc-4511	2	53	turkey	turkey	PROPN
dpc-4511	2	54	2	2	NUM
dpc-4511	2	55	department	department	NOUN
dpc-4511	2	56	of	of	ADP
dpc-4511	2	57	dermatology	dermatology	NOUN
dpc-4511	2	58	,	,	PUNCT
dpc-4511	2	59	yenimahalle	yenimahalle	NOUN
dpc-4511	2	60	training	training	NOUN
dpc-4511	2	61	and	and	CCONJ
dpc-4511	2	62	research	research	NOUN
dpc-4511	2	63	hospital	hospital	NOUN
dpc-4511	2	64	,	,	PUNCT
dpc-4511	2	65	ankara	ankara	PROPN
dpc-4511	2	66	,	,	PUNCT
dpc-4511	2	67	turkey	turkey	PROPN
dpc-4511	2	68	key	key	ADJ
dpc-4511	2	69	words	word	NOUN
dpc-4511	2	70	:	:	PUNCT
dpc-4511	2	71	psoriasis	psoriasis	NOUN
dpc-4511	2	72	,	,	PUNCT
dpc-4511	2	73	palmoplantar	palmoplantar	NOUN
dpc-4511	2	74	psoriasis	psoriasis	NOUN
dpc-4511	2	75	,	,	PUNCT
dpc-4511	2	76	keratoderma	keratoderma	NOUN
dpc-4511	2	77	,	,	PUNCT
dpc-4511	2	78	quality	quality	NOUN
dpc-4511	2	79	of	of	ADP
dpc-4511	2	80	life	life	NOUN
dpc-4511	2	81	citation	citation	NOUN
dpc-4511	2	82	:	:	PUNCT
dpc-4511	2	83	çalışkan	çalışkan	PROPN
dpc-4511	2	84	e	e	PROPN
dpc-4511	2	85	,	,	PUNCT
dpc-4511	2	86	edek	edek	NOUN
dpc-4511	2	87	yc	yc	NOUN
dpc-4511	2	88	,	,	PUNCT
dpc-4511	2	89	keskin	keskin	PROPN
dpc-4511	2	90	n	n	CCONJ
dpc-4511	2	91	,	,	PUNCT
dpc-4511	2	92	üstün	üstün	PROPN
dpc-4511	2	93	p	p	NOUN
dpc-4511	2	94	,	,	PUNCT
dpc-4511	2	95	adışen	adışen	PROPN
dpc-4511	2	96	e.	e.	PROPN
dpc-4511	2	97	geriatric	geriatric	PROPN
dpc-4511	2	98	psoriasis	psoriasis	NOUN
dpc-4511	2	99	:	:	PUNCT
dpc-4511	2	100	evaluation	evaluation	NOUN
dpc-4511	2	101	of	of	ADP
dpc-4511	2	102	clinical	clinical	ADJ
dpc-4511	2	103	features	feature	NOUN
dpc-4511	2	104	,	,	PUNCT
dpc-4511	2	105	disease	disease	NOUN
dpc-4511	2	106	course	course	NOUN
dpc-4511	2	107	,	,	PUNCT
dpc-4511	2	108	and	and	CCONJ
dpc-4511	2	109	treatment	treatment	NOUN
dpc-4511	2	110	modalities	modality	NOUN
dpc-4511	2	111	of	of	ADP
dpc-4511	2	112	patients	patient	NOUN
dpc-4511	2	113	from	from	ADP
dpc-4511	2	114	a	a	DET
dpc-4511	2	115	tertiary	tertiary	ADJ
dpc-4511	2	116	care	care	NOUN
dpc-4511	2	117	hospital	hospital	NOUN
dpc-4511	2	118	.	.	PUNCT
dpc-4511	3	1	dermatol	dermatol	NOUN
dpc-4511	3	2	pract	pract	PROPN
dpc-4511	3	3	concept	concept	NOUN
dpc-4511	3	4	.	.	PUNCT
dpc-4511	4	1	2025;15(1):4511	2025;15(1):4511	NUM
dpc-4511	4	2	.	.	PUNCT
dpc-4511	5	1	doi	doi	PROPN
dpc-4511	5	2	:	:	PUNCT
dpc-4511	5	3	https://doi.org/10.5826	https://doi.org/10.5826	PROPN
dpc-4511	5	4	/dpc.1501a4511	/dpc.1501a4511	PROPN
dpc-4511	5	5	accepted	accept	VERB
dpc-4511	5	6	:	:	PUNCT
dpc-4511	5	7	august	august	PROPN
dpc-4511	5	8	26	26	NUM
dpc-4511	5	9	,	,	PUNCT
dpc-4511	5	10	2024	2024	NUM
dpc-4511	5	11	;	;	PUNCT
dpc-4511	5	12	published	publish	VERB
dpc-4511	5	13	:	:	PUNCT
dpc-4511	6	1	january	january	PROPN
dpc-4511	6	2	2025	2025	NUM
dpc-4511	6	3	copyright	copyright	NOUN
dpc-4511	6	4	:	:	PUNCT
dpc-4511	6	5	©	©	PROPN
dpc-4511	6	6	2024	2024	NUM
dpc-4511	6	7	çalışkan	çalışkan	PROPN
dpc-4511	6	8	et	et	PROPN
dpc-4511	6	9	al	al	PROPN
dpc-4511	6	10	.	.	PUNCT
dpc-4511	7	1	this	this	PRON
dpc-4511	7	2	is	be	AUX
dpc-4511	7	3	an	an	DET
dpc-4511	7	4	open	open	ADJ
dpc-4511	7	5	-	-	PUNCT
dpc-4511	7	6	access	access	NOUN
dpc-4511	7	7	article	article	NOUN
dpc-4511	7	8	distributed	distribute	VERB
dpc-4511	7	9	under	under	ADP
dpc-4511	7	10	the	the	DET
dpc-4511	7	11	terms	term	NOUN
dpc-4511	7	12	of	of	ADP
dpc-4511	7	13	the	the	DET
dpc-4511	7	14	creative	creative	ADJ
dpc-4511	7	15	commons	common	NOUN
dpc-4511	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4511	7	17	license	license	NOUN
dpc-4511	7	18	(	(	PUNCT
dpc-4511	7	19	by	by	ADP
dpc-4511	7	20	-	-	PUNCT
dpc-4511	7	21	nc-4.0	nc-4.0	NOUN
dpc-4511	7	22	)	)	PUNCT
dpc-4511	7	23	,	,	PUNCT
dpc-4511	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4511	7	25	,	,	PUNCT
dpc-4511	7	26	which	which	PRON
dpc-4511	7	27	permits	permit	VERB
dpc-4511	7	28	unrestricted	unrestricted	ADJ
dpc-4511	7	29	noncommercial	noncommercial	ADJ
dpc-4511	7	30	use	use	NOUN
dpc-4511	7	31	,	,	PUNCT
dpc-4511	7	32	distribution	distribution	NOUN
dpc-4511	7	33	,	,	PUNCT
dpc-4511	7	34	and	and	CCONJ
dpc-4511	7	35	reproduction	reproduction	NOUN
dpc-4511	7	36	in	in	ADP
dpc-4511	7	37	any	any	DET
dpc-4511	7	38	medium	medium	NOUN
dpc-4511	7	39	,	,	PUNCT
dpc-4511	7	40	provided	provide	VERB
dpc-4511	7	41	the	the	DET
dpc-4511	7	42	original	original	ADJ
dpc-4511	7	43	authors	author	NOUN
dpc-4511	7	44	and	and	CCONJ
dpc-4511	7	45	source	source	NOUN
dpc-4511	7	46	are	be	AUX
dpc-4511	7	47	credited	credit	VERB
dpc-4511	7	48	.	.	PUNCT
dpc-4511	8	1	funding	funding	NOUN
dpc-4511	8	2	:	:	PUNCT
dpc-4511	8	3	none	none	NOUN
dpc-4511	8	4	.	.	PUNCT
dpc-4511	9	1	competing	compete	VERB
dpc-4511	9	2	interests	interest	NOUN
dpc-4511	9	3	:	:	PUNCT
dpc-4511	9	4	none	none	NOUN
dpc-4511	9	5	.	.	PUNCT
dpc-4511	10	1	authorship	authorship	NOUN
dpc-4511	10	2	:	:	PUNCT
dpc-4511	10	3	all	all	DET
dpc-4511	10	4	authors	author	NOUN
dpc-4511	10	5	have	have	AUX
dpc-4511	10	6	contributed	contribute	VERB
dpc-4511	10	7	significantly	significantly	ADV
dpc-4511	10	8	to	to	ADP
dpc-4511	10	9	this	this	DET
dpc-4511	10	10	publication	publication	NOUN
dpc-4511	10	11	.	.	PUNCT
dpc-4511	11	1	corresponding	correspond	VERB
dpc-4511	11	2	author	author	NOUN
dpc-4511	11	3	:	:	PUNCT
dpc-4511	11	4	yusuf	yusuf	PROPN
dpc-4511	11	5	can	can	AUX
dpc-4511	11	6	edek	edek	NOUN
dpc-4511	11	7	,	,	PUNCT
dpc-4511	11	8	gazi	gazi	PROPN
dpc-4511	11	9	universitesi	universitesi	PROPN
dpc-4511	11	10	tip	tip	PROPN
dpc-4511	11	11	fakultesi	fakultesi	PROPN
dpc-4511	11	12	hastanesi	hastanesi	NOUN
dpc-4511	11	13	,	,	PUNCT
dpc-4511	11	14	emniyet	emniyet	NOUN
dpc-4511	11	15	mahallesi	mahallesi	NOUN
dpc-4511	11	16	,	,	PUNCT
dpc-4511	11	17	mevlana	mevlana	NOUN
dpc-4511	11	18	bulvari	bulvari	NOUN
dpc-4511	11	19	,	,	PUNCT
dpc-4511	11	20	no:29	no:29	PROPN
dpc-4511	11	21	,	,	PUNCT
dpc-4511	11	22	06560	06560	NUM
dpc-4511	11	23	ankara/	ankara/	NUM
dpc-4511	11	24	turkey	turkey	NOUN
dpc-4511	11	25	.	.	PUNCT
dpc-4511	12	1	e	e	X
dpc-4511	12	2	-	-	NOUN
dpc-4511	12	3	mail	mail	NOUN
dpc-4511	12	4	:	:	PUNCT
dpc-4511	12	5	yusuf-can-35@hotmail.com	yusuf-can-35@hotmail.com	X
dpc-4511	12	6	introduction	introduction	NOUN
dpc-4511	12	7	:	:	PUNCT
dpc-4511	12	8	psoriasis	psoriasis	NOUN
dpc-4511	12	9	is	be	AUX
dpc-4511	12	10	an	an	DET
dpc-4511	12	11	inflammatory	inflammatory	ADJ
dpc-4511	12	12	skin	skin	NOUN
dpc-4511	12	13	disease	disease	NOUN
dpc-4511	12	14	characterized	characterize	VERB
dpc-4511	12	15	by	by	ADP
dpc-4511	12	16	erythematous	erythematous	ADJ
dpc-4511	12	17	,	,	PUNCT
dpc-4511	12	18	scaly	scaly	NOUN
dpc-4511	12	19	,	,	PUNCT
dpc-4511	12	20	pruritic	pruritic	ADJ
dpc-4511	12	21	plaques	plaque	NOUN
dpc-4511	12	22	on	on	ADP
dpc-4511	12	23	the	the	DET
dpc-4511	12	24	extensor	extensor	NOUN
dpc-4511	12	25	areas	area	NOUN
dpc-4511	12	26	of	of	ADP
dpc-4511	12	27	the	the	DET
dpc-4511	12	28	extremities	extremity	NOUN
dpc-4511	12	29	.	.	PUNCT
dpc-4511	13	1	it	it	PRON
dpc-4511	13	2	is	be	AUX
dpc-4511	13	3	one	one	NUM
dpc-4511	13	4	of	of	ADP
dpc-4511	13	5	the	the	DET
dpc-4511	13	6	most	most	ADV
dpc-4511	13	7	common	common	ADJ
dpc-4511	13	8	dermatological	dermatological	ADJ
dpc-4511	13	9	diseases	disease	NOUN
dpc-4511	13	10	in	in	ADP
dpc-4511	13	11	the	the	DET
dpc-4511	13	12	geriatric	geriatric	ADJ
dpc-4511	13	13	population	population	NOUN
dpc-4511	13	14	.	.	PUNCT
dpc-4511	14	1	objective	objective	NOUN
dpc-4511	14	2	:	:	PUNCT
dpc-4511	14	3	the	the	DET
dpc-4511	14	4	aim	aim	NOUN
dpc-4511	14	5	of	of	ADP
dpc-4511	14	6	this	this	DET
dpc-4511	14	7	investigation	investigation	NOUN
dpc-4511	14	8	was	be	AUX
dpc-4511	14	9	to	to	PART
dpc-4511	14	10	evaluate	evaluate	VERB
dpc-4511	14	11	the	the	DET
dpc-4511	14	12	demographic	demographic	ADJ
dpc-4511	14	13	data	datum	NOUN
dpc-4511	14	14	,	,	PUNCT
dpc-4511	14	15	clinical	clinical	ADJ
dpc-4511	14	16	characteristics	characteristic	NOUN
dpc-4511	14	17	,	,	PUNCT
dpc-4511	14	18	and	and	CCONJ
dpc-4511	14	19	treatment	treatment	NOUN
dpc-4511	14	20	responses	response	NOUN
dpc-4511	14	21	of	of	ADP
dpc-4511	14	22	the	the	DET
dpc-4511	14	23	geriatric	geriatric	ADJ
dpc-4511	14	24	population	population	NOUN
dpc-4511	14	25	(	(	PUNCT
dpc-4511	14	26	≥65	≥65	NUM
dpc-4511	14	27	years	year	NOUN
dpc-4511	14	28	)	)	PUNCT
dpc-4511	14	29	with	with	ADP
dpc-4511	14	30	psoriasis	psoriasis	NOUN
dpc-4511	14	31	at	at	ADP
dpc-4511	14	32	our	our	PRON
dpc-4511	14	33	hospital	hospital	NOUN
dpc-4511	14	34	.	.	PUNCT
dpc-4511	15	1	methods	method	NOUN
dpc-4511	15	2	:	:	PUNCT
dpc-4511	15	3	in	in	ADP
dpc-4511	15	4	this	this	DET
dpc-4511	15	5	study	study	NOUN
dpc-4511	15	6	,	,	PUNCT
dpc-4511	15	7	we	we	PRON
dpc-4511	15	8	examined	examine	VERB
dpc-4511	15	9	160	160	NUM
dpc-4511	15	10	geriatric	geriatric	ADJ
dpc-4511	15	11	patients	patient	NOUN
dpc-4511	15	12	diagnosed	diagnose	VERB
dpc-4511	15	13	with	with	ADP
dpc-4511	15	14	psoriasis	psoriasis	NOUN
dpc-4511	15	15	.	.	PUNCT
dpc-4511	16	1	we	we	PRON
dpc-4511	16	2	evaluated	evaluate	VERB
dpc-4511	16	3	patients	patient	NOUN
dpc-4511	16	4	in	in	ADP
dpc-4511	16	5	two	two	NUM
dpc-4511	16	6	groups	group	NOUN
dpc-4511	16	7	:	:	PUNCT
dpc-4511	16	8	early	early	ADJ
dpc-4511	16	9	onset	onset	NOUN
dpc-4511	16	10	(	(	PUNCT
dpc-4511	16	11	eao	eao	ADJ
dpc-4511	16	12	)	)	PUNCT
dpc-4511	16	13	(	(	PUNCT
dpc-4511	16	14	<	<	X
dpc-4511	16	15	60	60	NUM
dpc-4511	16	16	years	year	NOUN
dpc-4511	16	17	)	)	PUNCT
dpc-4511	16	18	and	and	CCONJ
dpc-4511	16	19	elderly	elderly	ADJ
dpc-4511	16	20	onset	onset	NOUN
dpc-4511	16	21	(	(	PUNCT
dpc-4511	16	22	eo	eo	PROPN
dpc-4511	16	23	)	)	PUNCT
dpc-4511	16	24	(	(	PUNCT
dpc-4511	16	25	≥60	≥60	PROPN
dpc-4511	16	26	years	year	NOUN
dpc-4511	16	27	)	)	PUNCT
dpc-4511	16	28	.	.	PUNCT
dpc-4511	17	1	results	result	NOUN
dpc-4511	17	2	:	:	PUNCT
dpc-4511	17	3	in	in	ADP
dpc-4511	17	4	our	our	PRON
dpc-4511	17	5	study	study	NOUN
dpc-4511	17	6	,	,	PUNCT
dpc-4511	17	7	53.8	53.8	NUM
dpc-4511	17	8	%	%	NOUN
dpc-4511	17	9	of	of	ADP
dpc-4511	17	10	the	the	DET
dpc-4511	17	11	patients	patient	NOUN
dpc-4511	17	12	were	be	AUX
dpc-4511	17	13	male	male	ADJ
dpc-4511	17	14	,	,	PUNCT
dpc-4511	17	15	the	the	DET
dpc-4511	17	16	average	average	ADJ
dpc-4511	17	17	age	age	NOUN
dpc-4511	17	18	was	be	AUX
dpc-4511	17	19	68.7	68.7	NUM
dpc-4511	17	20	years	year	NOUN
dpc-4511	17	21	,	,	PUNCT
dpc-4511	17	22	and	and	CCONJ
dpc-4511	17	23	65	65	NUM
dpc-4511	17	24	%	%	NOUN
dpc-4511	17	25	of	of	ADP
dpc-4511	17	26	the	the	DET
dpc-4511	17	27	patients	patient	NOUN
dpc-4511	17	28	were	be	AUX
dpc-4511	17	29	considered	consider	VERB
dpc-4511	17	30	eao	eao	ADJ
dpc-4511	17	31	.	.	PUNCT
dpc-4511	18	1	knee	knee	NOUN
dpc-4511	18	2	and	and	CCONJ
dpc-4511	18	3	elbow	elbow	NOUN
dpc-4511	18	4	lesions	lesion	NOUN
dpc-4511	18	5	were	be	AUX
dpc-4511	18	6	detected	detect	VERB
dpc-4511	18	7	more	more	ADV
dpc-4511	18	8	frequently	frequently	ADV
dpc-4511	18	9	at	at	ADP
dpc-4511	18	10	the	the	DET
dpc-4511	18	11	beginning	beginning	NOUN
dpc-4511	18	12	and	and	CCONJ
dpc-4511	18	13	during	during	ADP
dpc-4511	18	14	the	the	DET
dpc-4511	18	15	disease	disease	NOUN
dpc-4511	18	16	in	in	ADP
dpc-4511	18	17	the	the	DET
dpc-4511	18	18	eao	eao	ADJ
dpc-4511	18	19	group	group	NOUN
dpc-4511	18	20	;	;	PUNCT
dpc-4511	18	21	44.4	44.4	NUM
dpc-4511	18	22	%	%	NOUN
dpc-4511	18	23	of	of	ADP
dpc-4511	18	24	patients	patient	NOUN
dpc-4511	18	25	had	have	VERB
dpc-4511	18	26	nail	nail	NOUN
dpc-4511	18	27	psoriasis	psoriasis	NOUN
dpc-4511	18	28	,	,	PUNCT
dpc-4511	18	29	while	while	SCONJ
dpc-4511	18	30	20.6	20.6	NUM
dpc-4511	18	31	%	%	NOUN
dpc-4511	18	32	had	have	VERB
dpc-4511	18	33	psoriatic	psoriatic	ADJ
dpc-4511	18	34	arthritis	arthritis	NOUN
dpc-4511	18	35	.	.	PUNCT
dpc-4511	19	1	nail	nail	NOUN
dpc-4511	19	2	involvement	involvement	NOUN
dpc-4511	19	3	(	(	PUNCT
dpc-4511	19	4	p	p	X
dpc-4511	19	5	=	=	NOUN
dpc-4511	19	6	0.17	0.17	NUM
dpc-4511	19	7	)	)	PUNCT
dpc-4511	19	8	and	and	CCONJ
dpc-4511	19	9	the	the	DET
dpc-4511	19	10	presence	presence	NOUN
dpc-4511	19	11	of	of	ADP
dpc-4511	19	12	psoriatic	psoriatic	ADJ
dpc-4511	19	13	arthritis	arthritis	NOUN
dpc-4511	19	14	(	(	PUNCT
dpc-4511	19	15	p	p	NOUN
dpc-4511	19	16	=	=	NOUN
dpc-4511	19	17	0.035	0.035	NUM
dpc-4511	19	18	)	)	PUNCT
dpc-4511	19	19	were	be	AUX
dpc-4511	19	20	more	more	ADV
dpc-4511	19	21	common	common	ADJ
dpc-4511	19	22	in	in	ADP
dpc-4511	19	23	the	the	DET
dpc-4511	19	24	eao	eao	ADJ
dpc-4511	19	25	group	group	NOUN
dpc-4511	19	26	.	.	PUNCT
dpc-4511	20	1	erythrodermic	erythrodermic	ADJ
dpc-4511	20	2	psoriasis	psoriasis	NOUN
dpc-4511	20	3	was	be	AUX
dpc-4511	20	4	more	more	ADV
dpc-4511	20	5	common	common	ADJ
dpc-4511	20	6	in	in	ADP
dpc-4511	20	7	the	the	DET
dpc-4511	20	8	eao	eao	ADJ
dpc-4511	20	9	group	group	NOUN
dpc-4511	20	10	,	,	PUNCT
dpc-4511	20	11	but	but	CCONJ
dpc-4511	20	12	it	it	PRON
dpc-4511	20	13	was	be	AUX
dpc-4511	20	14	not	not	PART
dpc-4511	20	15	statistically	statistically	ADV
dpc-4511	20	16	significant	significant	ADJ
dpc-4511	20	17	(	(	PUNCT
dpc-4511	20	18	p	p	X
dpc-4511	20	19	=	=	NOUN
dpc-4511	20	20	0.097	0.097	NUM
dpc-4511	20	21	)	)	PUNCT
dpc-4511	20	22	.	.	PUNCT
dpc-4511	21	1	it	it	PRON
dpc-4511	21	2	was	be	AUX
dpc-4511	21	3	observed	observe	VERB
dpc-4511	21	4	that	that	SCONJ
dpc-4511	21	5	the	the	DET
dpc-4511	21	6	disease	disease	NOUN
dpc-4511	21	7	course	course	NOUN
dpc-4511	21	8	of	of	ADP
dpc-4511	21	9	psoriasis	psoriasis	NOUN
dpc-4511	21	10	was	be	AUX
dpc-4511	21	11	slower	slow	ADJ
dpc-4511	21	12	in	in	ADP
dpc-4511	21	13	the	the	DET
dpc-4511	21	14	eao	eao	ADJ
dpc-4511	21	15	group	group	NOUN
dpc-4511	21	16	compared	compare	VERB
dpc-4511	21	17	to	to	ADP
dpc-4511	21	18	the	the	DET
dpc-4511	21	19	eo	eo	PROPN
dpc-4511	21	20	group	group	NOUN
dpc-4511	21	21	(	(	PUNCT
dpc-4511	21	22	p	p	NOUN
dpc-4511	21	23	=	=	NOUN
dpc-4511	21	24	0.001	0.001	NUM
dpc-4511	21	25	)	)	PUNCT
dpc-4511	21	26	.	.	PUNCT
dpc-4511	22	1	systemic	systemic	ADJ
dpc-4511	22	2	treatment	treatment	NOUN
dpc-4511	22	3	was	be	AUX
dpc-4511	22	4	predominantly	predominantly	ADV
dpc-4511	22	5	initiated	initiate	VERB
dpc-4511	22	6	as	as	ADP
dpc-4511	22	7	the	the	DET
dpc-4511	22	8	first	first	ADJ
dpc-4511	22	9	treatment	treatment	NOUN
dpc-4511	22	10	agent	agent	NOUN
dpc-4511	22	11	in	in	ADP
dpc-4511	22	12	the	the	DET
dpc-4511	22	13	eo	eo	PROPN
dpc-4511	22	14	group	group	NOUN
dpc-4511	22	15	(	(	PUNCT
dpc-4511	22	16	p	p	X
dpc-4511	22	17	=	=	NOUN
dpc-4511	22	18	0.006	0.006	NUM
dpc-4511	22	19	)	)	PUNCT
dpc-4511	22	20	.	.	PUNCT
dpc-4511	23	1	patients	patient	NOUN
dpc-4511	23	2	in	in	ADP
dpc-4511	23	3	the	the	DET
dpc-4511	23	4	eao	eao	ADJ
dpc-4511	23	5	group	group	NOUN
dpc-4511	23	6	received	receive	VERB
dpc-4511	23	7	more	more	ADJ
dpc-4511	23	8	cyclosporine	cyclosporine	ADJ
dpc-4511	23	9	treatment	treatment	NOUN
dpc-4511	23	10	than	than	ADP
dpc-4511	23	11	the	the	DET
dpc-4511	23	12	others	other	NOUN
dpc-4511	23	13	(	(	PUNCT
dpc-4511	23	14	p	p	X
dpc-4511	23	15	=	=	NOUN
dpc-4511	23	16	0.004	0.004	NUM
dpc-4511	23	17	)	)	PUNCT
dpc-4511	23	18	.	.	PUNCT
dpc-4511	24	1	conclusions	conclusion	NOUN
dpc-4511	24	2	:	:	PUNCT
dpc-4511	24	3	the	the	DET
dpc-4511	24	4	geriatric	geriatric	ADJ
dpc-4511	24	5	population	population	NOUN
dpc-4511	24	6	is	be	AUX
dpc-4511	24	7	associated	associate	VERB
dpc-4511	24	8	with	with	ADP
dpc-4511	24	9	multiple	multiple	ADJ
dpc-4511	24	10	comorbidities	comorbiditie	NOUN
dpc-4511	24	11	and	and	CCONJ
dpc-4511	24	12	polypharmacy	polypharmacy	NOUN
dpc-4511	24	13	,	,	PUNCT
dpc-4511	24	14	highlighting	highlight	VERB
dpc-4511	24	15	the	the	DET
dpc-4511	24	16	importance	importance	NOUN
dpc-4511	24	17	of	of	ADP
dpc-4511	24	18	evaluating	evaluate	VERB
dpc-4511	24	19	patients	patient	NOUN
dpc-4511	24	20	’	'	PUNCT
dpc-4511	24	21	medications	medication	NOUN
dpc-4511	24	22	and	and	CCONJ
dpc-4511	24	23	comorbidities	comorbiditie	NOUN
dpc-4511	24	24	when	when	SCONJ
dpc-4511	24	25	selecting	select	VERB
dpc-4511	24	26	a	a	DET
dpc-4511	24	27	treatment	treatment	NOUN
dpc-4511	24	28	agent	agent	NOUN
dpc-4511	24	29	for	for	ADP
dpc-4511	24	30	psoriasis	psoriasis	NOUN
dpc-4511	24	31	.	.	PUNCT
dpc-4511	25	1	abstract	abstract	ADJ
dpc-4511	25	2	2	2	NUM
dpc-4511	25	3	original	original	ADJ
dpc-4511	25	4	article	article	NOUN
dpc-4511	25	5	|	|	ADV
dpc-4511	25	6	dermatol	dermatol	ADJ
dpc-4511	25	7	pract	pract	NOUN
dpc-4511	25	8	concept	concept	NOUN
dpc-4511	25	9	.	.	PUNCT
dpc-4511	26	1	2025;15(1):4511	2025;15(1):4511	NUM
dpc-4511	26	2	introduction	introduction	NOUN
dpc-4511	26	3	psoriasis	psoriasis	NOUN
dpc-4511	26	4	is	be	AUX
dpc-4511	26	5	an	an	DET
dpc-4511	26	6	immune	immune	NOUN
dpc-4511	26	7	-	-	PUNCT
dpc-4511	26	8	mediated	mediate	VERB
dpc-4511	26	9	inflammatory	inflammatory	ADJ
dpc-4511	26	10	skin	skin	NOUN
dpc-4511	26	11	disease	disease	NOUN
dpc-4511	26	12	that	that	PRON
dpc-4511	26	13	can	can	AUX
dpc-4511	26	14	manifest	manifest	VERB
dpc-4511	26	15	in	in	ADP
dpc-4511	26	16	various	various	ADJ
dpc-4511	26	17	clinical	clinical	ADJ
dpc-4511	26	18	forms	form	NOUN
dpc-4511	26	19	.	.	PUNCT
dpc-4511	27	1	the	the	DET
dpc-4511	27	2	development	development	NOUN
dpc-4511	27	3	of	of	ADP
dpc-4511	27	4	the	the	DET
dpc-4511	27	5	disease	disease	NOUN
dpc-4511	27	6	involves	involve	VERB
dpc-4511	27	7	multiple	multiple	ADJ
dpc-4511	27	8	factors	factor	NOUN
dpc-4511	27	9	,	,	PUNCT
dpc-4511	27	10	including	include	VERB
dpc-4511	27	11	genetic	genetic	ADJ
dpc-4511	27	12	factors	factor	NOUN
dpc-4511	27	13	,	,	PUNCT
dpc-4511	27	14	epigenetic	epigenetic	ADJ
dpc-4511	27	15	changes	change	NOUN
dpc-4511	27	16	,	,	PUNCT
dpc-4511	27	17	the	the	DET
dpc-4511	27	18	immune	immune	ADJ
dpc-4511	27	19	system	system	NOUN
dpc-4511	27	20	,	,	PUNCT
dpc-4511	27	21	microbiota	microbiota	NOUN
dpc-4511	27	22	,	,	PUNCT
dpc-4511	27	23	and	and	CCONJ
dpc-4511	27	24	environmental	environmental	ADJ
dpc-4511	27	25	factors	factor	NOUN
dpc-4511	27	26	.	.	PUNCT
dpc-4511	28	1	the	the	DET
dpc-4511	28	2	most	most	ADV
dpc-4511	28	3	common	common	ADJ
dpc-4511	28	4	presentation	presentation	NOUN
dpc-4511	28	5	of	of	ADP
dpc-4511	28	6	psoriasis	psoriasis	NOUN
dpc-4511	28	7	is	be	AUX
dpc-4511	28	8	psoriasis	psoriasis	NOUN
dpc-4511	28	9	vulgaris	vulgaris	NOUN
dpc-4511	28	10	,	,	PUNCT
dpc-4511	28	11	which	which	PRON
dpc-4511	28	12	is	be	AUX
dpc-4511	28	13	characterized	characterize	VERB
dpc-4511	28	14	by	by	ADP
dpc-4511	28	15	erythematous	erythematous	ADJ
dpc-4511	28	16	,	,	PUNCT
dpc-4511	28	17	scaly	scaly	NOUN
dpc-4511	28	18	,	,	PUNCT
dpc-4511	28	19	and	and	CCONJ
dpc-4511	28	20	well	well	ADV
dpc-4511	28	21	-	-	PUNCT
dpc-4511	28	22	demarcated	demarcate	VERB
dpc-4511	28	23	pruritic	pruritic	ADJ
dpc-4511	28	24	plaques	plaque	NOUN
dpc-4511	28	25	on	on	ADP
dpc-4511	28	26	the	the	DET
dpc-4511	28	27	extensor	extensor	NOUN
dpc-4511	28	28	areas	area	NOUN
dpc-4511	28	29	of	of	ADP
dpc-4511	28	30	the	the	DET
dpc-4511	28	31	extremities	extremity	NOUN
dpc-4511	28	32	.	.	PUNCT
dpc-4511	29	1	however	however	ADV
dpc-4511	29	2	,	,	PUNCT
dpc-4511	29	3	there	there	PRON
dpc-4511	29	4	are	be	VERB
dpc-4511	29	5	other	other	ADJ
dpc-4511	29	6	subtypes	subtype	NOUN
dpc-4511	29	7	,	,	PUNCT
dpc-4511	29	8	such	such	ADJ
dpc-4511	29	9	as	as	ADP
dpc-4511	29	10	guttate	guttate	ADJ
dpc-4511	29	11	psoriasis	psoriasis	NOUN
dpc-4511	29	12	,	,	PUNCT
dpc-4511	29	13	generalized	generalize	VERB
dpc-4511	29	14	pustular	pustular	ADJ
dpc-4511	29	15	psoriasis	psoriasis	NOUN
dpc-4511	29	16	,	,	PUNCT
dpc-4511	29	17	palmoplantar	palmoplantar	NOUN
dpc-4511	29	18	pustular	pustular	ADJ
dpc-4511	29	19	psoriasis	psoriasis	NOUN
dpc-4511	29	20	,	,	PUNCT
dpc-4511	29	21	palmoplantar	palmoplantar	NOUN
dpc-4511	29	22	psoriasis	psoriasis	NOUN
dpc-4511	29	23	,	,	PUNCT
dpc-4511	29	24	erythrodermic	erythrodermic	ADJ
dpc-4511	29	25	psoriasis	psoriasis	NOUN
dpc-4511	29	26	,	,	PUNCT
dpc-4511	29	27	and	and	CCONJ
dpc-4511	29	28	inverse	inverse	NOUN
dpc-4511	29	29	psoriasis	psoriasis	NOUN
dpc-4511	29	30	.	.	PUNCT
dpc-4511	30	1	diagnosing	diagnose	VERB
dpc-4511	30	2	psoriasis	psoriasis	NOUN
dpc-4511	30	3	relies	rely	VERB
dpc-4511	30	4	on	on	ADP
dpc-4511	30	5	clinical	clinical	ADJ
dpc-4511	30	6	examination	examination	NOUN
dpc-4511	30	7	and	and	CCONJ
dpc-4511	30	8	histopathological	histopathological	ADJ
dpc-4511	30	9	features	feature	NOUN
dpc-4511	30	10	[	[	X
dpc-4511	30	11	1,2	1,2	NUM
dpc-4511	30	12	]	]	PUNCT
dpc-4511	30	13	.	.	PUNCT
dpc-4511	31	1	although	although	SCONJ
dpc-4511	31	2	psoriasis	psoriasis	NOUN
dpc-4511	31	3	can	can	AUX
dpc-4511	31	4	develop	develop	VERB
dpc-4511	31	5	at	at	ADP
dpc-4511	31	6	any	any	DET
dpc-4511	31	7	age	age	NOUN
dpc-4511	31	8	,	,	PUNCT
dpc-4511	31	9	studies	study	NOUN
dpc-4511	31	10	have	have	AUX
dpc-4511	31	11	shown	show	VERB
dpc-4511	31	12	that	that	SCONJ
dpc-4511	31	13	disease	disease	NOUN
dpc-4511	31	14	onset	onset	NOUN
dpc-4511	31	15	has	have	VERB
dpc-4511	31	16	a	a	DET
dpc-4511	31	17	bimodal	bimodal	NOUN
dpc-4511	31	18	distribution	distribution	NOUN
dpc-4511	31	19	in	in	ADP
dpc-4511	31	20	the	the	DET
dpc-4511	31	21	4th	4th	ADJ
dpc-4511	31	22	and	and	CCONJ
dpc-4511	31	23	the	the	DET
dpc-4511	31	24	7th	7th	ADJ
dpc-4511	31	25	decades	decade	NOUN
dpc-4511	31	26	.	.	PUNCT
dpc-4511	32	1	in	in	ADP
dpc-4511	32	2	the	the	DET
dpc-4511	32	3	literature	literature	NOUN
dpc-4511	32	4	,	,	PUNCT
dpc-4511	32	5	the	the	DET
dpc-4511	32	6	disease	disease	NOUN
dpc-4511	32	7	is	be	AUX
dpc-4511	32	8	classified	classify	VERB
dpc-4511	32	9	as	as	ADP
dpc-4511	32	10	early	early	ADJ
dpc-4511	32	11	-	-	PUNCT
dpc-4511	32	12	elderly	elderly	ADJ
dpc-4511	32	13	onset	onset	NOUN
dpc-4511	32	14	(	(	PUNCT
dpc-4511	32	15	eao	eao	PROPN
dpc-4511	32	16	-	-	PUNCT
dpc-4511	32	17	eo	eo	NOUN
dpc-4511	32	18	)	)	PUNCT
dpc-4511	32	19	,	,	PUNCT
dpc-4511	32	20	and	and	CCONJ
dpc-4511	32	21	there	there	PRON
dpc-4511	32	22	may	may	AUX
dpc-4511	32	23	be	be	AUX
dpc-4511	32	24	differences	difference	NOUN
dpc-4511	32	25	between	between	ADP
dpc-4511	32	26	these	these	DET
dpc-4511	32	27	groups	group	NOUN
dpc-4511	32	28	in	in	ADP
dpc-4511	32	29	terms	term	NOUN
dpc-4511	32	30	of	of	ADP
dpc-4511	32	31	clinical	clinical	ADJ
dpc-4511	32	32	features	feature	NOUN
dpc-4511	32	33	,	,	PUNCT
dpc-4511	32	34	disease	disease	NOUN
dpc-4511	32	35	severity	severity	NOUN
dpc-4511	32	36	,	,	PUNCT
dpc-4511	32	37	presence	presence	NOUN
dpc-4511	32	38	of	of	ADP
dpc-4511	32	39	psoriatic	psoriatic	ADJ
dpc-4511	32	40	arthritis	arthritis	NOUN
dpc-4511	32	41	,	,	PUNCT
dpc-4511	32	42	and	and	CCONJ
dpc-4511	32	43	treatment	treatment	NOUN
dpc-4511	32	44	response	response	NOUN
dpc-4511	33	1	[	[	X
dpc-4511	33	2	3	3	NUM
dpc-4511	33	3	]	]	PUNCT
dpc-4511	33	4	.	.	PUNCT
dpc-4511	34	1	psoriasis	psoriasis	NOUN
dpc-4511	34	2	is	be	AUX
dpc-4511	34	3	a	a	DET
dpc-4511	34	4	significant	significant	ADJ
dpc-4511	34	5	and	and	CCONJ
dpc-4511	34	6	common	common	ADJ
dpc-4511	34	7	dermatological	dermatological	ADJ
dpc-4511	34	8	disease	disease	NOUN
dpc-4511	34	9	in	in	ADP
dpc-4511	34	10	the	the	DET
dpc-4511	34	11	geriatric	geriatric	ADJ
dpc-4511	34	12	population	population	NOUN
dpc-4511	34	13	.	.	PUNCT
dpc-4511	35	1	with	with	ADP
dpc-4511	35	2	its	its	PRON
dpc-4511	35	3	increasing	increase	VERB
dpc-4511	35	4	prevalence	prevalence	NOUN
dpc-4511	35	5	,	,	PUNCT
dpc-4511	35	6	dermatologists	dermatologist	NOUN
dpc-4511	35	7	need	need	VERB
dpc-4511	35	8	to	to	PART
dpc-4511	35	9	carefully	carefully	ADV
dpc-4511	35	10	examine	examine	VERB
dpc-4511	35	11	and	and	CCONJ
dpc-4511	35	12	manage	manage	VERB
dpc-4511	35	13	it	it	PRON
dpc-4511	35	14	.	.	PUNCT
dpc-4511	36	1	an	an	DET
dpc-4511	36	2	epidemiological	epidemiological	ADJ
dpc-4511	36	3	study	study	NOUN
dpc-4511	36	4	found	find	VERB
dpc-4511	36	5	that	that	SCONJ
dpc-4511	36	6	psoriasis	psoriasis	NOUN
dpc-4511	36	7	ranked	rank	VERB
dpc-4511	36	8	sixth	sixth	ADJ
dpc-4511	36	9	among	among	ADP
dpc-4511	36	10	the	the	DET
dpc-4511	36	11	most	most	ADV
dpc-4511	36	12	common	common	ADJ
dpc-4511	36	13	dermatological	dermatological	ADJ
dpc-4511	36	14	problems	problem	NOUN
dpc-4511	36	15	in	in	ADP
dpc-4511	36	16	the	the	DET
dpc-4511	36	17	geriatric	geriatric	ADJ
dpc-4511	36	18	population	population	NOUN
dpc-4511	37	1	[	[	X
dpc-4511	37	2	4	4	NUM
dpc-4511	37	3	-	-	SYM
dpc-4511	37	4	6	6	NUM
dpc-4511	37	5	]	]	PUNCT
dpc-4511	37	6	.	.	PUNCT
dpc-4511	38	1	another	another	DET
dpc-4511	38	2	important	important	ADJ
dpc-4511	38	3	aspect	aspect	NOUN
dpc-4511	38	4	in	in	ADP
dpc-4511	38	5	psoriasis	psoriasis	NOUN
dpc-4511	38	6	patients	patient	NOUN
dpc-4511	38	7	is	be	AUX
dpc-4511	38	8	the	the	DET
dpc-4511	38	9	presence	presence	NOUN
dpc-4511	38	10	of	of	ADP
dpc-4511	38	11	comorbidities	comorbiditie	NOUN
dpc-4511	38	12	,	,	PUNCT
dpc-4511	38	13	such	such	ADJ
dpc-4511	38	14	as	as	ADP
dpc-4511	38	15	psoriatic	psoriatic	ADJ
dpc-4511	38	16	arthritis	arthritis	NOUN
dpc-4511	38	17	,	,	PUNCT
dpc-4511	38	18	cardiovascular	cardiovascular	ADJ
dpc-4511	38	19	diseases	disease	NOUN
dpc-4511	38	20	,	,	PUNCT
dpc-4511	38	21	hepatobiliary	hepatobiliary	ADJ
dpc-4511	38	22	diseases	disease	NOUN
dpc-4511	38	23	,	,	PUNCT
dpc-4511	38	24	inflammatory	inflammatory	ADJ
dpc-4511	38	25	bowel	bowel	NOUN
dpc-4511	38	26	diseases	disease	NOUN
dpc-4511	38	27	,	,	PUNCT
dpc-4511	38	28	and	and	CCONJ
dpc-4511	38	29	metabolic	metabolic	NOUN
dpc-4511	38	30	syndrome	syndrome	NOUN
dpc-4511	38	31	.	.	PUNCT
dpc-4511	39	1	evaluating	evaluate	VERB
dpc-4511	39	2	and	and	CCONJ
dpc-4511	39	3	questioning	question	VERB
dpc-4511	39	4	patients	patient	NOUN
dpc-4511	39	5	about	about	ADP
dpc-4511	39	6	these	these	DET
dpc-4511	39	7	comorbidities	comorbiditie	NOUN
dpc-4511	39	8	is	be	AUX
dpc-4511	39	9	essential	essential	ADJ
dpc-4511	39	10	to	to	ADP
dpc-4511	39	11	managing	manage	VERB
dpc-4511	39	12	psoriasis	psoriasis	NOUN
dpc-4511	39	13	.	.	PUNCT
dpc-4511	40	1	the	the	DET
dpc-4511	40	2	association	association	NOUN
dpc-4511	40	3	of	of	ADP
dpc-4511	40	4	psoriasis	psoriasis	NOUN
dpc-4511	40	5	with	with	ADP
dpc-4511	40	6	these	these	DET
dpc-4511	40	7	comorbidities	comorbiditie	NOUN
dpc-4511	40	8	makes	make	VERB
dpc-4511	40	9	it	it	PRON
dpc-4511	40	10	a	a	DET
dpc-4511	40	11	significant	significant	ADJ
dpc-4511	40	12	cause	cause	NOUN
dpc-4511	40	13	of	of	ADP
dpc-4511	40	14	mortality	mortality	NOUN
dpc-4511	40	15	and	and	CCONJ
dpc-4511	40	16	morbidity	morbidity	NOUN
dpc-4511	40	17	,	,	PUNCT
dpc-4511	40	18	especially	especially	ADV
dpc-4511	40	19	in	in	ADP
dpc-4511	40	20	geriatric	geriatric	ADJ
dpc-4511	40	21	cases	case	NOUN
dpc-4511	40	22	.	.	PUNCT
dpc-4511	41	1	additionally	additionally	ADV
dpc-4511	41	2	,	,	PUNCT
dpc-4511	41	3	the	the	DET
dpc-4511	41	4	presence	presence	NOUN
dpc-4511	41	5	of	of	ADP
dpc-4511	41	6	comorbidities	comorbiditie	NOUN
dpc-4511	41	7	plays	play	VERB
dpc-4511	41	8	a	a	DET
dpc-4511	41	9	crucial	crucial	ADJ
dpc-4511	41	10	role	role	NOUN
dpc-4511	41	11	in	in	ADP
dpc-4511	41	12	determining	determine	VERB
dpc-4511	41	13	the	the	DET
dpc-4511	41	14	appropriate	appropriate	ADJ
dpc-4511	41	15	treatment	treatment	NOUN
dpc-4511	41	16	for	for	ADP
dpc-4511	41	17	psoriasis	psoriasis	NOUN
dpc-4511	41	18	patients	patient	NOUN
dpc-4511	41	19	[	[	X
dpc-4511	41	20	7	7	NUM
dpc-4511	41	21	-	-	SYM
dpc-4511	41	22	9	9	NUM
dpc-4511	41	23	]	]	PUNCT
dpc-4511	41	24	.	.	PUNCT
dpc-4511	42	1	the	the	DET
dpc-4511	42	2	treatment	treatment	NOUN
dpc-4511	42	3	of	of	ADP
dpc-4511	42	4	psoriasis	psoriasis	NOUN
dpc-4511	42	5	depends	depend	VERB
dpc-4511	42	6	on	on	ADP
dpc-4511	42	7	the	the	DET
dpc-4511	42	8	severity	severity	NOUN
dpc-4511	42	9	of	of	ADP
dpc-4511	42	10	the	the	DET
dpc-4511	42	11	disease	disease	NOUN
dpc-4511	42	12	,	,	PUNCT
dpc-4511	42	13	the	the	DET
dpc-4511	42	14	patient	patient	NOUN
dpc-4511	42	15	’s	’s	PART
dpc-4511	42	16	comorbidities	comorbiditie	NOUN
dpc-4511	42	17	,	,	PUNCT
dpc-4511	42	18	and	and	CCONJ
dpc-4511	42	19	the	the	DET
dpc-4511	42	20	presence	presence	NOUN
dpc-4511	42	21	of	of	ADP
dpc-4511	42	22	psoriatic	psoriatic	ADJ
dpc-4511	42	23	arthritis	arthritis	NOUN
dpc-4511	42	24	.	.	PUNCT
dpc-4511	43	1	dermatologists	dermatologist	NOUN
dpc-4511	43	2	may	may	AUX
dpc-4511	43	3	prescribe	prescribe	VERB
dpc-4511	43	4	topical	topical	ADJ
dpc-4511	43	5	agents	agent	NOUN
dpc-4511	43	6	,	,	PUNCT
dpc-4511	43	7	phototherapy	phototherapy	NOUN
dpc-4511	43	8	,	,	PUNCT
dpc-4511	43	9	conventional	conventional	ADJ
dpc-4511	43	10	agents	agent	NOUN
dpc-4511	43	11	(	(	PUNCT
dpc-4511	43	12	such	such	ADJ
dpc-4511	43	13	as	as	ADP
dpc-4511	43	14	methotrexate	methotrexate	NOUN
dpc-4511	43	15	,	,	PUNCT
dpc-4511	43	16	acitretin	acitretin	NOUN
dpc-4511	43	17	,	,	PUNCT
dpc-4511	43	18	and	and	CCONJ
dpc-4511	43	19	cyclosporine	cyclosporine	NOUN
dpc-4511	43	20	)	)	PUNCT
dpc-4511	43	21	,	,	PUNCT
dpc-4511	43	22	and	and	CCONJ
dpc-4511	43	23	biologic	biologic	ADJ
dpc-4511	43	24	agents	agent	NOUN
dpc-4511	43	25	,	,	PUNCT
dpc-4511	43	26	including	include	VERB
dpc-4511	43	27	tumor	tumor	NOUN
dpc-4511	43	28	necrosis	necrosis	NOUN
dpc-4511	43	29	factor	factor	NOUN
dpc-4511	43	30	-	-	PUNCT
dpc-4511	43	31	α	α	X
dpc-4511	43	32	(	(	PUNCT
dpc-4511	43	33	tnf	tnf	PROPN
dpc-4511	43	34	-	-	PUNCT
dpc-4511	43	35	α	α	NOUN
dpc-4511	43	36	)	)	PUNCT
dpc-4511	43	37	inhibitors	inhibitor	NOUN
dpc-4511	43	38	,	,	PUNCT
dpc-4511	43	39	il-12	il-12	NOUN
dpc-4511	43	40	/	/	SYM
dpc-4511	43	41	il-23	il-23	NOUN
dpc-4511	43	42	inhibitors	inhibitor	NOUN
dpc-4511	43	43	,	,	PUNCT
dpc-4511	43	44	il-17	il-17	ADV
dpc-4511	43	45	inhibitors	inhibitor	NOUN
dpc-4511	43	46	,	,	PUNCT
dpc-4511	43	47	and	and	CCONJ
dpc-4511	43	48	il-23	il-23	ADJ
dpc-4511	43	49	inhibitors	inhibitor	NOUN
dpc-4511	43	50	,	,	PUNCT
dpc-4511	43	51	based	base	VERB
dpc-4511	43	52	on	on	ADP
dpc-4511	43	53	these	these	DET
dpc-4511	43	54	factors.10	factors.10	NOUN
dpc-4511	43	55	managing	manage	VERB
dpc-4511	43	56	the	the	DET
dpc-4511	43	57	disease	disease	NOUN
dpc-4511	43	58	and	and	CCONJ
dpc-4511	43	59	selecting	select	VERB
dpc-4511	43	60	the	the	DET
dpc-4511	43	61	best	good	ADJ
dpc-4511	43	62	treatment	treatment	NOUN
dpc-4511	43	63	for	for	ADP
dpc-4511	43	64	older	old	ADJ
dpc-4511	43	65	individuals	individual	NOUN
dpc-4511	43	66	with	with	ADP
dpc-4511	43	67	psoriasis	psoriasis	NOUN
dpc-4511	43	68	can	can	AUX
dpc-4511	43	69	be	be	AUX
dpc-4511	43	70	challenging	challenge	VERB
dpc-4511	43	71	due	due	ADJ
dpc-4511	43	72	to	to	ADP
dpc-4511	43	73	systemic	systemic	ADJ
dpc-4511	43	74	comorbidities	comorbiditie	NOUN
dpc-4511	43	75	,	,	PUNCT
dpc-4511	43	76	polypharmacy	polypharmacy	NOUN
dpc-4511	43	77	,	,	PUNCT
dpc-4511	43	78	drug	drug	NOUN
dpc-4511	43	79	interactions	interaction	NOUN
dpc-4511	43	80	,	,	PUNCT
dpc-4511	43	81	adverse	adverse	ADJ
dpc-4511	43	82	drug	drug	NOUN
dpc-4511	43	83	reactions	reaction	NOUN
dpc-4511	43	84	,	,	PUNCT
dpc-4511	43	85	and	and	CCONJ
dpc-4511	43	86	an	an	DET
dpc-4511	43	87	increased	increase	VERB
dpc-4511	43	88	risk	risk	NOUN
dpc-4511	43	89	of	of	ADP
dpc-4511	43	90	hepatotoxicity	hepatotoxicity	NOUN
dpc-4511	43	91	[	[	X
dpc-4511	43	92	4,5,11	4,5,11	NUM
dpc-4511	43	93	-	-	SYM
dpc-4511	43	94	13	13	NUM
dpc-4511	43	95	]	]	PUNCT
dpc-4511	43	96	.	.	PUNCT
dpc-4511	44	1	objective	objective	NOUN
dpc-4511	44	2	the	the	DET
dpc-4511	44	3	aim	aim	NOUN
dpc-4511	44	4	of	of	ADP
dpc-4511	44	5	this	this	DET
dpc-4511	44	6	investigation	investigation	NOUN
dpc-4511	44	7	was	be	AUX
dpc-4511	44	8	to	to	PART
dpc-4511	44	9	evaluate	evaluate	VERB
dpc-4511	44	10	the	the	DET
dpc-4511	44	11	demographic	demographic	ADJ
dpc-4511	44	12	data	datum	NOUN
dpc-4511	44	13	,	,	PUNCT
dpc-4511	44	14	clinical	clinical	ADJ
dpc-4511	44	15	characteristics	characteristic	NOUN
dpc-4511	44	16	,	,	PUNCT
dpc-4511	44	17	and	and	CCONJ
dpc-4511	44	18	treatment	treatment	NOUN
dpc-4511	44	19	responses	response	NOUN
dpc-4511	44	20	of	of	ADP
dpc-4511	44	21	the	the	DET
dpc-4511	44	22	geriatric	geriatric	ADJ
dpc-4511	44	23	population	population	NOUN
dpc-4511	44	24	(	(	PUNCT
dpc-4511	44	25	age	age	NOUN
dpc-4511	44	26	≥65	≥65	NOUN
dpc-4511	44	27	)	)	PUNCT
dpc-4511	44	28	with	with	ADP
dpc-4511	44	29	psoriasis	psoriasis	NOUN
dpc-4511	44	30	at	at	ADP
dpc-4511	44	31	our	our	PRON
dpc-4511	44	32	hospital	hospital	NOUN
dpc-4511	44	33	,	,	PUNCT
dpc-4511	44	34	is	be	AUX
dpc-4511	44	35	a	a	DET
dpc-4511	44	36	tertiary	tertiary	ADJ
dpc-4511	44	37	care	care	NOUN
dpc-4511	44	38	center	center	NOUN
dpc-4511	44	39	.	.	PUNCT
dpc-4511	45	1	methods	method	NOUN
dpc-4511	45	2	study	study	NOUN
dpc-4511	45	3	design	design	NOUN
dpc-4511	45	4	this	this	DET
dpc-4511	45	5	study	study	NOUN
dpc-4511	45	6	was	be	AUX
dpc-4511	45	7	planned	plan	VERB
dpc-4511	45	8	as	as	ADP
dpc-4511	45	9	a	a	DET
dpc-4511	45	10	single	single	ADJ
dpc-4511	45	11	-	-	PUNCT
dpc-4511	45	12	center	center	NOUN
dpc-4511	45	13	retrospective	retrospective	ADJ
dpc-4511	45	14	observational	observational	ADJ
dpc-4511	45	15	cross	cross	ADJ
dpc-4511	45	16	-	-	ADJ
dpc-4511	45	17	sectional	sectional	ADJ
dpc-4511	45	18	study	study	NOUN
dpc-4511	45	19	.	.	PUNCT
dpc-4511	46	1	between	between	ADP
dpc-4511	46	2	2016	2016	NUM
dpc-4511	46	3	and	and	CCONJ
dpc-4511	46	4	2022	2022	NUM
dpc-4511	46	5	,	,	PUNCT
dpc-4511	46	6	we	we	PRON
dpc-4511	46	7	evaluated	evaluate	VERB
dpc-4511	46	8	geriatric	geriatric	ADJ
dpc-4511	46	9	cases	case	NOUN
dpc-4511	46	10	over	over	ADP
dpc-4511	46	11	65	65	NUM
dpc-4511	46	12	years	year	NOUN
dpc-4511	46	13	of	of	ADP
dpc-4511	46	14	age	age	NOUN
dpc-4511	46	15	with	with	ADP
dpc-4511	46	16	a	a	DET
dpc-4511	46	17	psoriasis	psoriasis	NOUN
dpc-4511	46	18	diagnosis	diagnosis	NOUN
dpc-4511	46	19	at	at	ADP
dpc-4511	46	20	gazi	gazi	PROPN
dpc-4511	46	21	university	university	PROPN
dpc-4511	46	22	faculty	faculty	NOUN
dpc-4511	46	23	of	of	ADP
dpc-4511	46	24	medicine	medicine	NOUN
dpc-4511	46	25	,	,	PUNCT
dpc-4511	46	26	department	department	NOUN
dpc-4511	46	27	of	of	ADP
dpc-4511	46	28	dermatology	dermatology	NOUN
dpc-4511	46	29	,	,	PUNCT
dpc-4511	46	30	ankara	ankara	PROPN
dpc-4511	46	31	,	,	PUNCT
dpc-4511	46	32	turkey	turkey	PROPN
dpc-4511	46	33	.	.	PUNCT
dpc-4511	47	1	the	the	DET
dpc-4511	47	2	psoriasis	psoriasis	NOUN
dpc-4511	47	3	diagnosis	diagnosis	NOUN
dpc-4511	47	4	was	be	AUX
dpc-4511	47	5	based	base	VERB
dpc-4511	47	6	on	on	ADP
dpc-4511	47	7	clinical	clinical	ADJ
dpc-4511	47	8	examination	examination	NOUN
dpc-4511	47	9	and	and	CCONJ
dpc-4511	47	10	histopathological	histopathological	ADJ
dpc-4511	47	11	findings	finding	NOUN
dpc-4511	47	12	.	.	PUNCT
dpc-4511	48	1	the	the	DET
dpc-4511	48	2	study	study	NOUN
dpc-4511	48	3	was	be	AUX
dpc-4511	48	4	approved	approve	VERB
dpc-4511	48	5	by	by	ADP
dpc-4511	48	6	the	the	DET
dpc-4511	48	7	gazi	gazi	PROPN
dpc-4511	48	8	university	university	PROPN
dpc-4511	48	9	faculty	faculty	NOUN
dpc-4511	48	10	of	of	ADP
dpc-4511	48	11	medicine	medicine	NOUN
dpc-4511	48	12	local	local	ADJ
dpc-4511	48	13	ethics	ethic	NOUN
dpc-4511	48	14	committee	committee	NOUN
dpc-4511	48	15	.	.	PUNCT
dpc-4511	49	1	we	we	PRON
dpc-4511	49	2	followed	follow	VERB
dpc-4511	49	3	the	the	DET
dpc-4511	49	4	helsinki	helsinki	PROPN
dpc-4511	49	5	declaration	declaration	PROPN
dpc-4511	49	6	and	and	CCONJ
dpc-4511	49	7	guidelines	guideline	NOUN
dpc-4511	49	8	for	for	ADP
dpc-4511	49	9	good	good	ADJ
dpc-4511	49	10	clinical	clinical	ADJ
dpc-4511	49	11	practice	practice	NOUN
dpc-4511	49	12	in	in	ADP
dpc-4511	49	13	its	its	PRON
dpc-4511	49	14	most	most	ADV
dpc-4511	49	15	recent	recent	ADJ
dpc-4511	49	16	revisions	revision	NOUN
dpc-4511	49	17	.	.	PUNCT
dpc-4511	50	1	we	we	PRON
dpc-4511	50	2	obtained	obtain	VERB
dpc-4511	50	3	fully	fully	ADV
dpc-4511	50	4	informed	informed	ADJ
dpc-4511	50	5	consent	consent	NOUN
dpc-4511	50	6	from	from	ADP
dpc-4511	50	7	the	the	DET
dpc-4511	50	8	patients	patient	NOUN
dpc-4511	50	9	.	.	PUNCT
dpc-4511	51	1	we	we	PRON
dpc-4511	51	2	retrospectively	retrospectively	ADV
dpc-4511	51	3	reviewed	review	VERB
dpc-4511	51	4	the	the	DET
dpc-4511	51	5	patients	patient	NOUN
dpc-4511	51	6	’	'	PUNCT
dpc-4511	51	7	demographic	demographic	ADJ
dpc-4511	51	8	features	feature	NOUN
dpc-4511	51	9	(	(	PUNCT
dpc-4511	51	10	age	age	NOUN
dpc-4511	51	11	,	,	PUNCT
dpc-4511	51	12	sex	sex	NOUN
dpc-4511	51	13	,	,	PUNCT
dpc-4511	51	14	height	height	NOUN
dpc-4511	51	15	,	,	PUNCT
dpc-4511	51	16	weight	weight	NOUN
dpc-4511	51	17	,	,	PUNCT
dpc-4511	51	18	body	body	NOUN
dpc-4511	51	19	mass	mass	PROPN
dpc-4511	51	20	index	index	NOUN
dpc-4511	51	21	,	,	PUNCT
dpc-4511	51	22	family	family	NOUN
dpc-4511	51	23	history	history	NOUN
dpc-4511	51	24	)	)	PUNCT
dpc-4511	51	25	,	,	PUNCT
dpc-4511	51	26	clinical	clinical	ADJ
dpc-4511	51	27	characteristics	characteristic	NOUN
dpc-4511	51	28	(	(	PUNCT
dpc-4511	51	29	age	age	NOUN
dpc-4511	51	30	at	at	ADP
dpc-4511	51	31	diagnosis	diagnosis	NOUN
dpc-4511	51	32	,	,	PUNCT
dpc-4511	51	33	duration	duration	NOUN
dpc-4511	51	34	of	of	ADP
dpc-4511	51	35	disease	disease	NOUN
dpc-4511	51	36	,	,	PUNCT
dpc-4511	51	37	psoriasis	psoriasis	NOUN
dpc-4511	51	38	type	type	NOUN
dpc-4511	51	39	,	,	PUNCT
dpc-4511	51	40	accompanying	accompany	VERB
dpc-4511	51	41	symptoms	symptom	NOUN
dpc-4511	51	42	,	,	PUNCT
dpc-4511	51	43	distribution	distribution	NOUN
dpc-4511	51	44	of	of	ADP
dpc-4511	51	45	skin	skin	NOUN
dpc-4511	51	46	lesions	lesion	NOUN
dpc-4511	51	47	,	,	PUNCT
dpc-4511	51	48	disease	disease	NOUN
dpc-4511	51	49	severity	severity	NOUN
dpc-4511	51	50	,	,	PUNCT
dpc-4511	51	51	nail	nail	NOUN
dpc-4511	51	52	involvement	involvement	NOUN
dpc-4511	51	53	,	,	PUNCT
dpc-4511	51	54	psoriatic	psoriatic	ADJ
dpc-4511	51	55	arthritis	arthritis	NOUN
dpc-4511	51	56	,	,	PUNCT
dpc-4511	51	57	triggering	trigger	VERB
dpc-4511	51	58	factors	factor	NOUN
dpc-4511	51	59	,	,	PUNCT
dpc-4511	51	60	systemic	systemic	ADJ
dpc-4511	51	61	comorbidities	comorbiditie	NOUN
dpc-4511	51	62	)	)	PUNCT
dpc-4511	51	63	,	,	PUNCT
dpc-4511	51	64	and	and	CCONJ
dpc-4511	51	65	treatment	treatment	NOUN
dpc-4511	51	66	modalities	modality	NOUN
dpc-4511	51	67	(	(	PUNCT
dpc-4511	51	68	treatment	treatment	NOUN
dpc-4511	51	69	agents	agent	NOUN
dpc-4511	51	70	used	use	VERB
dpc-4511	51	71	,	,	PUNCT
dpc-4511	51	72	first	first	ADJ
dpc-4511	51	73	treatment	treatment	NOUN
dpc-4511	51	74	given	give	VERB
dpc-4511	51	75	,	,	PUNCT
dpc-4511	51	76	duration	duration	NOUN
dpc-4511	51	77	of	of	ADP
dpc-4511	51	78	treatment	treatment	NOUN
dpc-4511	51	79	,	,	PUNCT
dpc-4511	51	80	response	response	NOUN
dpc-4511	51	81	,	,	PUNCT
dpc-4511	51	82	side	side	NOUN
dpc-4511	51	83	effects	effect	NOUN
dpc-4511	51	84	observed	observe	VERB
dpc-4511	51	85	during	during	ADP
dpc-4511	51	86	treatment	treatment	NOUN
dpc-4511	51	87	,	,	PUNCT
dpc-4511	51	88	reason	reason	NOUN
dpc-4511	51	89	for	for	ADP
dpc-4511	51	90	discontinuation	discontinuation	NOUN
dpc-4511	51	91	)	)	PUNCT
dpc-4511	51	92	.	.	PUNCT
dpc-4511	52	1	we	we	PRON
dpc-4511	52	2	obtained	obtain	VERB
dpc-4511	52	3	the	the	DET
dpc-4511	52	4	patients	patient	NOUN
dpc-4511	52	5	’	’	PART
dpc-4511	52	6	data	datum	NOUN
dpc-4511	52	7	from	from	ADP
dpc-4511	52	8	our	our	PRON
dpc-4511	52	9	hospital	hospital	NOUN
dpc-4511	52	10	’s	’s	PART
dpc-4511	52	11	electronic	electronic	ADJ
dpc-4511	52	12	database	database	NOUN
dpc-4511	52	13	.	.	PUNCT
dpc-4511	53	1	the	the	DET
dpc-4511	53	2	patients	patient	NOUN
dpc-4511	53	3	were	be	AUX
dpc-4511	53	4	analyzed	analyze	VERB
dpc-4511	53	5	in	in	ADP
dpc-4511	53	6	four	four	NUM
dpc-4511	53	7	groups	group	NOUN
dpc-4511	53	8	based	base	VERB
dpc-4511	53	9	on	on	ADP
dpc-4511	53	10	the	the	DET
dpc-4511	53	11	course	course	NOUN
dpc-4511	53	12	of	of	ADP
dpc-4511	53	13	their	their	PRON
dpc-4511	53	14	disease	disease	NOUN
dpc-4511	53	15	:	:	PUNCT
dpc-4511	53	16	mild	mild	ADJ
dpc-4511	53	17	initial	initial	ADJ
dpc-4511	53	18	severity	severity	NOUN
dpc-4511	53	19	(	(	PUNCT
dpc-4511	53	20	psoriasis	psoriasis	NOUN
dpc-4511	53	21	area	area	NOUN
dpc-4511	53	22	severity	severity	NOUN
dpc-4511	53	23	index	index	NOUN
dpc-4511	53	24	(	(	PUNCT
dpc-4511	53	25	pasi	pasi	NOUN
dpc-4511	53	26	)	)	PUNCT
dpc-4511	53	27	≤10	≤10	PROPN
dpc-4511	53	28	)	)	PUNCT
dpc-4511	53	29	,	,	PUNCT
dpc-4511	53	30	moderate	moderate	ADJ
dpc-4511	53	31	-	-	PUNCT
dpc-4511	53	32	severe	severe	ADJ
dpc-4511	53	33	initial	initial	ADJ
dpc-4511	53	34	severity	severity	NOUN
dpc-4511	53	35	(	(	PUNCT
dpc-4511	53	36	pasi	pasi	NOUN
dpc-4511	53	37	>	>	X
dpc-4511	53	38	10	10	NUM
dpc-4511	53	39	)	)	PUNCT
dpc-4511	53	40	,	,	PUNCT
dpc-4511	53	41	slow	slow	ADJ
dpc-4511	53	42	disease	disease	NOUN
dpc-4511	53	43	course	course	NOUN
dpc-4511	53	44	(	(	PUNCT
dpc-4511	53	45	<	<	X
dpc-4511	53	46	10	10	NUM
dpc-4511	53	47	%	%	NOUN
dpc-4511	53	48	change	change	NOUN
dpc-4511	53	49	in	in	ADP
dpc-4511	53	50	body	body	NOUN
dpc-4511	53	51	surface	surface	NOUN
dpc-4511	53	52	area	area	NOUN
dpc-4511	53	53	(	(	PUNCT
dpc-4511	53	54	bsa	bsa	PROPN
dpc-4511	53	55	)	)	PUNCT
dpc-4511	53	56	from	from	ADP
dpc-4511	53	57	baseline	baseline	NOUN
dpc-4511	53	58	in	in	ADP
dpc-4511	53	59	the	the	DET
dpc-4511	53	60	first	first	ADJ
dpc-4511	53	61	year	year	NOUN
dpc-4511	53	62	)	)	PUNCT
dpc-4511	53	63	,	,	PUNCT
dpc-4511	53	64	and	and	CCONJ
dpc-4511	53	65	rapid	rapid	ADJ
dpc-4511	53	66	disease	disease	NOUN
dpc-4511	53	67	course	course	NOUN
dpc-4511	53	68	(	(	PUNCT
dpc-4511	53	69	erythroderma	erythroderma	PROPN
dpc-4511	53	70	)	)	PUNCT
dpc-4511	53	71	.	.	PUNCT
dpc-4511	54	1	we	we	PRON
dpc-4511	54	2	evaluated	evaluate	VERB
dpc-4511	54	3	the	the	DET
dpc-4511	54	4	patients	patient	NOUN
dpc-4511	54	5	in	in	ADP
dpc-4511	54	6	two	two	NUM
dpc-4511	54	7	groups	group	NOUN
dpc-4511	54	8	based	base	VERB
dpc-4511	54	9	on	on	ADP
dpc-4511	54	10	the	the	DET
dpc-4511	54	11	age	age	NOUN
dpc-4511	54	12	of	of	ADP
dpc-4511	54	13	disease	disease	NOUN
dpc-4511	54	14	onset	onset	VERB
dpc-4511	54	15	:	:	PUNCT
dpc-4511	54	16	early	early	ADV
dpc-4511	54	17	(	(	PUNCT
dpc-4511	54	18	<	<	X
dpc-4511	54	19	60	60	NUM
dpc-4511	54	20	years	year	NOUN
dpc-4511	54	21	)	)	PUNCT
dpc-4511	54	22	and	and	CCONJ
dpc-4511	54	23	elderly	elderly	ADJ
dpc-4511	54	24	(	(	PUNCT
dpc-4511	54	25	≥	≥	NOUN
dpc-4511	54	26	60	60	NUM
dpc-4511	54	27	years	year	NOUN
dpc-4511	54	28	)	)	PUNCT
dpc-4511	54	29	.	.	PUNCT
dpc-4511	55	1	we	we	PRON
dpc-4511	55	2	examined	examine	VERB
dpc-4511	55	3	whether	whether	SCONJ
dpc-4511	55	4	there	there	PRON
dpc-4511	55	5	were	be	VERB
dpc-4511	55	6	differences	difference	NOUN
dpc-4511	55	7	between	between	ADP
dpc-4511	55	8	these	these	DET
dpc-4511	55	9	two	two	NUM
dpc-4511	55	10	groups	group	NOUN
dpc-4511	55	11	in	in	ADP
dpc-4511	55	12	terms	term	NOUN
dpc-4511	55	13	of	of	ADP
dpc-4511	55	14	clinical	clinical	ADJ
dpc-4511	55	15	features	feature	NOUN
dpc-4511	55	16	,	,	PUNCT
dpc-4511	55	17	disease	disease	NOUN
dpc-4511	55	18	severity	severity	NOUN
dpc-4511	55	19	,	,	PUNCT
dpc-4511	55	20	and	and	CCONJ
dpc-4511	55	21	treatment	treatment	NOUN
dpc-4511	55	22	modalities	modality	NOUN
dpc-4511	55	23	.	.	PUNCT
dpc-4511	56	1	statistical	statistical	ADJ
dpc-4511	56	2	analysis	analysis	NOUN
dpc-4511	56	3	the	the	DET
dpc-4511	56	4	research	research	NOUN
dpc-4511	56	5	data	datum	NOUN
dpc-4511	56	6	were	be	AUX
dpc-4511	56	7	analyzed	analyze	VERB
dpc-4511	56	8	using	use	VERB
dpc-4511	56	9	the	the	DET
dpc-4511	56	10	spss	spss	PROPN
dpc-4511	56	11	22.0	22.0	NUM
dpc-4511	56	12	statistics	statistic	NOUN
dpc-4511	56	13	package	package	NOUN
dpc-4511	56	14	program	program	NOUN
dpc-4511	56	15	.	.	PUNCT
dpc-4511	57	1	descriptive	descriptive	ADJ
dpc-4511	57	2	statistics	statistic	NOUN
dpc-4511	57	3	are	be	AUX
dpc-4511	57	4	presented	present	VERB
dpc-4511	57	5	as	as	ADP
dpc-4511	57	6	mean	mean	NOUN
dpc-4511	57	7	(	(	PUNCT
dpc-4511	57	8	±	±	NOUN
dpc-4511	57	9	standard	standard	ADJ
dpc-4511	57	10	deviation	deviation	NOUN
dpc-4511	57	11	)	)	PUNCT
dpc-4511	57	12	,	,	PUNCT
dpc-4511	57	13	median	median	NOUN
dpc-4511	57	14	(	(	PUNCT
dpc-4511	57	15	min	min	PROPN
dpc-4511	57	16	,	,	PUNCT
dpc-4511	57	17	max	max	PROPN
dpc-4511	57	18	)	)	PUNCT
dpc-4511	57	19	,	,	PUNCT
dpc-4511	57	20	frequency	frequency	NOUN
dpc-4511	57	21	distribution	distribution	NOUN
dpc-4511	57	22	,	,	PUNCT
dpc-4511	57	23	and	and	CCONJ
dpc-4511	57	24	percentage	percentage	NOUN
dpc-4511	57	25	.	.	PUNCT
dpc-4511	58	1	for	for	ADP
dpc-4511	58	2	categorical	categorical	ADJ
dpc-4511	58	3	variables	variable	NOUN
dpc-4511	58	4	,	,	PUNCT
dpc-4511	58	5	we	we	PRON
dpc-4511	58	6	compared	compare	VERB
dpc-4511	58	7	the	the	DET
dpc-4511	58	8	frequency	frequency	NOUN
dpc-4511	58	9	differences	difference	NOUN
dpc-4511	58	10	between	between	ADP
dpc-4511	58	11	groups	group	NOUN
dpc-4511	58	12	using	use	VERB
dpc-4511	58	13	the	the	DET
dpc-4511	58	14	pearson	pearson	NOUN
dpc-4511	58	15	’s	’s	PART
dpc-4511	58	16	chi	chi	ADJ
dpc-4511	58	17	-	-	PUNCT
dpc-4511	58	18	squared	square	VERB
dpc-4511	58	19	test	test	NOUN
dpc-4511	58	20	.	.	PUNCT
dpc-4511	59	1	the	the	DET
dpc-4511	59	2	statistical	statistical	ADJ
dpc-4511	59	3	significance	significance	NOUN
dpc-4511	59	4	value	value	NOUN
dpc-4511	59	5	for	for	ADP
dpc-4511	59	6	this	this	DET
dpc-4511	59	7	study	study	NOUN
dpc-4511	59	8	was	be	AUX
dpc-4511	59	9	accepted	accept	VERB
dpc-4511	59	10	as	as	ADP
dpc-4511	59	11	p	p	NOUN
dpc-4511	59	12	≤0.05	≤0.05	NOUN
dpc-4511	59	13	.	.	PUNCT
dpc-4511	60	1	results	result	VERB
dpc-4511	60	2	a	a	DET
dpc-4511	60	3	total	total	NOUN
dpc-4511	60	4	of	of	ADP
dpc-4511	60	5	160	160	NUM
dpc-4511	60	6	geriatric	geriatric	ADJ
dpc-4511	60	7	patients	patient	NOUN
dpc-4511	60	8	with	with	ADP
dpc-4511	60	9	a	a	DET
dpc-4511	60	10	diagnosis	diagnosis	NOUN
dpc-4511	60	11	of	of	ADP
dpc-4511	60	12	psoriasis	psoriasis	NOUN
dpc-4511	60	13	were	be	AUX
dpc-4511	60	14	included	include	VERB
dpc-4511	60	15	in	in	ADP
dpc-4511	60	16	the	the	DET
dpc-4511	60	17	study	study	NOUN
dpc-4511	60	18	,	,	PUNCT
dpc-4511	60	19	of	of	ADP
dpc-4511	60	20	whom	whom	PRON
dpc-4511	60	21	53.8	53.8	NUM
dpc-4511	60	22	%	%	NOUN
dpc-4511	60	23	of	of	ADP
dpc-4511	60	24	the	the	DET
dpc-4511	60	25	original	original	ADJ
dpc-4511	60	26	article	article	NOUN
dpc-4511	60	27	|	|	ADV
dpc-4511	60	28	dermatol	dermatol	ADJ
dpc-4511	60	29	pract	pract	NOUN
dpc-4511	60	30	concept	concept	NOUN
dpc-4511	60	31	.	.	PUNCT
dpc-4511	61	1	2025;15(1):4511	2025;15(1):4511	NUM
dpc-4511	61	2	3	3	NUM
dpc-4511	61	3	patients	patient	NOUN
dpc-4511	61	4	were	be	AUX
dpc-4511	61	5	male	male	ADJ
dpc-4511	61	6	,	,	PUNCT
dpc-4511	61	7	and	and	CCONJ
dpc-4511	61	8	46.3	46.3	NUM
dpc-4511	61	9	%	%	NOUN
dpc-4511	61	10	were	be	AUX
dpc-4511	61	11	female	female	ADJ
dpc-4511	61	12	.	.	PUNCT
dpc-4511	62	1	the	the	DET
dpc-4511	62	2	average	average	ADJ
dpc-4511	62	3	age	age	NOUN
dpc-4511	62	4	at	at	ADP
dpc-4511	62	5	the	the	DET
dpc-4511	62	6	time	time	NOUN
dpc-4511	62	7	of	of	ADP
dpc-4511	62	8	enrollment	enrollment	NOUN
dpc-4511	62	9	was	be	AUX
dpc-4511	62	10	68.7	68.7	NUM
dpc-4511	62	11	years	year	NOUN
dpc-4511	62	12	(	(	PUNCT
dpc-4511	62	13	ranging	range	VERB
dpc-4511	62	14	from	from	ADP
dpc-4511	62	15	65	65	NUM
dpc-4511	62	16	to	to	PART
dpc-4511	62	17	83	83	NUM
dpc-4511	62	18	years	year	NOUN
dpc-4511	62	19	)	)	PUNCT
dpc-4511	62	20	.	.	PUNCT
dpc-4511	63	1	the	the	DET
dpc-4511	63	2	average	average	ADJ
dpc-4511	63	3	age	age	NOUN
dpc-4511	63	4	at	at	ADP
dpc-4511	63	5	onset	onset	NOUN
dpc-4511	63	6	of	of	ADP
dpc-4511	63	7	psoriasis	psoriasis	NOUN
dpc-4511	63	8	was	be	AUX
dpc-4511	63	9	50.6	50.6	NUM
dpc-4511	63	10	years	year	NOUN
dpc-4511	63	11	,	,	PUNCT
dpc-4511	63	12	with	with	ADP
dpc-4511	63	13	a	a	DET
dpc-4511	63	14	median	median	ADJ
dpc-4511	63	15	disease	disease	NOUN
dpc-4511	63	16	duration	duration	NOUN
dpc-4511	63	17	of	of	ADP
dpc-4511	63	18	17.8	17.8	NUM
dpc-4511	63	19	years	year	NOUN
dpc-4511	63	20	(	(	PUNCT
dpc-4511	63	21	ranging	range	VERB
dpc-4511	63	22	from	from	ADP
dpc-4511	63	23	6	6	NUM
dpc-4511	63	24	months	month	NOUN
dpc-4511	63	25	to	to	ADP
dpc-4511	63	26	53	53	NUM
dpc-4511	63	27	years	year	NOUN
dpc-4511	63	28	)	)	PUNCT
dpc-4511	63	29	.	.	PUNCT
dpc-4511	64	1	based	base	VERB
dpc-4511	64	2	on	on	ADP
dpc-4511	64	3	the	the	DET
dpc-4511	64	4	age	age	NOUN
dpc-4511	64	5	of	of	ADP
dpc-4511	64	6	disease	disease	NOUN
dpc-4511	64	7	onset	onset	VERB
dpc-4511	64	8	65	65	NUM
dpc-4511	64	9	%	%	NOUN
dpc-4511	64	10	of	of	ADP
dpc-4511	64	11	the	the	DET
dpc-4511	64	12	patients	patient	NOUN
dpc-4511	64	13	accepted	accept	VERB
dpc-4511	64	14	it	it	PRON
dpc-4511	64	15	as	as	ADP
dpc-4511	64	16	eao	eao	ADJ
dpc-4511	64	17	.	.	PUNCT
dpc-4511	65	1	the	the	DET
dpc-4511	65	2	mean	mean	ADJ
dpc-4511	65	3	body	body	NOUN
dpc-4511	65	4	mass	mass	NOUN
dpc-4511	65	5	index	index	NOUN
dpc-4511	65	6	(	(	PUNCT
dpc-4511	65	7	bmi	bmi	NOUN
dpc-4511	65	8	)	)	PUNCT
dpc-4511	65	9	level	level	NOUN
dpc-4511	65	10	of	of	ADP
dpc-4511	65	11	the	the	DET
dpc-4511	65	12	patients	patient	NOUN
dpc-4511	65	13	was	be	AUX
dpc-4511	65	14	28.3	28.3	NUM
dpc-4511	65	15	(	(	PUNCT
dpc-4511	65	16	17.8–48.3	17.8–48.3	NUM
dpc-4511	65	17	)	)	PUNCT
dpc-4511	65	18	.	.	PUNCT
dpc-4511	66	1	furthermore	furthermore	ADV
dpc-4511	66	2	,	,	PUNCT
dpc-4511	66	3	30	30	NUM
dpc-4511	66	4	%	%	NOUN
dpc-4511	66	5	of	of	ADP
dpc-4511	66	6	the	the	DET
dpc-4511	66	7	patient	patient	ADJ
dpc-4511	66	8	cohort	cohort	NOUN
dpc-4511	66	9	had	have	VERB
dpc-4511	66	10	a	a	DET
dpc-4511	66	11	positive	positive	ADJ
dpc-4511	66	12	family	family	NOUN
dpc-4511	66	13	history	history	NOUN
dpc-4511	66	14	of	of	ADP
dpc-4511	66	15	psoriasis	psoriasis	NOUN
dpc-4511	66	16	,	,	PUNCT
dpc-4511	66	17	70.6	70.6	NUM
dpc-4511	66	18	%	%	NOUN
dpc-4511	66	19	of	of	ADP
dpc-4511	66	20	patients	patient	NOUN
dpc-4511	66	21	had	have	VERB
dpc-4511	66	22	a	a	DET
dpc-4511	66	23	smoking	smoking	NOUN
dpc-4511	66	24	history	history	NOUN
dpc-4511	66	25	,	,	PUNCT
dpc-4511	66	26	and	and	CCONJ
dpc-4511	66	27	11.7	11.7	NUM
dpc-4511	66	28	%	%	NOUN
dpc-4511	66	29	had	have	VERB
dpc-4511	66	30	a	a	DET
dpc-4511	66	31	history	history	NOUN
dpc-4511	66	32	of	of	ADP
dpc-4511	66	33	alcohol	alcohol	NOUN
dpc-4511	66	34	consumption	consumption	NOUN
dpc-4511	66	35	.	.	PUNCT
dpc-4511	67	1	the	the	DET
dpc-4511	67	2	most	most	ADV
dpc-4511	67	3	common	common	ADJ
dpc-4511	67	4	subjective	subjective	ADJ
dpc-4511	67	5	symptom	symptom	NOUN
dpc-4511	67	6	reported	report	VERB
dpc-4511	67	7	by	by	ADP
dpc-4511	67	8	patients	patient	NOUN
dpc-4511	67	9	was	be	AUX
dpc-4511	67	10	itching	itch	VERB
dpc-4511	67	11	,	,	PUNCT
dpc-4511	67	12	with	with	ADP
dpc-4511	67	13	77.5	77.5	NUM
dpc-4511	67	14	%	%	NOUN
dpc-4511	67	15	experiencing	experience	VERB
dpc-4511	67	16	pruritus	pruritus	NOUN
dpc-4511	67	17	.	.	PUNCT
dpc-4511	68	1	psoriasis	psoriasis	NOUN
dpc-4511	68	2	vulgaris	vulgaris	NOUN
dpc-4511	68	3	was	be	AUX
dpc-4511	68	4	the	the	DET
dpc-4511	68	5	most	most	ADV
dpc-4511	68	6	common	common	ADJ
dpc-4511	68	7	type	type	NOUN
dpc-4511	68	8	of	of	ADP
dpc-4511	68	9	psoriasis	psoriasis	NOUN
dpc-4511	68	10	,	,	PUNCT
dpc-4511	68	11	accounting	account	VERB
dpc-4511	68	12	for	for	ADP
dpc-4511	68	13	65	65	NUM
dpc-4511	68	14	%	%	NOUN
dpc-4511	68	15	of	of	ADP
dpc-4511	68	16	cases	case	NOUN
dpc-4511	68	17	.	.	PUNCT
dpc-4511	69	1	the	the	DET
dpc-4511	69	2	second	second	ADJ
dpc-4511	69	3	most	most	ADV
dpc-4511	69	4	common	common	ADJ
dpc-4511	69	5	type	type	NOUN
dpc-4511	69	6	was	be	AUX
dpc-4511	69	7	palmoplantar	palmoplantar	NOUN
dpc-4511	69	8	psoriasis	psoriasis	NOUN
dpc-4511	69	9	,	,	PUNCT
dpc-4511	69	10	which	which	PRON
dpc-4511	69	11	constituted	constitute	VERB
dpc-4511	69	12	15	15	NUM
dpc-4511	69	13	%	%	NOUN
dpc-4511	69	14	of	of	ADP
dpc-4511	69	15	the	the	DET
dpc-4511	69	16	cases	case	NOUN
dpc-4511	69	17	.	.	PUNCT
dpc-4511	70	1	other	other	ADJ
dpc-4511	70	2	observed	observe	VERB
dpc-4511	70	3	psoriasis	psoriasis	NOUN
dpc-4511	70	4	subtypes	subtype	NOUN
dpc-4511	70	5	in	in	ADP
dpc-4511	70	6	our	our	PRON
dpc-4511	70	7	patient	patient	ADJ
dpc-4511	70	8	cohort	cohort	NOUN
dpc-4511	70	9	included	include	VERB
dpc-4511	70	10	palmoplantar	palmoplantar	NOUN
dpc-4511	70	11	pustular	pustular	ADJ
dpc-4511	70	12	psoriasis	psoriasis	NOUN
dpc-4511	70	13	(	(	PUNCT
dpc-4511	70	14	5.6	5.6	NUM
dpc-4511	70	15	%	%	NOUN
dpc-4511	70	16	)	)	PUNCT
dpc-4511	70	17	,	,	PUNCT
dpc-4511	70	18	guttate	guttate	NOUN
dpc-4511	70	19	psoriasis	psoriasis	NOUN
dpc-4511	70	20	(	(	PUNCT
dpc-4511	70	21	5.6	5.6	NUM
dpc-4511	70	22	%	%	NOUN
dpc-4511	70	23	)	)	PUNCT
dpc-4511	70	24	,	,	PUNCT
dpc-4511	70	25	generalized	generalize	VERB
dpc-4511	70	26	pustular	pustular	ADJ
dpc-4511	70	27	psoriasis	psoriasis	NOUN
dpc-4511	70	28	(	(	PUNCT
dpc-4511	70	29	5	5	NUM
dpc-4511	70	30	%	%	NOUN
dpc-4511	70	31	)	)	PUNCT
dpc-4511	70	32	,	,	PUNCT
dpc-4511	70	33	and	and	CCONJ
dpc-4511	70	34	erythrodermic	erythrodermic	ADJ
dpc-4511	70	35	psoriasis	psoriasis	NOUN
dpc-4511	70	36	(	(	PUNCT
dpc-4511	70	37	3.8	3.8	NUM
dpc-4511	70	38	%	%	NOUN
dpc-4511	70	39	)	)	PUNCT
dpc-4511	70	40	.	.	PUNCT
dpc-4511	71	1	plaque	plaque	NOUN
dpc-4511	71	2	psoriasis	psoriasis	NOUN
dpc-4511	71	3	was	be	AUX
dpc-4511	71	4	the	the	DET
dpc-4511	71	5	most	most	ADV
dpc-4511	71	6	common	common	ADJ
dpc-4511	71	7	type	type	NOUN
dpc-4511	71	8	in	in	ADP
dpc-4511	71	9	both	both	CCONJ
dpc-4511	71	10	the	the	DET
dpc-4511	71	11	eao	eao	ADJ
dpc-4511	71	12	and	and	CCONJ
dpc-4511	71	13	eo	eo	PROPN
dpc-4511	71	14	groups	group	NOUN
dpc-4511	71	15	.	.	PUNCT
dpc-4511	72	1	erythrodermic	erythrodermic	ADJ
dpc-4511	72	2	psoriasis	psoriasis	NOUN
dpc-4511	72	3	was	be	AUX
dpc-4511	72	4	more	more	ADV
dpc-4511	72	5	common	common	ADJ
dpc-4511	72	6	in	in	ADP
dpc-4511	72	7	the	the	DET
dpc-4511	72	8	eao	eao	ADJ
dpc-4511	72	9	group	group	NOUN
dpc-4511	72	10	,	,	PUNCT
dpc-4511	72	11	but	but	CCONJ
dpc-4511	72	12	it	it	PRON
dpc-4511	72	13	was	be	AUX
dpc-4511	72	14	not	not	PART
dpc-4511	72	15	statistically	statistically	ADV
dpc-4511	72	16	significant	significant	ADJ
dpc-4511	72	17	(	(	PUNCT
dpc-4511	72	18	p	p	X
dpc-4511	72	19	=	=	NOUN
dpc-4511	72	20	0.097	0.097	NUM
dpc-4511	72	21	)	)	PUNCT
dpc-4511	72	22	.	.	PUNCT
dpc-4511	73	1	there	there	PRON
dpc-4511	73	2	was	be	VERB
dpc-4511	73	3	no	no	DET
dpc-4511	73	4	difference	difference	NOUN
dpc-4511	73	5	in	in	ADP
dpc-4511	73	6	the	the	DET
dpc-4511	73	7	frequency	frequency	NOUN
dpc-4511	73	8	of	of	ADP
dpc-4511	73	9	other	other	ADJ
dpc-4511	73	10	types	type	NOUN
dpc-4511	73	11	of	of	ADP
dpc-4511	73	12	psoriasis	psoriasis	NOUN
dpc-4511	73	13	between	between	ADP
dpc-4511	73	14	the	the	DET
dpc-4511	73	15	two	two	NUM
dpc-4511	73	16	groups	group	NOUN
dpc-4511	73	17	.	.	PUNCT
dpc-4511	74	1	in	in	ADP
dpc-4511	74	2	60	60	NUM
dpc-4511	74	3	%	%	NOUN
dpc-4511	74	4	of	of	ADP
dpc-4511	74	5	the	the	DET
dpc-4511	74	6	patients	patient	NOUN
dpc-4511	74	7	,	,	PUNCT
dpc-4511	74	8	the	the	DET
dpc-4511	74	9	disease	disease	NOUN
dpc-4511	74	10	began	begin	VERB
dpc-4511	74	11	in	in	ADP
dpc-4511	74	12	a	a	DET
dpc-4511	74	13	mild	mild	ADJ
dpc-4511	74	14	form	form	NOUN
dpc-4511	74	15	,	,	PUNCT
dpc-4511	74	16	while	while	SCONJ
dpc-4511	74	17	in	in	ADP
dpc-4511	74	18	40	40	NUM
dpc-4511	74	19	%	%	NOUN
dpc-4511	74	20	of	of	ADP
dpc-4511	74	21	the	the	DET
dpc-4511	74	22	patients	patient	NOUN
dpc-4511	74	23	,	,	PUNCT
dpc-4511	74	24	it	it	PRON
dpc-4511	74	25	began	begin	VERB
dpc-4511	74	26	in	in	ADP
dpc-4511	74	27	a	a	DET
dpc-4511	74	28	moderatesevere	moderatesevere	NOUN
dpc-4511	74	29	form	form	NOUN
dpc-4511	74	30	.	.	PUNCT
dpc-4511	75	1	mild	mild	ADJ
dpc-4511	75	2	onset	onset	NOUN
dpc-4511	75	3	severity	severity	NOUN
dpc-4511	75	4	was	be	AUX
dpc-4511	75	5	higher	high	ADJ
dpc-4511	75	6	in	in	ADP
dpc-4511	75	7	the	the	DET
dpc-4511	75	8	eao	eao	ADJ
dpc-4511	75	9	group	group	NOUN
dpc-4511	75	10	(	(	PUNCT
dpc-4511	75	11	p	p	X
dpc-4511	75	12	=	=	NOUN
dpc-4511	75	13	0.46	0.46	NUM
dpc-4511	75	14	)	)	PUNCT
dpc-4511	75	15	;	;	PUNCT
dpc-4511	75	16	83.1	83.1	NUM
dpc-4511	75	17	%	%	NOUN
dpc-4511	75	18	of	of	ADP
dpc-4511	75	19	our	our	PRON
dpc-4511	75	20	patient	patient	ADJ
dpc-4511	75	21	cohort	cohort	NOUN
dpc-4511	75	22	had	have	VERB
dpc-4511	75	23	a	a	DET
dpc-4511	75	24	slow	slow	ADJ
dpc-4511	75	25	disease	disease	NOUN
dpc-4511	75	26	course	course	NOUN
dpc-4511	75	27	.	.	PUNCT
dpc-4511	76	1	it	it	PRON
dpc-4511	76	2	was	be	AUX
dpc-4511	76	3	observed	observe	VERB
dpc-4511	76	4	that	that	SCONJ
dpc-4511	76	5	the	the	DET
dpc-4511	76	6	disease	disease	NOUN
dpc-4511	76	7	course	course	NOUN
dpc-4511	76	8	of	of	ADP
dpc-4511	76	9	psoriasis	psoriasis	NOUN
dpc-4511	76	10	was	be	AUX
dpc-4511	76	11	slower	slow	ADJ
dpc-4511	76	12	in	in	ADP
dpc-4511	76	13	the	the	DET
dpc-4511	76	14	eao	eao	ADJ
dpc-4511	76	15	group	group	NOUN
dpc-4511	76	16	compared	compare	VERB
dpc-4511	76	17	to	to	ADP
dpc-4511	76	18	the	the	DET
dpc-4511	76	19	eo	eo	PROPN
dpc-4511	76	20	group	group	NOUN
dpc-4511	76	21	(	(	PUNCT
dpc-4511	76	22	p	p	NOUN
dpc-4511	76	23	=	=	NOUN
dpc-4511	76	24	0.001	0.001	NUM
dpc-4511	76	25	)	)	PUNCT
dpc-4511	76	26	.	.	PUNCT
dpc-4511	77	1	when	when	SCONJ
dpc-4511	77	2	evaluating	evaluate	VERB
dpc-4511	77	3	the	the	DET
dpc-4511	77	4	initial	initial	ADJ
dpc-4511	77	5	body	body	NOUN
dpc-4511	77	6	area	area	NOUN
dpc-4511	77	7	of	of	ADP
dpc-4511	77	8	psoriasis	psoriasis	NOUN
dpc-4511	77	9	,	,	PUNCT
dpc-4511	77	10	it	it	PRON
dpc-4511	77	11	was	be	AUX
dpc-4511	77	12	found	find	VERB
dpc-4511	77	13	that	that	SCONJ
dpc-4511	77	14	33.1	33.1	NUM
dpc-4511	77	15	%	%	NOUN
dpc-4511	77	16	of	of	ADP
dpc-4511	77	17	the	the	DET
dpc-4511	77	18	patients	patient	NOUN
dpc-4511	77	19	had	have	VERB
dpc-4511	77	20	knee	knee	NOUN
dpc-4511	77	21	-	-	PUNCT
dpc-4511	77	22	elbow	elbow	NOUN
dpc-4511	77	23	lesions	lesion	NOUN
dpc-4511	77	24	,	,	PUNCT
dpc-4511	77	25	22.7	22.7	NUM
dpc-4511	77	26	%	%	NOUN
dpc-4511	77	27	had	have	VERB
dpc-4511	77	28	palmoplantar	palmoplantar	NOUN
dpc-4511	77	29	lesions	lesion	NOUN
dpc-4511	77	30	,	,	PUNCT
dpc-4511	77	31	17.5	17.5	NUM
dpc-4511	77	32	%	%	NOUN
dpc-4511	77	33	had	have	VERB
dpc-4511	77	34	lower	low	ADJ
dpc-4511	77	35	extremity	extremity	NOUN
dpc-4511	77	36	lesions	lesion	NOUN
dpc-4511	77	37	,	,	PUNCT
dpc-4511	77	38	13.6	13.6	NUM
dpc-4511	77	39	%	%	NOUN
dpc-4511	77	40	had	have	VERB
dpc-4511	77	41	scalp	scalp	NOUN
dpc-4511	77	42	lesions	lesion	NOUN
dpc-4511	77	43	,	,	PUNCT
dpc-4511	77	44	11.7	11.7	NUM
dpc-4511	77	45	%	%	NOUN
dpc-4511	77	46	had	have	VERB
dpc-4511	77	47	trunk	trunk	NOUN
dpc-4511	77	48	lesions	lesion	NOUN
dpc-4511	77	49	,	,	PUNCT
dpc-4511	77	50	9.7	9.7	NUM
dpc-4511	77	51	%	%	NOUN
dpc-4511	77	52	had	have	VERB
dpc-4511	77	53	upper	upper	ADJ
dpc-4511	77	54	extremity	extremity	NOUN
dpc-4511	77	55	lesions	lesion	NOUN
dpc-4511	77	56	,	,	PUNCT
dpc-4511	77	57	2.6	2.6	NUM
dpc-4511	77	58	%	%	NOUN
dpc-4511	77	59	had	have	VERB
dpc-4511	77	60	intertriginous	intertriginous	ADJ
dpc-4511	77	61	lesions	lesion	NOUN
dpc-4511	77	62	,	,	PUNCT
dpc-4511	77	63	and	and	CCONJ
dpc-4511	77	64	1.9	1.9	NUM
dpc-4511	77	65	%	%	NOUN
dpc-4511	77	66	had	have	VERB
dpc-4511	77	67	face	face	NOUN
dpc-4511	77	68	lesions	lesion	NOUN
dpc-4511	77	69	.	.	PUNCT
dpc-4511	78	1	while	while	SCONJ
dpc-4511	78	2	lesions	lesion	NOUN
dpc-4511	78	3	located	locate	VERB
dpc-4511	78	4	at	at	ADP
dpc-4511	78	5	the	the	DET
dpc-4511	78	6	knee	knee	NOUN
dpc-4511	78	7	and	and	CCONJ
dpc-4511	78	8	elbow	elbow	NOUN
dpc-4511	78	9	were	be	AUX
dpc-4511	78	10	observed	observe	VERB
dpc-4511	78	11	more	more	ADV
dpc-4511	78	12	frequently	frequently	ADV
dpc-4511	78	13	in	in	ADP
dpc-4511	78	14	the	the	DET
dpc-4511	78	15	eao	eao	ADJ
dpc-4511	78	16	group	group	NOUN
dpc-4511	78	17	,	,	PUNCT
dpc-4511	78	18	no	no	DET
dpc-4511	78	19	statistical	statistical	ADJ
dpc-4511	78	20	difference	difference	NOUN
dpc-4511	78	21	was	be	AUX
dpc-4511	78	22	found	find	VERB
dpc-4511	78	23	between	between	ADP
dpc-4511	78	24	the	the	DET
dpc-4511	78	25	initial	initial	ADJ
dpc-4511	78	26	areas	area	NOUN
dpc-4511	78	27	in	in	ADP
dpc-4511	78	28	other	other	ADJ
dpc-4511	78	29	anatomical	anatomical	ADJ
dpc-4511	78	30	regions	region	NOUN
dpc-4511	78	31	(	(	PUNCT
dpc-4511	78	32	p	p	X
dpc-4511	78	33	=	=	NOUN
dpc-4511	78	34	0.032	0.032	NUM
dpc-4511	78	35	)	)	PUNCT
dpc-4511	78	36	.	.	PUNCT
dpc-4511	79	1	throughout	throughout	ADP
dpc-4511	79	2	the	the	DET
dpc-4511	79	3	course	course	NOUN
dpc-4511	79	4	of	of	ADP
dpc-4511	79	5	the	the	DET
dpc-4511	79	6	disease	disease	NOUN
dpc-4511	79	7	,	,	PUNCT
dpc-4511	79	8	knee	knee	NOUN
dpc-4511	79	9	-	-	PUNCT
dpc-4511	79	10	elbow	elbow	NOUN
dpc-4511	79	11	involvement	involvement	NOUN
dpc-4511	79	12	occurred	occur	VERB
dpc-4511	79	13	in	in	ADP
dpc-4511	79	14	71.9	71.9	NUM
dpc-4511	79	15	%	%	NOUN
dpc-4511	79	16	of	of	ADP
dpc-4511	79	17	the	the	DET
dpc-4511	79	18	cases	case	NOUN
dpc-4511	79	19	.	.	PUNCT
dpc-4511	80	1	lower	low	ADJ
dpc-4511	80	2	extremity	extremity	NOUN
dpc-4511	80	3	involvement	involvement	NOUN
dpc-4511	80	4	was	be	AUX
dpc-4511	80	5	present	present	ADJ
dpc-4511	80	6	in	in	ADP
dpc-4511	80	7	64.4	64.4	NUM
dpc-4511	80	8	%	%	NOUN
dpc-4511	80	9	of	of	ADP
dpc-4511	80	10	the	the	DET
dpc-4511	80	11	patients	patient	NOUN
dpc-4511	80	12	,	,	PUNCT
dpc-4511	80	13	while	while	SCONJ
dpc-4511	80	14	scalp	scalp	NOUN
dpc-4511	80	15	,	,	PUNCT
dpc-4511	80	16	trunk	trunk	NOUN
dpc-4511	80	17	,	,	PUNCT
dpc-4511	80	18	upper	upper	ADJ
dpc-4511	80	19	extremity	extremity	NOUN
dpc-4511	80	20	,	,	PUNCT
dpc-4511	80	21	palmoplantar	palmoplantar	NOUN
dpc-4511	80	22	,	,	PUNCT
dpc-4511	80	23	intertriginous	intertriginous	ADJ
dpc-4511	80	24	,	,	PUNCT
dpc-4511	80	25	and	and	CCONJ
dpc-4511	80	26	facial	facial	ADJ
dpc-4511	80	27	involvement	involvement	NOUN
dpc-4511	80	28	was	be	AUX
dpc-4511	80	29	observed	observe	VERB
dpc-4511	80	30	in	in	ADP
dpc-4511	80	31	57.5	57.5	NUM
dpc-4511	80	32	%	%	NOUN
dpc-4511	80	33	,	,	PUNCT
dpc-4511	80	34	56.3	56.3	NUM
dpc-4511	80	35	%	%	NOUN
dpc-4511	80	36	,	,	PUNCT
dpc-4511	80	37	56.3	56.3	NUM
dpc-4511	80	38	%	%	NOUN
dpc-4511	80	39	,	,	PUNCT
dpc-4511	80	40	33.1	33.1	NUM
dpc-4511	80	41	%	%	NOUN
dpc-4511	80	42	,	,	PUNCT
dpc-4511	80	43	33.1	33.1	NUM
dpc-4511	80	44	%	%	NOUN
dpc-4511	80	45	,	,	PUNCT
dpc-4511	80	46	and	and	CCONJ
dpc-4511	80	47	21.3	21.3	NUM
dpc-4511	80	48	%	%	NOUN
dpc-4511	80	49	of	of	ADP
dpc-4511	80	50	the	the	DET
dpc-4511	80	51	patients	patient	NOUN
dpc-4511	80	52	,	,	PUNCT
dpc-4511	80	53	respectively	respectively	ADV
dpc-4511	80	54	(	(	PUNCT
dpc-4511	80	55	figure	figure	NOUN
dpc-4511	80	56	1	1	NUM
dpc-4511	80	57	)	)	PUNCT
dpc-4511	80	58	.	.	PUNCT
dpc-4511	81	1	the	the	DET
dpc-4511	81	2	eao	eao	PROPN
dpc-4511	81	3	group	group	NOUN
dpc-4511	81	4	had	have	VERB
dpc-4511	81	5	a	a	DET
dpc-4511	81	6	higher	high	ADJ
dpc-4511	81	7	frequency	frequency	NOUN
dpc-4511	81	8	of	of	ADP
dpc-4511	81	9	knee	knee	NOUN
dpc-4511	81	10	and	and	CCONJ
dpc-4511	81	11	elbow	elbow	NOUN
dpc-4511	81	12	involvement	involvement	NOUN
dpc-4511	81	13	,	,	PUNCT
dpc-4511	81	14	which	which	PRON
dpc-4511	81	15	was	be	AUX
dpc-4511	81	16	statistically	statistically	ADV
dpc-4511	81	17	significant	significant	ADJ
dpc-4511	81	18	(	(	PUNCT
dpc-4511	81	19	p	p	X
dpc-4511	81	20	=	=	NOUN
dpc-4511	81	21	0.026	0.026	NUM
dpc-4511	81	22	)	)	PUNCT
dpc-4511	81	23	.	.	PUNCT
dpc-4511	82	1	there	there	PRON
dpc-4511	82	2	was	be	VERB
dpc-4511	82	3	no	no	DET
dpc-4511	82	4	relationship	relationship	NOUN
dpc-4511	82	5	between	between	ADP
dpc-4511	82	6	involvement	involvement	NOUN
dpc-4511	82	7	of	of	ADP
dpc-4511	82	8	other	other	ADJ
dpc-4511	82	9	regions	region	NOUN
dpc-4511	82	10	and	and	CCONJ
dpc-4511	82	11	age	age	NOUN
dpc-4511	82	12	at	at	ADP
dpc-4511	82	13	disease	disease	NOUN
dpc-4511	82	14	onset	onset	VERB
dpc-4511	82	15	.	.	PUNCT
dpc-4511	83	1	forty	forty	NUM
dpc-4511	83	2	-	-	PUNCT
dpc-4511	83	3	four	four	NUM
dpc-4511	83	4	point	point	NOUN
dpc-4511	83	5	four	four	NUM
dpc-4511	83	6	percent	percent	NOUN
dpc-4511	83	7	of	of	ADP
dpc-4511	83	8	patients	patient	NOUN
dpc-4511	83	9	had	have	VERB
dpc-4511	83	10	nail	nail	NOUN
dpc-4511	83	11	psoriasis	psoriasis	NOUN
dpc-4511	83	12	,	,	PUNCT
dpc-4511	83	13	while	while	SCONJ
dpc-4511	83	14	20.6	20.6	NUM
dpc-4511	83	15	%	%	NOUN
dpc-4511	83	16	had	have	VERB
dpc-4511	83	17	psoriatic	psoriatic	ADJ
dpc-4511	83	18	arthritis	arthritis	NOUN
dpc-4511	83	19	(	(	PUNCT
dpc-4511	83	20	figure	figure	NOUN
dpc-4511	83	21	2	2	NUM
dpc-4511	83	22	)	)	PUNCT
dpc-4511	83	23	.	.	PUNCT
dpc-4511	84	1	nail	nail	NOUN
dpc-4511	84	2	involvement	involvement	NOUN
dpc-4511	84	3	(	(	PUNCT
dpc-4511	84	4	p	p	X
dpc-4511	84	5	=	=	NOUN
dpc-4511	84	6	0.17	0.17	NUM
dpc-4511	84	7	)	)	PUNCT
dpc-4511	84	8	and	and	CCONJ
dpc-4511	84	9	the	the	DET
dpc-4511	84	10	presence	presence	NOUN
dpc-4511	84	11	of	of	ADP
dpc-4511	84	12	psoriatic	psoriatic	ADJ
dpc-4511	84	13	arthritis	arthritis	NOUN
dpc-4511	84	14	(	(	PUNCT
dpc-4511	84	15	p	p	NOUN
dpc-4511	84	16	=	=	NOUN
dpc-4511	84	17	0.035	0.035	NUM
dpc-4511	84	18	)	)	PUNCT
dpc-4511	84	19	were	be	AUX
dpc-4511	84	20	more	more	ADV
dpc-4511	84	21	common	common	ADJ
dpc-4511	84	22	in	in	ADP
dpc-4511	84	23	the	the	DET
dpc-4511	84	24	eao	eao	ADJ
dpc-4511	84	25	group	group	NOUN
dpc-4511	84	26	.	.	PUNCT
dpc-4511	85	1	when	when	SCONJ
dpc-4511	85	2	patients	patient	NOUN
dpc-4511	85	3	were	be	AUX
dpc-4511	85	4	questioned	question	VERB
dpc-4511	85	5	about	about	ADP
dpc-4511	85	6	triggering	trigger	VERB
dpc-4511	85	7	factors	factor	NOUN
dpc-4511	85	8	,	,	PUNCT
dpc-4511	85	9	75.6	75.6	NUM
dpc-4511	85	10	%	%	NOUN
dpc-4511	85	11	of	of	ADP
dpc-4511	85	12	the	the	DET
dpc-4511	85	13	patients	patient	NOUN
dpc-4511	85	14	reported	report	VERB
dpc-4511	85	15	having	have	VERB
dpc-4511	85	16	a	a	DET
dpc-4511	85	17	triggering	trigger	VERB
dpc-4511	85	18	factor	factor	NOUN
dpc-4511	85	19	.	.	PUNCT
dpc-4511	86	1	stress	stress	NOUN
dpc-4511	86	2	(	(	PUNCT
dpc-4511	86	3	68.1	68.1	NUM
dpc-4511	86	4	%	%	NOUN
dpc-4511	86	5	)	)	PUNCT
dpc-4511	86	6	was	be	AUX
dpc-4511	86	7	one	one	NUM
dpc-4511	86	8	of	of	ADP
dpc-4511	86	9	the	the	DET
dpc-4511	86	10	most	most	ADV
dpc-4511	86	11	frequently	frequently	ADV
dpc-4511	86	12	reported	report	VERB
dpc-4511	86	13	triggering	trigger	VERB
dpc-4511	86	14	factors	factor	NOUN
dpc-4511	86	15	at	at	ADP
dpc-4511	86	16	the	the	DET
dpc-4511	86	17	onset	onset	NOUN
dpc-4511	86	18	of	of	ADP
dpc-4511	86	19	the	the	DET
dpc-4511	86	20	disease	disease	NOUN
dpc-4511	86	21	.	.	PUNCT
dpc-4511	87	1	patients	patient	NOUN
dpc-4511	87	2	also	also	ADV
dpc-4511	87	3	reported	report	VERB
dpc-4511	87	4	physical	physical	ADJ
dpc-4511	87	5	factors	factor	NOUN
dpc-4511	87	6	(	(	PUNCT
dpc-4511	87	7	6.3	6.3	NUM
dpc-4511	87	8	%	%	NOUN
dpc-4511	87	9	)	)	PUNCT
dpc-4511	87	10	,	,	PUNCT
dpc-4511	87	11	infection	infection	NOUN
dpc-4511	87	12	(	(	PUNCT
dpc-4511	87	13	5.6	5.6	NUM
dpc-4511	87	14	%	%	NOUN
dpc-4511	87	15	)	)	PUNCT
dpc-4511	87	16	,	,	PUNCT
dpc-4511	87	17	uv	uv	NOUN
dpc-4511	87	18	exposure	exposure	NOUN
dpc-4511	87	19	(	(	PUNCT
dpc-4511	87	20	5.6	5.6	NUM
dpc-4511	87	21	%	%	NOUN
dpc-4511	87	22	)	)	PUNCT
dpc-4511	87	23	,	,	PUNCT
dpc-4511	87	24	surgery	surgery	NOUN
dpc-4511	87	25	(	(	PUNCT
dpc-4511	87	26	1.3	1.3	NUM
dpc-4511	87	27	%	%	NOUN
dpc-4511	87	28	)	)	PUNCT
dpc-4511	87	29	,	,	PUNCT
dpc-4511	87	30	and	and	CCONJ
dpc-4511	87	31	radiotherapy	radiotherapy	NOUN
dpc-4511	87	32	(	(	PUNCT
dpc-4511	87	33	1.3	1.3	NUM
dpc-4511	87	34	%	%	NOUN
dpc-4511	87	35	)	)	PUNCT
dpc-4511	87	36	as	as	ADP
dpc-4511	87	37	triggering	trigger	VERB
dpc-4511	87	38	factors	factor	NOUN
dpc-4511	87	39	for	for	ADP
dpc-4511	87	40	disease	disease	NOUN
dpc-4511	87	41	activation	activation	NOUN
dpc-4511	87	42	during	during	ADP
dpc-4511	87	43	the	the	DET
dpc-4511	87	44	course	course	NOUN
dpc-4511	87	45	of	of	ADP
dpc-4511	87	46	psoriasis	psoriasis	NOUN
dpc-4511	87	47	.	.	PUNCT
dpc-4511	88	1	there	there	PRON
dpc-4511	88	2	was	be	VERB
dpc-4511	88	3	no	no	DET
dpc-4511	88	4	statistically	statistically	ADV
dpc-4511	88	5	significant	significant	ADJ
dpc-4511	88	6	difference	difference	NOUN
dpc-4511	88	7	in	in	ADP
dpc-4511	88	8	terms	term	NOUN
dpc-4511	88	9	of	of	ADP
dpc-4511	88	10	triggering	trigger	VERB
dpc-4511	88	11	factors	factor	NOUN
dpc-4511	88	12	between	between	ADP
dpc-4511	88	13	the	the	DET
dpc-4511	88	14	eao	eao	PROPN
dpc-4511	88	15	-	-	PUNCT
dpc-4511	88	16	eo	eo	PROPN
dpc-4511	88	17	groups	group	NOUN
dpc-4511	88	18	.	.	PUNCT
dpc-4511	89	1	figure	figure	VERB
dpc-4511	89	2	1	1	NUM
dpc-4511	89	3	.	.	PUNCT
dpc-4511	89	4	clinical	clinical	ADJ
dpc-4511	89	5	images	image	NOUN
dpc-4511	89	6	from	from	ADP
dpc-4511	89	7	our	our	PRON
dpc-4511	89	8	geriatric	geriatric	ADJ
dpc-4511	89	9	patient	patient	NOUN
dpc-4511	89	10	cohort	cohort	NOUN
dpc-4511	89	11	;	;	PUNCT
dpc-4511	89	12	(	(	PUNCT
dpc-4511	89	13	a	a	X
dpc-4511	89	14	)	)	PUNCT
dpc-4511	89	15	,	,	PUNCT
dpc-4511	89	16	(	(	PUNCT
dpc-4511	89	17	b	b	X
dpc-4511	89	18	)	)	PUNCT
dpc-4511	89	19	psoriasis	psoriasis	NOUN
dpc-4511	89	20	vulgaris	vulgaris	NOUN
dpc-4511	89	21	,	,	PUNCT
dpc-4511	89	22	(	(	PUNCT
dpc-4511	89	23	c	c	X
dpc-4511	89	24	)	)	PUNCT
dpc-4511	89	25	generalized	generalize	VERB
dpc-4511	89	26	pustular	pustular	ADJ
dpc-4511	89	27	psoriasis	psoriasis	NOUN
dpc-4511	89	28	,	,	PUNCT
dpc-4511	89	29	(	(	PUNCT
dpc-4511	89	30	d	d	X
dpc-4511	89	31	)	)	PUNCT
dpc-4511	89	32	palmoplantar	palmoplantar	NOUN
dpc-4511	89	33	pustular	pustular	ADJ
dpc-4511	89	34	psoriasis	psoriasis	NOUN
dpc-4511	89	35	.	.	PUNCT
dpc-4511	90	1	4	4	NUM
dpc-4511	90	2	original	original	ADJ
dpc-4511	90	3	article	article	NOUN
dpc-4511	90	4	|	|	ADV
dpc-4511	90	5	dermatol	dermatol	ADJ
dpc-4511	90	6	pract	pract	NOUN
dpc-4511	90	7	concept	concept	NOUN
dpc-4511	90	8	.	.	PUNCT
dpc-4511	91	1	2025;15(1):4511	2025;15(1):4511	NUM
dpc-4511	91	2	of	of	ADP
dpc-4511	91	3	our	our	PRON
dpc-4511	91	4	patients	patient	NOUN
dpc-4511	91	5	,	,	PUNCT
dpc-4511	91	6	84.3	84.3	NUM
dpc-4511	91	7	%	%	NOUN
dpc-4511	91	8	had	have	VERB
dpc-4511	91	9	concomitant	concomitant	ADJ
dpc-4511	91	10	systemic	systemic	ADJ
dpc-4511	91	11	comorbidities	comorbiditie	NOUN
dpc-4511	91	12	,	,	PUNCT
dpc-4511	91	13	and	and	CCONJ
dpc-4511	91	14	76.2	76.2	NUM
dpc-4511	91	15	%	%	NOUN
dpc-4511	91	16	were	be	AUX
dpc-4511	91	17	taking	take	VERB
dpc-4511	91	18	at	at	ADV
dpc-4511	91	19	least	least	ADJ
dpc-4511	91	20	1	1	NUM
dpc-4511	91	21	drug	drug	NOUN
dpc-4511	91	22	.	.	PUNCT
dpc-4511	92	1	hypertension	hypertension	NOUN
dpc-4511	92	2	was	be	AUX
dpc-4511	92	3	the	the	DET
dpc-4511	92	4	most	most	ADV
dpc-4511	92	5	common	common	ADJ
dpc-4511	92	6	comorbidity	comorbidity	NOUN
dpc-4511	92	7	(	(	PUNCT
dpc-4511	92	8	51.2	51.2	NUM
dpc-4511	92	9	%	%	NOUN
dpc-4511	92	10	)	)	PUNCT
dpc-4511	92	11	,	,	PUNCT
dpc-4511	92	12	followed	follow	VERB
dpc-4511	92	13	by	by	ADP
dpc-4511	92	14	hyperlipidemia	hyperlipidemia	NOUN
dpc-4511	92	15	(	(	PUNCT
dpc-4511	92	16	45	45	NUM
dpc-4511	92	17	%	%	NOUN
dpc-4511	92	18	)	)	PUNCT
dpc-4511	92	19	,	,	PUNCT
dpc-4511	92	20	cardiovascular	cardiovascular	ADJ
dpc-4511	92	21	diseases	disease	NOUN
dpc-4511	92	22	(	(	PUNCT
dpc-4511	92	23	33.1	33.1	NUM
dpc-4511	92	24	%	%	NOUN
dpc-4511	92	25	)	)	PUNCT
dpc-4511	92	26	,	,	PUNCT
dpc-4511	92	27	type	type	NOUN
dpc-4511	92	28	2	2	NUM
dpc-4511	92	29	diabetes	diabetes	NOUN
dpc-4511	92	30	mellitus	mellitus	NOUN
dpc-4511	92	31	(	(	PUNCT
dpc-4511	92	32	27.5	27.5	NUM
dpc-4511	92	33	%	%	NOUN
dpc-4511	92	34	)	)	PUNCT
dpc-4511	92	35	,	,	PUNCT
dpc-4511	92	36	depression	depression	NOUN
dpc-4511	92	37	(	(	PUNCT
dpc-4511	92	38	26.3	26.3	NUM
dpc-4511	92	39	%	%	NOUN
dpc-4511	92	40	)	)	PUNCT
dpc-4511	92	41	,	,	PUNCT
dpc-4511	92	42	malignancies	malignancy	NOUN
dpc-4511	92	43	(	(	PUNCT
dpc-4511	92	44	11.9	11.9	NUM
dpc-4511	92	45	%	%	NOUN
dpc-4511	92	46	)	)	PUNCT
dpc-4511	92	47	,	,	PUNCT
dpc-4511	92	48	autoimmune	autoimmune	ADJ
dpc-4511	92	49	diseases	disease	NOUN
dpc-4511	92	50	(	(	PUNCT
dpc-4511	92	51	8.1	8.1	NUM
dpc-4511	92	52	%	%	NOUN
dpc-4511	92	53	)	)	PUNCT
dpc-4511	92	54	,	,	PUNCT
dpc-4511	92	55	and	and	CCONJ
dpc-4511	92	56	uveitis	uveitis	NOUN
dpc-4511	92	57	(	(	PUNCT
dpc-4511	92	58	1.3	1.3	NUM
dpc-4511	92	59	%	%	NOUN
dpc-4511	92	60	)	)	PUNCT
dpc-4511	92	61	.	.	PUNCT
dpc-4511	93	1	the	the	DET
dpc-4511	93	2	majority	majority	NOUN
dpc-4511	93	3	of	of	ADP
dpc-4511	93	4	patients	patient	NOUN
dpc-4511	93	5	(	(	PUNCT
dpc-4511	93	6	86.9	86.9	NUM
dpc-4511	93	7	%	%	NOUN
dpc-4511	93	8	)	)	PUNCT
dpc-4511	93	9	initially	initially	ADV
dpc-4511	93	10	received	receive	VERB
dpc-4511	93	11	topical	topical	ADJ
dpc-4511	93	12	treatment	treatment	NOUN
dpc-4511	93	13	,	,	PUNCT
dpc-4511	93	14	while	while	SCONJ
dpc-4511	93	15	5.6	5.6	NUM
dpc-4511	93	16	%	%	NOUN
dpc-4511	93	17	,	,	PUNCT
dpc-4511	93	18	2.5	2.5	NUM
dpc-4511	93	19	%	%	NOUN
dpc-4511	93	20	,	,	PUNCT
dpc-4511	93	21	1.3	1.3	NUM
dpc-4511	93	22	%	%	NOUN
dpc-4511	93	23	,	,	PUNCT
dpc-4511	93	24	1.3	1.3	NUM
dpc-4511	93	25	%	%	NOUN
dpc-4511	93	26	,	,	PUNCT
dpc-4511	93	27	and	and	CCONJ
dpc-4511	93	28	1.3	1.3	NUM
dpc-4511	93	29	%	%	NOUN
dpc-4511	93	30	of	of	ADP
dpc-4511	93	31	patients	patient	NOUN
dpc-4511	93	32	were	be	AUX
dpc-4511	93	33	treated	treat	VERB
dpc-4511	93	34	with	with	ADP
dpc-4511	93	35	methotrexate	methotrexate	NOUN
dpc-4511	93	36	,	,	PUNCT
dpc-4511	93	37	acitretin	acitretin	NOUN
dpc-4511	93	38	,	,	PUNCT
dpc-4511	93	39	cyclosporine	cyclosporine	NOUN
dpc-4511	93	40	,	,	PUNCT
dpc-4511	93	41	phototherapy	phototherapy	NOUN
dpc-4511	93	42	(	(	PUNCT
dpc-4511	93	43	narrow	narrow	ADJ
dpc-4511	93	44	band	band	NOUN
dpc-4511	93	45	uvb	uvb	ADJ
dpc-4511	93	46	)	)	PUNCT
dpc-4511	93	47	,	,	PUNCT
dpc-4511	93	48	and	and	CCONJ
dpc-4511	93	49	biologic	biologic	ADJ
dpc-4511	93	50	agents	agent	NOUN
dpc-4511	93	51	,	,	PUNCT
dpc-4511	93	52	respectively	respectively	ADV
dpc-4511	93	53	.	.	PUNCT
dpc-4511	94	1	systemic	systemic	ADJ
dpc-4511	94	2	treatment	treatment	NOUN
dpc-4511	94	3	was	be	AUX
dpc-4511	94	4	predominantly	predominantly	ADV
dpc-4511	94	5	initiated	initiate	VERB
dpc-4511	94	6	as	as	ADP
dpc-4511	94	7	the	the	DET
dpc-4511	94	8	first	first	ADJ
dpc-4511	94	9	treatment	treatment	NOUN
dpc-4511	94	10	agent	agent	NOUN
dpc-4511	94	11	in	in	ADP
dpc-4511	94	12	the	the	DET
dpc-4511	94	13	eo	eo	PROPN
dpc-4511	94	14	group	group	NOUN
dpc-4511	94	15	(	(	PUNCT
dpc-4511	94	16	p	p	X
dpc-4511	94	17	=	=	NOUN
dpc-4511	94	18	0.006	0.006	NUM
dpc-4511	94	19	)	)	PUNCT
dpc-4511	94	20	.	.	PUNCT
dpc-4511	95	1	throughout	throughout	ADP
dpc-4511	95	2	the	the	DET
dpc-4511	95	3	course	course	NOUN
dpc-4511	95	4	of	of	ADP
dpc-4511	95	5	the	the	DET
dpc-4511	95	6	disease	disease	NOUN
dpc-4511	95	7	,	,	PUNCT
dpc-4511	95	8	93.8	93.8	NUM
dpc-4511	95	9	%	%	NOUN
dpc-4511	95	10	of	of	ADP
dpc-4511	95	11	patients	patient	NOUN
dpc-4511	95	12	received	receive	VERB
dpc-4511	95	13	topical	topical	ADJ
dpc-4511	95	14	treatment	treatment	NOUN
dpc-4511	95	15	.	.	PUNCT
dpc-4511	96	1	methotrexate	methotrexate	PROPN
dpc-4511	96	2	was	be	AUX
dpc-4511	96	3	used	use	VERB
dpc-4511	96	4	in	in	ADP
dpc-4511	96	5	57.5	57.5	NUM
dpc-4511	96	6	%	%	NOUN
dpc-4511	96	7	of	of	ADP
dpc-4511	96	8	cases	case	NOUN
dpc-4511	96	9	,	,	PUNCT
dpc-4511	96	10	acitretin	acitretin	VERB
dpc-4511	96	11	in	in	ADP
dpc-4511	96	12	35.6	35.6	NUM
dpc-4511	96	13	%	%	NOUN
dpc-4511	96	14	,	,	PUNCT
dpc-4511	96	15	phototherapy	phototherapy	NOUN
dpc-4511	96	16	(	(	PUNCT
dpc-4511	96	17	narrow	narrow	ADJ
dpc-4511	96	18	band	band	NOUN
dpc-4511	96	19	uvb	uvb	NOUN
dpc-4511	96	20	)	)	PUNCT
dpc-4511	96	21	in	in	ADP
dpc-4511	96	22	33.1	33.1	NUM
dpc-4511	96	23	%	%	NOUN
dpc-4511	96	24	,	,	PUNCT
dpc-4511	96	25	cyclosporine	cyclosporine	NOUN
dpc-4511	96	26	in	in	ADP
dpc-4511	96	27	26.3	26.3	NUM
dpc-4511	96	28	%	%	NOUN
dpc-4511	96	29	,	,	PUNCT
dpc-4511	96	30	and	and	CCONJ
dpc-4511	96	31	biologic	biologic	NOUN
dpc-4511	96	32	agents	agent	NOUN
dpc-4511	96	33	in	in	ADP
dpc-4511	96	34	23.8	23.8	NUM
dpc-4511	96	35	%	%	NOUN
dpc-4511	96	36	.	.	PUNCT
dpc-4511	97	1	among	among	ADP
dpc-4511	97	2	the	the	DET
dpc-4511	97	3	biologic	biologic	NOUN
dpc-4511	97	4	agents	agent	NOUN
dpc-4511	97	5	,	,	PUNCT
dpc-4511	97	6	adalimumab	adalimumab	NOUN
dpc-4511	97	7	(	(	PUNCT
dpc-4511	97	8	8.1	8.1	NUM
dpc-4511	97	9	%	%	NOUN
dpc-4511	97	10	)	)	PUNCT
dpc-4511	97	11	and	and	CCONJ
dpc-4511	97	12	infliximab	infliximab	NOUN
dpc-4511	97	13	(	(	PUNCT
dpc-4511	97	14	5.6	5.6	NUM
dpc-4511	97	15	%	%	NOUN
dpc-4511	97	16	)	)	PUNCT
dpc-4511	97	17	were	be	AUX
dpc-4511	97	18	the	the	DET
dpc-4511	97	19	most	most	ADV
dpc-4511	97	20	commonly	commonly	ADV
dpc-4511	97	21	prescribed	prescribe	VERB
dpc-4511	97	22	agents	agent	NOUN
dpc-4511	97	23	.	.	PUNCT
dpc-4511	98	1	additionally	additionally	ADV
dpc-4511	98	2	,	,	PUNCT
dpc-4511	98	3	ustekinumab	ustekinumab	NOUN
dpc-4511	98	4	(	(	PUNCT
dpc-4511	98	5	3.8	3.8	NUM
dpc-4511	98	6	%	%	NOUN
dpc-4511	98	7	)	)	PUNCT
dpc-4511	98	8	,	,	PUNCT
dpc-4511	98	9	secukinumab	secukinumab	NOUN
dpc-4511	98	10	(	(	PUNCT
dpc-4511	98	11	2.5	2.5	NUM
dpc-4511	98	12	%	%	NOUN
dpc-4511	98	13	)	)	PUNCT
dpc-4511	98	14	,	,	PUNCT
dpc-4511	98	15	ixekizumab	ixekizumab	NOUN
dpc-4511	98	16	(	(	PUNCT
dpc-4511	98	17	2.5	2.5	NUM
dpc-4511	98	18	%	%	NOUN
dpc-4511	98	19	)	)	PUNCT
dpc-4511	98	20	,	,	PUNCT
dpc-4511	98	21	and	and	CCONJ
dpc-4511	98	22	etanercept	etanercept	VERB
dpc-4511	98	23	(	(	PUNCT
dpc-4511	98	24	1.3	1.3	NUM
dpc-4511	98	25	%	%	NOUN
dpc-4511	98	26	)	)	PUNCT
dpc-4511	98	27	were	be	AUX
dpc-4511	98	28	utilized	utilize	VERB
dpc-4511	98	29	in	in	ADP
dpc-4511	98	30	the	the	DET
dpc-4511	98	31	treatment	treatment	NOUN
dpc-4511	98	32	.	.	PUNCT
dpc-4511	99	1	patients	patient	NOUN
dpc-4511	99	2	in	in	ADP
dpc-4511	99	3	the	the	DET
dpc-4511	99	4	eao	eao	ADJ
dpc-4511	99	5	group	group	NOUN
dpc-4511	99	6	received	receive	VERB
dpc-4511	99	7	more	more	ADJ
dpc-4511	99	8	cyclosporine	cyclosporine	ADJ
dpc-4511	99	9	treatment	treatment	NOUN
dpc-4511	99	10	than	than	SCONJ
dpc-4511	99	11	did	do	VERB
dpc-4511	99	12	the	the	DET
dpc-4511	99	13	others	other	NOUN
dpc-4511	99	14	(	(	PUNCT
dpc-4511	99	15	p	p	X
dpc-4511	99	16	=	=	NOUN
dpc-4511	99	17	0.004	0.004	NUM
dpc-4511	99	18	)	)	PUNCT
dpc-4511	99	19	.	.	PUNCT
dpc-4511	100	1	tables	table	NOUN
dpc-4511	100	2	1	1	NUM
dpc-4511	100	3	and	and	CCONJ
dpc-4511	100	4	2	2	NUM
dpc-4511	100	5	present	present	VERB
dpc-4511	100	6	the	the	DET
dpc-4511	100	7	treatment	treatment	NOUN
dpc-4511	100	8	modalities	modality	NOUN
dpc-4511	100	9	of	of	ADP
dpc-4511	100	10	the	the	DET
dpc-4511	100	11	patients	patient	NOUN
dpc-4511	100	12	.	.	PUNCT
dpc-4511	101	1	discussion	discussion	NOUN
dpc-4511	101	2	psoriasis	psoriasis	NOUN
dpc-4511	101	3	is	be	AUX
dpc-4511	101	4	a	a	DET
dpc-4511	101	5	chronic	chronic	ADJ
dpc-4511	101	6	inflammatory	inflammatory	ADJ
dpc-4511	101	7	skin	skin	NOUN
dpc-4511	101	8	disease	disease	NOUN
dpc-4511	101	9	that	that	PRON
dpc-4511	101	10	affects	affect	VERB
dpc-4511	101	11	125	125	NUM
dpc-4511	101	12	million	million	NUM
dpc-4511	101	13	people	people	NOUN
dpc-4511	101	14	worldwide	worldwide	ADV
dpc-4511	101	15	.	.	PUNCT
dpc-4511	102	1	the	the	DET
dpc-4511	102	2	most	most	ADV
dpc-4511	102	3	common	common	ADJ
dpc-4511	102	4	form	form	NOUN
dpc-4511	102	5	of	of	ADP
dpc-4511	102	6	the	the	DET
dpc-4511	102	7	disease	disease	NOUN
dpc-4511	102	8	is	be	AUX
dpc-4511	102	9	psoriasis	psoriasis	NOUN
dpc-4511	102	10	vulgaris	vulgaris	NOUN
dpc-4511	102	11	,	,	PUNCT
dpc-4511	102	12	which	which	PRON
dpc-4511	102	13	accounts	account	VERB
dpc-4511	102	14	for	for	ADP
dpc-4511	102	15	approximately	approximately	ADV
dpc-4511	102	16	80	80	NUM
dpc-4511	102	17	%	%	NOUN
dpc-4511	102	18	of	of	ADP
dpc-4511	102	19	psoriasis	psoriasis	NOUN
dpc-4511	102	20	cases	case	NOUN
dpc-4511	102	21	.	.	PUNCT
dpc-4511	103	1	there	there	PRON
dpc-4511	103	2	are	be	VERB
dpc-4511	103	3	also	also	ADV
dpc-4511	103	4	other	other	ADJ
dpc-4511	103	5	subtypes	subtype	NOUN
dpc-4511	103	6	of	of	ADP
dpc-4511	103	7	psoriasis	psoriasis	NOUN
dpc-4511	103	8	,	,	PUNCT
dpc-4511	103	9	such	such	ADJ
dpc-4511	103	10	as	as	ADP
dpc-4511	103	11	palmoplantar	palmoplantar	NOUN
dpc-4511	103	12	psoriasis	psoriasis	NOUN
dpc-4511	103	13	,	,	PUNCT
dpc-4511	103	14	guttate	guttate	NOUN
dpc-4511	103	15	table	table	NOUN
dpc-4511	103	16	1	1	NUM
dpc-4511	103	17	.	.	PUNCT
dpc-4511	103	18	evaluation	evaluation	NOUN
dpc-4511	103	19	of	of	ADP
dpc-4511	103	20	first	first	ADJ
dpc-4511	103	21	treatment	treatment	NOUN
dpc-4511	103	22	agents	agent	NOUN
dpc-4511	103	23	of	of	ADP
dpc-4511	103	24	patients	patient	NOUN
dpc-4511	103	25	.	.	PUNCT
dpc-4511	104	1	first	first	ADJ
dpc-4511	104	2	treatment	treatment	NOUN
dpc-4511	104	3	agent	agent	NOUN
dpc-4511	104	4	all	all	DET
dpc-4511	104	5	patients	patient	NOUN
dpc-4511	104	6	(	(	PUNCT
dpc-4511	104	7	%	%	INTJ
dpc-4511	104	8	)	)	PUNCT
dpc-4511	104	9	earlyonset	earlyonset	NOUN
dpc-4511	104	10	group	group	NOUN
dpc-4511	104	11	(	(	PUNCT
dpc-4511	104	12	%	%	INTJ
dpc-4511	104	13	)	)	PUNCT
dpc-4511	104	14	elderlyonset	elderlyonset	VERB
dpc-4511	104	15	group	group	NOUN
dpc-4511	104	16	(	(	PUNCT
dpc-4511	104	17	%	%	INTJ
dpc-4511	104	18	)	)	PUNCT
dpc-4511	104	19	topical	topical	NOUN
dpc-4511	104	20	86.9	86.9	NUM
dpc-4511	104	21	96.1	96.1	NUM
dpc-4511	104	22	80.7	80.7	NUM
dpc-4511	104	23	methotrexate	methotrexate	NOUN
dpc-4511	104	24	5.6	5.6	NUM
dpc-4511	104	25	4.8	4.8	NUM
dpc-4511	104	26	7	7	NUM
dpc-4511	104	27	acitretin	acitretin	VERB
dpc-4511	104	28	2.5	2.5	NUM
dpc-4511	104	29	1.9	1.9	NUM
dpc-4511	104	30	3.5	3.5	NUM
dpc-4511	104	31	cyclosporine	cyclosporine	NOUN
dpc-4511	104	32	1.3	1.3	NUM
dpc-4511	104	33	0	0	NUM
dpc-4511	104	34	3.5	3.5	NUM
dpc-4511	104	35	phototherapy	phototherapy	NOUN
dpc-4511	104	36	1.3	1.3	NUM
dpc-4511	104	37	0.9	0.9	NUM
dpc-4511	104	38	1.7	1.7	NUM
dpc-4511	104	39	biological	biological	ADJ
dpc-4511	104	40	treatments	treatment	NOUN
dpc-4511	104	41	1.3	1.3	NUM
dpc-4511	104	42	0	0	NUM
dpc-4511	104	43	3,5	3,5	NUM
dpc-4511	104	44	table	table	NOUN
dpc-4511	104	45	2	2	NUM
dpc-4511	104	46	.	.	PUNCT
dpc-4511	104	47	comparison	comparison	NOUN
dpc-4511	104	48	of	of	ADP
dpc-4511	104	49	treatment	treatment	NOUN
dpc-4511	104	50	modalities	modality	NOUN
dpc-4511	104	51	of	of	ADP
dpc-4511	104	52	early	early	ADJ
dpc-4511	104	53	-	-	PUNCT
dpc-4511	104	54	onset	onset	NOUN
dpc-4511	104	55	and	and	CCONJ
dpc-4511	104	56	elderly	elderly	ADJ
dpc-4511	104	57	-	-	PUNCT
dpc-4511	104	58	onset	onset	NOUN
dpc-4511	104	59	groups	group	NOUN
dpc-4511	104	60	.	.	PUNCT
dpc-4511	105	1	drugs	drug	NOUN
dpc-4511	105	2	used	use	VERB
dpc-4511	105	3	during	during	ADP
dpc-4511	105	4	the	the	DET
dpc-4511	105	5	disease	disease	NOUN
dpc-4511	105	6	all	all	DET
dpc-4511	105	7	patients	patient	NOUN
dpc-4511	105	8	(	(	PUNCT
dpc-4511	105	9	%	%	INTJ
dpc-4511	105	10	)	)	PUNCT
dpc-4511	105	11	earlyonset	earlyonset	NOUN
dpc-4511	105	12	group	group	NOUN
dpc-4511	105	13	(	(	PUNCT
dpc-4511	105	14	%	%	INTJ
dpc-4511	105	15	)	)	PUNCT
dpc-4511	105	16	elderlyonset	elderlyonset	VERB
dpc-4511	105	17	group	group	NOUN
dpc-4511	105	18	(	(	PUNCT
dpc-4511	105	19	%	%	INTJ
dpc-4511	105	20	)	)	PUNCT
dpc-4511	105	21	topical	topical	NOUN
dpc-4511	105	22	93.8	93.8	NUM
dpc-4511	105	23	96.1	96.1	NUM
dpc-4511	105	24	92.9	92.9	NUM
dpc-4511	105	25	methotrexate	methotrexate	VERB
dpc-4511	105	26	57.5	57.5	NUM
dpc-4511	105	27	62.1	62.1	NUM
dpc-4511	105	28	50.8	50.8	NUM
dpc-4511	105	29	acitretin	acitretin	NOUN
dpc-4511	105	30	35.6	35.6	NUM
dpc-4511	105	31	37.8	37.8	NUM
dpc-4511	105	32	26.3	26.3	NUM
dpc-4511	105	33	cyclosporine	cyclosporine	NOUN
dpc-4511	105	34	26.3	26.3	NUM
dpc-4511	105	35	34.3	34.3	NUM
dpc-4511	105	36	13	13	NUM
dpc-4511	105	37	phototherapy	phototherapy	NOUN
dpc-4511	105	38	33.1	33.1	NUM
dpc-4511	105	39	40.7	40.7	NUM
dpc-4511	105	40	19.2	19.2	NUM
dpc-4511	105	41	biological	biological	ADJ
dpc-4511	105	42	treatments	treatment	NOUN
dpc-4511	105	43	23.8	23.8	NUM
dpc-4511	105	44	30	30	NUM
dpc-4511	105	45	11.3	11.3	NUM
dpc-4511	105	46	figure	figure	NOUN
dpc-4511	105	47	2	2	NUM
dpc-4511	105	48	.	.	PUNCT
dpc-4511	105	49	clinical	clinical	ADJ
dpc-4511	105	50	images	image	NOUN
dpc-4511	105	51	of	of	ADP
dpc-4511	105	52	psoriatic	psoriatic	ADJ
dpc-4511	105	53	arthritis	arthritis	NOUN
dpc-4511	105	54	(	(	PUNCT
dpc-4511	105	55	a	a	NOUN
dpc-4511	105	56	)	)	PUNCT
dpc-4511	105	57	,	,	PUNCT
dpc-4511	105	58	nail	nail	NOUN
dpc-4511	105	59	psoriasis	psoriasis	NOUN
dpc-4511	105	60	(	(	PUNCT
dpc-4511	105	61	b	b	NOUN
dpc-4511	105	62	)	)	PUNCT
dpc-4511	105	63	,	,	PUNCT
dpc-4511	105	64	(	(	PUNCT
dpc-4511	105	65	c	c	X
dpc-4511	105	66	)	)	PUNCT
dpc-4511	105	67	from	from	ADP
dpc-4511	105	68	our	our	PRON
dpc-4511	105	69	patient	patient	NOUN
dpc-4511	105	70	cohort	cohort	NOUN
dpc-4511	105	71	.	.	PUNCT
dpc-4511	106	1	psoriasis	psoriasis	NOUN
dpc-4511	106	2	,	,	PUNCT
dpc-4511	106	3	generalized	generalize	VERB
dpc-4511	106	4	pustular	pustular	ADJ
dpc-4511	106	5	psoriasis	psoriasis	NOUN
dpc-4511	106	6	,	,	PUNCT
dpc-4511	106	7	erythrodermic	erythrodermic	ADJ
dpc-4511	106	8	psoriasis	psoriasis	NOUN
dpc-4511	106	9	,	,	PUNCT
dpc-4511	106	10	palmoplantar	palmoplantar	NOUN
dpc-4511	106	11	pustular	pustular	ADJ
dpc-4511	106	12	psoriasis	psoriasis	NOUN
dpc-4511	106	13	,	,	PUNCT
dpc-4511	106	14	and	and	CCONJ
dpc-4511	106	15	inverse	inverse	ADJ
dpc-4511	106	16	psoriasis	psoriasis	NOUN
dpc-4511	106	17	[	[	X
dpc-4511	106	18	1,2	1,2	NUM
dpc-4511	106	19	]	]	PUNCT
dpc-4511	106	20	.	.	PUNCT
dpc-4511	107	1	in	in	ADP
dpc-4511	107	2	this	this	DET
dpc-4511	107	3	study	study	NOUN
dpc-4511	107	4	,	,	PUNCT
dpc-4511	107	5	the	the	DET
dpc-4511	107	6	most	most	ADV
dpc-4511	107	7	frequently	frequently	ADV
dpc-4511	107	8	observed	observe	VERB
dpc-4511	107	9	subtype	subtype	NOUN
dpc-4511	107	10	was	be	AUX
dpc-4511	107	11	psoriasis	psoriasis	NOUN
dpc-4511	107	12	vulgaris	vulgaris	NOUN
dpc-4511	107	13	.	.	PUNCT
dpc-4511	108	1	our	our	PRON
dpc-4511	108	2	patient	patient	ADJ
dpc-4511	108	3	cohort	cohort	NOUN
dpc-4511	108	4	also	also	ADV
dpc-4511	108	5	exhibited	exhibit	VERB
dpc-4511	108	6	other	other	ADJ
dpc-4511	108	7	subtypes	subtype	NOUN
dpc-4511	108	8	of	of	ADP
dpc-4511	108	9	psoriasis	psoriasis	NOUN
dpc-4511	108	10	.	.	PUNCT
dpc-4511	109	1	eo	eo	PROPN
dpc-4511	109	2	patients	patient	NOUN
dpc-4511	109	3	tend	tend	VERB
dpc-4511	109	4	to	to	PART
dpc-4511	109	5	have	have	VERB
dpc-4511	109	6	a	a	DET
dpc-4511	109	7	higher	high	ADJ
dpc-4511	109	8	original	original	ADJ
dpc-4511	109	9	article	article	NOUN
dpc-4511	109	10	|	|	ADV
dpc-4511	109	11	dermatol	dermatol	ADJ
dpc-4511	109	12	pract	pract	NOUN
dpc-4511	109	13	concept	concept	NOUN
dpc-4511	109	14	.	.	PUNCT
dpc-4511	110	1	2025;15(1):4511	2025;15(1):4511	NUM
dpc-4511	110	2	5	5	NUM
dpc-4511	110	3	a	a	DET
dpc-4511	110	4	cutoff	cutoff	NOUN
dpc-4511	110	5	age	age	NOUN
dpc-4511	110	6	of	of	ADP
dpc-4511	110	7	60	60	NUM
dpc-4511	110	8	years	year	NOUN
dpc-4511	110	9	.	.	PUNCT
dpc-4511	111	1	these	these	DET
dpc-4511	111	2	studies	study	NOUN
dpc-4511	111	3	have	have	AUX
dpc-4511	111	4	observed	observe	VERB
dpc-4511	111	5	that	that	SCONJ
dpc-4511	111	6	eo	eo	PROPN
dpc-4511	111	7	psoriasis	psoriasis	NOUN
dpc-4511	111	8	has	have	VERB
dpc-4511	111	9	a	a	DET
dpc-4511	111	10	milder	mild	ADJ
dpc-4511	111	11	disease	disease	NOUN
dpc-4511	111	12	course	course	NOUN
dpc-4511	111	13	compared	compare	VERB
dpc-4511	111	14	to	to	ADP
dpc-4511	111	15	early	early	ADJ
dpc-4511	111	16	onset	onset	VERB
dpc-4511	111	17	psoriasis	psoriasis	NOUN
dpc-4511	111	18	.	.	PUNCT
dpc-4511	112	1	our	our	PRON
dpc-4511	112	2	study	study	NOUN
dpc-4511	112	3	categorized	categorize	VERB
dpc-4511	112	4	patients	patient	NOUN
dpc-4511	112	5	into	into	ADP
dpc-4511	112	6	eao	eao	PROPN
dpc-4511	112	7	(	(	PUNCT
dpc-4511	112	8	<	<	NOUN
dpc-4511	112	9	60	60	NUM
dpc-4511	112	10	years	year	NOUN
dpc-4511	112	11	)	)	PUNCT
dpc-4511	112	12	and	and	CCONJ
dpc-4511	112	13	eo	eo	INTJ
dpc-4511	112	14	(	(	PUNCT
dpc-4511	112	15	≥60	≥60	PROPN
dpc-4511	112	16	years	year	NOUN
dpc-4511	112	17	)	)	PUNCT
dpc-4511	112	18	groups	group	NOUN
dpc-4511	112	19	,	,	PUNCT
dpc-4511	112	20	and	and	CCONJ
dpc-4511	112	21	we	we	PRON
dpc-4511	112	22	found	find	VERB
dpc-4511	112	23	similar	similar	ADJ
dpc-4511	112	24	results	result	NOUN
dpc-4511	112	25	regarding	regard	VERB
dpc-4511	112	26	the	the	DET
dpc-4511	112	27	milder	mild	ADJ
dpc-4511	112	28	disease	disease	NOUN
dpc-4511	112	29	course	course	NOUN
dpc-4511	112	30	in	in	ADP
dpc-4511	112	31	the	the	DET
dpc-4511	112	32	eo	eo	PROPN
dpc-4511	112	33	group	group	NOUN
dpc-4511	112	34	.	.	PUNCT
dpc-4511	113	1	kwon	kwon	VERB
dpc-4511	113	2	et	et	PROPN
dpc-4511	113	3	al	al	PROPN
dpc-4511	113	4	.	.	PROPN
dpc-4511	114	1	analyzed	analyze	VERB
dpc-4511	114	2	4049	4049	NUM
dpc-4511	114	3	psoriasis	psoriasis	NOUN
dpc-4511	114	4	patients	patient	NOUN
dpc-4511	114	5	,	,	PUNCT
dpc-4511	114	6	categorizing	categorize	VERB
dpc-4511	114	7	patients	patient	NOUN
dpc-4511	114	8	as	as	ADP
dpc-4511	114	9	eao	eao	ADJ
dpc-4511	114	10	psoriasis	psoriasis	NOUN
dpc-4511	114	11	(	(	PUNCT
dpc-4511	114	12	onset	onset	VERB
dpc-4511	114	13	age	age	NOUN
dpc-4511	114	14	before	before	ADP
dpc-4511	114	15	30	30	NUM
dpc-4511	114	16	years	year	NOUN
dpc-4511	114	17	)	)	PUNCT
dpc-4511	114	18	,	,	PUNCT
dpc-4511	114	19	middle	middle	ADJ
dpc-4511	114	20	onset	onset	NOUN
dpc-4511	114	21	psoriasis	psoriasis	NOUN
dpc-4511	114	22	(	(	PUNCT
dpc-4511	114	23	onset	onset	NOUN
dpc-4511	114	24	age	age	NOUN
dpc-4511	114	25	between	between	ADP
dpc-4511	114	26	30	30	NUM
dpc-4511	114	27	and	and	CCONJ
dpc-4511	114	28	60	60	NUM
dpc-4511	114	29	years	year	NOUN
dpc-4511	114	30	)	)	PUNCT
dpc-4511	114	31	,	,	PUNCT
dpc-4511	114	32	or	or	CCONJ
dpc-4511	114	33	eo	eo	PROPN
dpc-4511	114	34	psoriasis	psoriasis	NOUN
dpc-4511	114	35	(	(	PUNCT
dpc-4511	114	36	onset	onset	VERB
dpc-4511	114	37	age	age	NOUN
dpc-4511	114	38	over	over	ADP
dpc-4511	114	39	60	60	NUM
dpc-4511	114	40	years	year	NOUN
dpc-4511	114	41	)	)	PUNCT
dpc-4511	114	42	,	,	PUNCT
dpc-4511	114	43	compared	compare	VERB
dpc-4511	114	44	the	the	DET
dpc-4511	114	45	clinical	clinical	ADJ
dpc-4511	114	46	features	feature	NOUN
dpc-4511	114	47	of	of	ADP
dpc-4511	114	48	these	these	DET
dpc-4511	114	49	groups	group	NOUN
dpc-4511	114	50	,	,	PUNCT
dpc-4511	114	51	and	and	CCONJ
dpc-4511	114	52	observed	observe	VERB
dpc-4511	114	53	that	that	SCONJ
dpc-4511	114	54	the	the	DET
dpc-4511	114	55	eo	eo	PROPN
dpc-4511	114	56	psoriasis	psoriasis	NOUN
dpc-4511	114	57	group	group	NOUN
dpc-4511	114	58	has	have	VERB
dpc-4511	114	59	a	a	DET
dpc-4511	114	60	milder	mild	ADJ
dpc-4511	114	61	disease	disease	NOUN
dpc-4511	114	62	course	course	NOUN
dpc-4511	114	63	[	[	X
dpc-4511	114	64	24	24	NUM
dpc-4511	114	65	]	]	PUNCT
dpc-4511	114	66	.	.	PUNCT
dpc-4511	115	1	tseng	tseng	PROPN
dpc-4511	115	2	et	et	PROPN
dpc-4511	115	3	al	al	PROPN
dpc-4511	115	4	.	.	PROPN
dpc-4511	115	5	evaluated	evaluate	VERB
dpc-4511	115	6	geriatric	geriatric	ADJ
dpc-4511	115	7	psoriasis	psoriasis	NOUN
dpc-4511	115	8	cases	case	NOUN
dpc-4511	115	9	and	and	CCONJ
dpc-4511	115	10	analyzed	analyze	VERB
dpc-4511	115	11	patients	patient	NOUN
dpc-4511	115	12	according	accord	VERB
dpc-4511	115	13	to	to	ADP
dpc-4511	115	14	the	the	DET
dpc-4511	115	15	age	age	NOUN
dpc-4511	115	16	at	at	ADP
dpc-4511	115	17	disease	disease	NOUN
dpc-4511	115	18	onset	onset	VERB
dpc-4511	115	19	as	as	ADP
dpc-4511	115	20	eao	eao	PROPN
dpc-4511	115	21	(	(	PUNCT
dpc-4511	115	22	aged	aged	ADJ
dpc-4511	115	23	<	<	X
dpc-4511	115	24	60	60	NUM
dpc-4511	115	25	years	year	NOUN
dpc-4511	115	26	)	)	PUNCT
dpc-4511	115	27	or	or	CCONJ
dpc-4511	115	28	eo	eo	INTJ
dpc-4511	115	29	(	(	PUNCT
dpc-4511	115	30	aged	age	VERB
dpc-4511	115	31	≥60	≥60	PROPN
dpc-4511	115	32	years	year	NOUN
dpc-4511	115	33	)	)	PUNCT
dpc-4511	115	34	,	,	PUNCT
dpc-4511	115	35	similar	similar	ADJ
dpc-4511	115	36	to	to	ADP
dpc-4511	115	37	our	our	PRON
dpc-4511	115	38	study	study	NOUN
dpc-4511	115	39	.	.	PUNCT
dpc-4511	116	1	tseng	tseng	PROPN
dpc-4511	116	2	et	et	PROPN
dpc-4511	116	3	al	al	PROPN
dpc-4511	116	4	.	.	PROPN
dpc-4511	117	1	observed	observe	VERB
dpc-4511	117	2	milder	mild	ADJ
dpc-4511	117	3	disease	disease	NOUN
dpc-4511	117	4	onset	onset	VERB
dpc-4511	117	5	,	,	PUNCT
dpc-4511	117	6	less	less	ADV
dpc-4511	117	7	nail	nail	NOUN
dpc-4511	117	8	involvement	involvement	NOUN
dpc-4511	117	9	,	,	PUNCT
dpc-4511	117	10	and	and	CCONJ
dpc-4511	117	11	arthritis	arthritis	NOUN
dpc-4511	117	12	in	in	ADP
dpc-4511	117	13	the	the	DET
dpc-4511	117	14	eo	eo	PROPN
dpc-4511	117	15	group	group	NOUN
dpc-4511	117	16	,	,	PUNCT
dpc-4511	117	17	emphasizing	emphasize	VERB
dpc-4511	117	18	that	that	SCONJ
dpc-4511	117	19	eo	eo	PROPN
dpc-4511	117	20	psoriasis	psoriasis	NOUN
dpc-4511	117	21	exhibits	exhibit	VERB
dpc-4511	117	22	distinct	distinct	ADJ
dpc-4511	117	23	features	feature	NOUN
dpc-4511	117	24	from	from	ADP
dpc-4511	117	25	eao	eao	ADJ
dpc-4511	117	26	psoriasis	psoriasis	NOUN
dpc-4511	117	27	,	,	PUNCT
dpc-4511	117	28	thus	thus	ADV
dpc-4511	117	29	warranting	warrant	VERB
dpc-4511	117	30	evaluation	evaluation	NOUN
dpc-4511	117	31	as	as	ADP
dpc-4511	117	32	a	a	DET
dpc-4511	117	33	specific	specific	ADJ
dpc-4511	117	34	subtype	subtype	NOUN
dpc-4511	118	1	[	[	X
dpc-4511	118	2	4	4	NUM
dpc-4511	118	3	]	]	PUNCT
dpc-4511	118	4	similar	similar	ADJ
dpc-4511	118	5	to	to	ADP
dpc-4511	118	6	the	the	DET
dpc-4511	118	7	literature	literature	NOUN
dpc-4511	118	8	,	,	PUNCT
dpc-4511	118	9	mild	mild	ADJ
dpc-4511	118	10	disease	disease	NOUN
dpc-4511	118	11	onset	onset	VERB
dpc-4511	118	12	severity	severity	NOUN
dpc-4511	118	13	and	and	CCONJ
dpc-4511	118	14	slow	slow	ADJ
dpc-4511	118	15	disease	disease	NOUN
dpc-4511	118	16	course	course	NOUN
dpc-4511	118	17	in	in	ADP
dpc-4511	118	18	our	our	PRON
dpc-4511	118	19	study	study	NOUN
dpc-4511	118	20	were	be	AUX
dpc-4511	118	21	found	find	VERB
dpc-4511	118	22	more	more	ADV
dpc-4511	118	23	frequently	frequently	ADV
dpc-4511	118	24	in	in	ADP
dpc-4511	118	25	the	the	DET
dpc-4511	118	26	eao	eao	ADJ
dpc-4511	118	27	group	group	NOUN
dpc-4511	118	28	.	.	PUNCT
dpc-4511	119	1	psoriasis	psoriasis	NOUN
dpc-4511	119	2	is	be	AUX
dpc-4511	119	3	considered	consider	VERB
dpc-4511	119	4	a	a	DET
dpc-4511	119	5	systemic	systemic	ADJ
dpc-4511	119	6	inflammatory	inflammatory	ADJ
dpc-4511	119	7	disease	disease	NOUN
dpc-4511	119	8	and	and	CCONJ
dpc-4511	119	9	is	be	AUX
dpc-4511	119	10	associated	associate	VERB
dpc-4511	119	11	with	with	ADP
dpc-4511	119	12	various	various	ADJ
dpc-4511	119	13	comorbidities	comorbiditie	NOUN
dpc-4511	119	14	such	such	ADJ
dpc-4511	119	15	as	as	ADP
dpc-4511	119	16	hypertension	hypertension	NOUN
dpc-4511	119	17	,	,	PUNCT
dpc-4511	119	18	metabolic	metabolic	NOUN
dpc-4511	119	19	syndrome	syndrome	NOUN
dpc-4511	119	20	,	,	PUNCT
dpc-4511	119	21	type-2	type-2	NUM
dpc-4511	119	22	diabetes	diabetes	NOUN
dpc-4511	119	23	mellitus	mellitus	NOUN
dpc-4511	119	24	,	,	PUNCT
dpc-4511	119	25	hyperlipidemia	hyperlipidemia	NOUN
dpc-4511	119	26	,	,	PUNCT
dpc-4511	119	27	cardiovascular	cardiovascular	ADJ
dpc-4511	119	28	diseases	disease	NOUN
dpc-4511	119	29	,	,	PUNCT
dpc-4511	119	30	cerebrovascular	cerebrovascular	ADJ
dpc-4511	119	31	events	event	NOUN
dpc-4511	119	32	,	,	PUNCT
dpc-4511	119	33	malignancies	malignancy	NOUN
dpc-4511	119	34	,	,	PUNCT
dpc-4511	119	35	and	and	CCONJ
dpc-4511	119	36	autoimmune	autoimmune	ADJ
dpc-4511	119	37	diseases	disease	NOUN
dpc-4511	119	38	.	.	PUNCT
dpc-4511	120	1	the	the	DET
dpc-4511	120	2	exact	exact	ADJ
dpc-4511	120	3	mechanism	mechanism	NOUN
dpc-4511	120	4	behind	behind	ADP
dpc-4511	120	5	the	the	DET
dpc-4511	120	6	development	development	NOUN
dpc-4511	120	7	of	of	ADP
dpc-4511	120	8	comorbid	comorbid	NOUN
dpc-4511	120	9	diseases	disease	NOUN
dpc-4511	120	10	in	in	ADP
dpc-4511	120	11	psoriasis	psoriasis	NOUN
dpc-4511	120	12	is	be	AUX
dpc-4511	120	13	not	not	PART
dpc-4511	120	14	fully	fully	ADV
dpc-4511	120	15	understood	understand	VERB
dpc-4511	120	16	,	,	PUNCT
dpc-4511	120	17	but	but	CCONJ
dpc-4511	120	18	common	common	ADJ
dpc-4511	120	19	inflammatory	inflammatory	ADJ
dpc-4511	120	20	pathways	pathway	NOUN
dpc-4511	120	21	,	,	PUNCT
dpc-4511	120	22	cellular	cellular	ADJ
dpc-4511	120	23	mediators	mediator	NOUN
dpc-4511	120	24	,	,	PUNCT
dpc-4511	120	25	and	and	CCONJ
dpc-4511	120	26	genetic	genetic	ADJ
dpc-4511	120	27	predisposition	predisposition	NOUN
dpc-4511	120	28	are	be	AUX
dpc-4511	120	29	believed	believe	VERB
dpc-4511	120	30	to	to	PART
dpc-4511	120	31	play	play	VERB
dpc-4511	120	32	a	a	DET
dpc-4511	120	33	role	role	NOUN
dpc-4511	120	34	.	.	PUNCT
dpc-4511	121	1	the	the	DET
dpc-4511	121	2	fact	fact	NOUN
dpc-4511	121	3	that	that	SCONJ
dpc-4511	121	4	systemic	systemic	ADJ
dpc-4511	121	5	comorbidities	comorbiditie	NOUN
dpc-4511	121	6	benefit	benefit	VERB
dpc-4511	121	7	from	from	ADP
dpc-4511	121	8	conventional	conventional	ADJ
dpc-4511	121	9	and	and	CCONJ
dpc-4511	121	10	biologic	biologic	NOUN
dpc-4511	121	11	treatments	treatment	NOUN
dpc-4511	121	12	supports	support	VERB
dpc-4511	121	13	the	the	DET
dpc-4511	121	14	idea	idea	NOUN
dpc-4511	121	15	of	of	ADP
dpc-4511	121	16	common	common	ADJ
dpc-4511	121	17	inflammatory	inflammatory	ADJ
dpc-4511	121	18	pathways	pathway	NOUN
dpc-4511	122	1	[	[	X
dpc-4511	122	2	7	7	NUM
dpc-4511	122	3	-	-	SYM
dpc-4511	122	4	9	9	NUM
dpc-4511	122	5	]	]	PUNCT
dpc-4511	122	6	.	.	PUNCT
dpc-4511	123	1	in	in	ADP
dpc-4511	123	2	our	our	PRON
dpc-4511	123	3	study	study	NOUN
dpc-4511	123	4	,	,	PUNCT
dpc-4511	123	5	hypertension	hypertension	NOUN
dpc-4511	123	6	,	,	PUNCT
dpc-4511	123	7	hyperlipidemia	hyperlipidemia	NOUN
dpc-4511	123	8	,	,	PUNCT
dpc-4511	123	9	and	and	CCONJ
dpc-4511	123	10	type-2	type-2	NUM
dpc-4511	123	11	diabetes	diabetes	NOUN
dpc-4511	123	12	mellitus	mellitus	NOUN
dpc-4511	123	13	were	be	AUX
dpc-4511	123	14	the	the	DET
dpc-4511	123	15	most	most	ADV
dpc-4511	123	16	frequently	frequently	ADV
dpc-4511	123	17	detected	detect	VERB
dpc-4511	123	18	comorbidities	comorbiditie	NOUN
dpc-4511	123	19	,	,	PUNCT
dpc-4511	123	20	consistent	consistent	ADJ
dpc-4511	123	21	with	with	ADP
dpc-4511	123	22	other	other	ADJ
dpc-4511	123	23	geriatric	geriatric	ADJ
dpc-4511	123	24	psoriasis	psoriasis	NOUN
dpc-4511	123	25	studies	study	NOUN
dpc-4511	123	26	.	.	PUNCT
dpc-4511	124	1	topical	topical	ADJ
dpc-4511	124	2	treatments	treatment	NOUN
dpc-4511	124	3	are	be	AUX
dpc-4511	124	4	usually	usually	ADV
dpc-4511	124	5	the	the	DET
dpc-4511	124	6	first	first	ADJ
dpc-4511	124	7	-	-	PUNCT
dpc-4511	124	8	line	line	NOUN
dpc-4511	124	9	therapy	therapy	NOUN
dpc-4511	124	10	for	for	ADP
dpc-4511	124	11	psoriasis	psoriasis	NOUN
dpc-4511	124	12	management	management	NOUN
dpc-4511	124	13	,	,	PUNCT
dpc-4511	124	14	especially	especially	ADV
dpc-4511	124	15	in	in	ADP
dpc-4511	124	16	geriatric	geriatric	ADJ
dpc-4511	124	17	patients	patient	NOUN
dpc-4511	124	18	.	.	PUNCT
dpc-4511	125	1	these	these	DET
dpc-4511	125	2	treatments	treatment	NOUN
dpc-4511	125	3	are	be	AUX
dpc-4511	125	4	preferred	prefer	VERB
dpc-4511	125	5	due	due	ADP
dpc-4511	125	6	to	to	ADP
dpc-4511	125	7	the	the	DET
dpc-4511	125	8	challenges	challenge	NOUN
dpc-4511	125	9	associated	associate	VERB
dpc-4511	125	10	with	with	ADP
dpc-4511	125	11	systemic	systemic	ADJ
dpc-4511	125	12	and	and	CCONJ
dpc-4511	125	13	biologic	biologic	ADJ
dpc-4511	125	14	treatments	treatment	NOUN
dpc-4511	125	15	.	.	PUNCT
dpc-4511	126	1	however	however	ADV
dpc-4511	126	2	,	,	PUNCT
dpc-4511	126	3	these	these	DET
dpc-4511	126	4	challenges	challenge	NOUN
dpc-4511	126	5	often	often	ADV
dpc-4511	126	6	result	result	VERB
dpc-4511	126	7	in	in	ADP
dpc-4511	126	8	inadequate	inadequate	ADJ
dpc-4511	126	9	treatment	treatment	NOUN
dpc-4511	126	10	and	and	CCONJ
dpc-4511	126	11	cause	cause	VERB
dpc-4511	126	12	physical	physical	ADJ
dpc-4511	126	13	and	and	CCONJ
dpc-4511	126	14	psychological	psychological	ADJ
dpc-4511	126	15	suffering	suffering	NOUN
dpc-4511	126	16	for	for	ADP
dpc-4511	126	17	psoriasis	psoriasis	NOUN
dpc-4511	126	18	patients	patient	NOUN
dpc-4511	126	19	[	[	X
dpc-4511	126	20	1,2,4,5,11	1,2,4,5,11	NOUN
dpc-4511	126	21	-	-	SYM
dpc-4511	126	22	14	14	NUM
dpc-4511	126	23	]	]	PUNCT
dpc-4511	126	24	.	.	PUNCT
dpc-4511	127	1	in	in	ADP
dpc-4511	127	2	our	our	PRON
dpc-4511	127	3	study	study	NOUN
dpc-4511	127	4	,	,	PUNCT
dpc-4511	127	5	topical	topical	ADJ
dpc-4511	127	6	treatment	treatment	NOUN
dpc-4511	127	7	agents	agent	NOUN
dpc-4511	127	8	were	be	AUX
dpc-4511	127	9	the	the	DET
dpc-4511	127	10	preferred	preferred	ADJ
dpc-4511	127	11	first	first	ADJ
dpc-4511	127	12	treatment	treatment	NOUN
dpc-4511	127	13	option	option	NOUN
dpc-4511	127	14	,	,	PUNCT
dpc-4511	127	15	followed	follow	VERB
dpc-4511	127	16	by	by	ADP
dpc-4511	127	17	conventional	conventional	ADJ
dpc-4511	127	18	and	and	CCONJ
dpc-4511	127	19	biologic	biologic	ADJ
dpc-4511	127	20	agents	agent	NOUN
dpc-4511	127	21	.	.	PUNCT
dpc-4511	128	1	throughout	throughout	ADP
dpc-4511	128	2	the	the	DET
dpc-4511	128	3	disease	disease	NOUN
dpc-4511	128	4	,	,	PUNCT
dpc-4511	128	5	topical	topical	ADJ
dpc-4511	128	6	treatment	treatment	NOUN
dpc-4511	128	7	,	,	PUNCT
dpc-4511	128	8	methotrexate	methotrexate	NOUN
dpc-4511	128	9	,	,	PUNCT
dpc-4511	128	10	and	and	CCONJ
dpc-4511	128	11	acitretin	acitretin	NOUN
dpc-4511	128	12	were	be	AUX
dpc-4511	128	13	the	the	DET
dpc-4511	128	14	most	most	ADV
dpc-4511	128	15	commonly	commonly	ADV
dpc-4511	128	16	used	use	VERB
dpc-4511	128	17	treatment	treatment	NOUN
dpc-4511	128	18	agents	agent	NOUN
dpc-4511	128	19	.	.	PUNCT
dpc-4511	129	1	this	this	PRON
dpc-4511	129	2	was	be	AUX
dpc-4511	129	3	similar	similar	ADJ
dpc-4511	129	4	to	to	ADP
dpc-4511	129	5	other	other	ADJ
dpc-4511	129	6	studies	study	NOUN
dpc-4511	129	7	in	in	ADP
dpc-4511	129	8	the	the	DET
dpc-4511	129	9	literature	literature	NOUN
dpc-4511	129	10	.	.	PUNCT
dpc-4511	130	1	also	also	ADV
dpc-4511	130	2	,	,	PUNCT
dpc-4511	130	3	23.8	23.8	NUM
dpc-4511	130	4	%	%	NOUN
dpc-4511	130	5	of	of	ADP
dpc-4511	130	6	our	our	PRON
dpc-4511	130	7	patient	patient	ADJ
dpc-4511	130	8	cohort	cohort	NOUN
dpc-4511	130	9	had	have	VERB
dpc-4511	130	10	biologic	biologic	ADJ
dpc-4511	130	11	agent	agent	NOUN
dpc-4511	130	12	treatment	treatment	NOUN
dpc-4511	130	13	.	.	PUNCT
dpc-4511	131	1	eo	eo	PROPN
dpc-4511	131	2	cases	case	NOUN
dpc-4511	131	3	may	may	AUX
dpc-4511	131	4	require	require	VERB
dpc-4511	131	5	systemic	systemic	ADJ
dpc-4511	131	6	treatment	treatment	NOUN
dpc-4511	131	7	as	as	ADP
dpc-4511	131	8	the	the	DET
dpc-4511	131	9	primary	primary	ADJ
dpc-4511	131	10	approach	approach	NOUN
dpc-4511	131	11	,	,	PUNCT
dpc-4511	131	12	unlike	unlike	ADP
dpc-4511	131	13	eao	eao	ADJ
dpc-4511	131	14	cases	case	NOUN
dpc-4511	131	15	,	,	PUNCT
dpc-4511	131	16	due	due	ADP
dpc-4511	131	17	to	to	ADP
dpc-4511	131	18	the	the	DET
dpc-4511	131	19	faster	fast	ADJ
dpc-4511	131	20	progression	progression	NOUN
dpc-4511	131	21	of	of	ADP
dpc-4511	131	22	the	the	DET
dpc-4511	131	23	disease	disease	NOUN
dpc-4511	131	24	and	and	CCONJ
dpc-4511	131	25	the	the	DET
dpc-4511	131	26	presence	presence	NOUN
dpc-4511	131	27	of	of	ADP
dpc-4511	131	28	moderate	moderate	ADJ
dpc-4511	131	29	-	-	PUNCT
dpc-4511	131	30	severe	severe	ADJ
dpc-4511	131	31	psoriasis	psoriasis	NOUN
dpc-4511	131	32	.	.	PUNCT
dpc-4511	132	1	the	the	DET
dpc-4511	132	2	faster	fast	ADJ
dpc-4511	132	3	course	course	NOUN
dpc-4511	132	4	of	of	ADP
dpc-4511	132	5	the	the	DET
dpc-4511	132	6	disease	disease	NOUN
dpc-4511	132	7	in	in	ADP
dpc-4511	132	8	eo	eo	PROPN
dpc-4511	132	9	cases	case	NOUN
dpc-4511	132	10	and	and	CCONJ
dpc-4511	132	11	the	the	DET
dpc-4511	132	12	presence	presence	NOUN
dpc-4511	132	13	of	of	ADP
dpc-4511	132	14	moderate	moderate	ADJ
dpc-4511	132	15	-	-	PUNCT
dpc-4511	132	16	severe	severe	ADJ
dpc-4511	132	17	psoriasis	psoriasis	NOUN
dpc-4511	132	18	may	may	AUX
dpc-4511	132	19	explain	explain	VERB
dpc-4511	132	20	this	this	PRON
dpc-4511	132	21	.	.	PUNCT
dpc-4511	133	1	the	the	DET
dpc-4511	133	2	eao	eao	PROPN
dpc-4511	133	3	group	group	NOUN
dpc-4511	133	4	received	receive	VERB
dpc-4511	133	5	less	less	ADJ
dpc-4511	133	6	cyclosporine	cyclosporine	ADJ
dpc-4511	133	7	frequency	frequency	NOUN
dpc-4511	133	8	of	of	ADP
dpc-4511	133	9	erythrodermic	erythrodermic	ADJ
dpc-4511	133	10	psoriasis	psoriasis	NOUN
dpc-4511	133	11	,	,	PUNCT
dpc-4511	133	12	as	as	SCONJ
dpc-4511	133	13	reported	report	VERB
dpc-4511	133	14	in	in	ADP
dpc-4511	133	15	previous	previous	ADJ
dpc-4511	133	16	studies	study	NOUN
dpc-4511	133	17	[	[	X
dpc-4511	133	18	11,14	11,14	X
dpc-4511	133	19	]	]	PUNCT
dpc-4511	133	20	in	in	ADP
dpc-4511	133	21	this	this	DET
dpc-4511	133	22	study	study	NOUN
dpc-4511	133	23	,	,	PUNCT
dpc-4511	133	24	in	in	ADP
dpc-4511	133	25	addition	addition	NOUN
dpc-4511	133	26	to	to	ADP
dpc-4511	133	27	the	the	DET
dpc-4511	133	28	knees	knee	NOUN
dpc-4511	133	29	and	and	CCONJ
dpc-4511	133	30	elbows	elbow	NOUN
dpc-4511	133	31	,	,	PUNCT
dpc-4511	133	32	which	which	PRON
dpc-4511	133	33	are	be	AUX
dpc-4511	133	34	the	the	DET
dpc-4511	133	35	classical	classical	ADJ
dpc-4511	133	36	involvement	involvement	NOUN
dpc-4511	133	37	areas	area	NOUN
dpc-4511	133	38	of	of	ADP
dpc-4511	133	39	psoriasis	psoriasis	NOUN
dpc-4511	133	40	,	,	PUNCT
dpc-4511	133	41	lesions	lesion	NOUN
dpc-4511	133	42	were	be	AUX
dpc-4511	133	43	also	also	ADV
dpc-4511	133	44	detected	detect	VERB
dpc-4511	133	45	in	in	ADP
dpc-4511	133	46	the	the	DET
dpc-4511	133	47	face	face	NOUN
dpc-4511	133	48	,	,	PUNCT
dpc-4511	133	49	palmoplantar	palmoplantar	NOUN
dpc-4511	133	50	region	region	NOUN
dpc-4511	133	51	and	and	CCONJ
dpc-4511	133	52	intertriginous	intertriginous	ADJ
dpc-4511	133	53	region	region	NOUN
dpc-4511	133	54	.	.	PUNCT
dpc-4511	134	1	knee	knee	NOUN
dpc-4511	134	2	and	and	CCONJ
dpc-4511	134	3	elbow	elbow	NOUN
dpc-4511	134	4	lesions	lesion	NOUN
dpc-4511	134	5	were	be	AUX
dpc-4511	134	6	detected	detect	VERB
dpc-4511	134	7	more	more	ADV
dpc-4511	134	8	frequently	frequently	ADV
dpc-4511	134	9	at	at	ADP
dpc-4511	134	10	the	the	DET
dpc-4511	134	11	beginning	beginning	NOUN
dpc-4511	134	12	and	and	CCONJ
dpc-4511	134	13	during	during	ADP
dpc-4511	134	14	the	the	DET
dpc-4511	134	15	disease	disease	NOUN
dpc-4511	134	16	in	in	ADP
dpc-4511	134	17	the	the	DET
dpc-4511	134	18	eao	eao	ADJ
dpc-4511	134	19	group	group	NOUN
dpc-4511	134	20	.	.	PUNCT
dpc-4511	135	1	nail	nail	NOUN
dpc-4511	135	2	involvement	involvement	NOUN
dpc-4511	135	3	and	and	CCONJ
dpc-4511	135	4	psoriatic	psoriatic	ADJ
dpc-4511	135	5	arthritis	arthritis	NOUN
dpc-4511	135	6	are	be	AUX
dpc-4511	135	7	important	important	ADJ
dpc-4511	135	8	factors	factor	NOUN
dpc-4511	135	9	in	in	ADP
dpc-4511	135	10	determining	determine	VERB
dpc-4511	135	11	the	the	DET
dpc-4511	135	12	choice	choice	NOUN
dpc-4511	135	13	of	of	ADP
dpc-4511	135	14	treatment	treatment	NOUN
dpc-4511	135	15	for	for	ADP
dpc-4511	135	16	psoriasis	psoriasis	NOUN
dpc-4511	135	17	patients	patient	NOUN
dpc-4511	135	18	.	.	PUNCT
dpc-4511	136	1	in	in	ADP
dpc-4511	136	2	this	this	DET
dpc-4511	136	3	study	study	NOUN
dpc-4511	136	4	,	,	PUNCT
dpc-4511	136	5	the	the	DET
dpc-4511	136	6	eao	eao	ADJ
dpc-4511	136	7	group	group	NOUN
dpc-4511	136	8	had	have	VERB
dpc-4511	136	9	a	a	DET
dpc-4511	136	10	higher	high	ADJ
dpc-4511	136	11	frequency	frequency	NOUN
dpc-4511	136	12	of	of	ADP
dpc-4511	136	13	nail	nail	NOUN
dpc-4511	136	14	involvement	involvement	NOUN
dpc-4511	136	15	and	and	CCONJ
dpc-4511	136	16	psoriatic	psoriatic	ADJ
dpc-4511	136	17	arthritis	arthritis	NOUN
dpc-4511	136	18	.	.	PUNCT
dpc-4511	137	1	psoriatic	psoriatic	ADJ
dpc-4511	137	2	arthritis	arthritis	NOUN
dpc-4511	137	3	typically	typically	ADV
dpc-4511	137	4	develops	develop	VERB
dpc-4511	137	5	approximately	approximately	ADV
dpc-4511	137	6	7–8	7–8	NUM
dpc-4511	137	7	years	year	NOUN
dpc-4511	137	8	after	after	ADP
dpc-4511	137	9	the	the	DET
dpc-4511	137	10	onset	onset	NOUN
dpc-4511	137	11	of	of	ADP
dpc-4511	137	12	psoriasis	psoriasis	NOUN
dpc-4511	137	13	,	,	PUNCT
dpc-4511	137	14	and	and	CCONJ
dpc-4511	137	15	the	the	DET
dpc-4511	137	16	longer	long	ADJ
dpc-4511	137	17	duration	duration	NOUN
dpc-4511	137	18	of	of	ADP
dpc-4511	137	19	the	the	DET
dpc-4511	137	20	disease	disease	NOUN
dpc-4511	137	21	in	in	ADP
dpc-4511	137	22	the	the	DET
dpc-4511	137	23	eao	eao	ADJ
dpc-4511	137	24	group	group	NOUN
dpc-4511	137	25	may	may	AUX
dpc-4511	137	26	explain	explain	VERB
dpc-4511	137	27	the	the	DET
dpc-4511	137	28	higher	high	ADJ
dpc-4511	137	29	frequency	frequency	NOUN
dpc-4511	137	30	of	of	ADP
dpc-4511	137	31	observed	observe	VERB
dpc-4511	137	32	psoriatic	psoriatic	ADJ
dpc-4511	137	33	arthritis	arthritis	NOUN
dpc-4511	137	34	and	and	CCONJ
dpc-4511	137	35	nail	nail	NOUN
dpc-4511	137	36	involvement	involvement	NOUN
dpc-4511	137	37	[	[	X
dpc-4511	137	38	1,2,4	1,2,4	NUM
dpc-4511	137	39	]	]	X
dpc-4511	137	40	psoriasis	psoriasis	NOUN
dpc-4511	137	41	is	be	AUX
dpc-4511	137	42	characterized	characterize	VERB
dpc-4511	137	43	by	by	ADP
dpc-4511	137	44	various	various	ADJ
dpc-4511	137	45	factors	factor	NOUN
dpc-4511	137	46	such	such	ADJ
dpc-4511	137	47	as	as	ADP
dpc-4511	137	48	increased	increase	VERB
dpc-4511	137	49	keratinocyte	keratinocyte	NOUN
dpc-4511	137	50	proliferation	proliferation	NOUN
dpc-4511	137	51	,	,	PUNCT
dpc-4511	137	52	abnormal	abnormal	ADJ
dpc-4511	137	53	keratinocyte	keratinocyte	NOUN
dpc-4511	137	54	differentiation	differentiation	NOUN
dpc-4511	137	55	,	,	PUNCT
dpc-4511	137	56	changes	change	NOUN
dpc-4511	137	57	in	in	ADP
dpc-4511	137	58	dermal	dermal	ADJ
dpc-4511	137	59	vascularity	vascularity	NOUN
dpc-4511	137	60	,	,	PUNCT
dpc-4511	137	61	increased	increase	VERB
dpc-4511	137	62	cellular	cellular	ADJ
dpc-4511	137	63	antioxidant	antioxidant	ADJ
dpc-4511	137	64	activity	activity	NOUN
dpc-4511	137	65	,	,	PUNCT
dpc-4511	137	66	and	and	CCONJ
dpc-4511	137	67	the	the	DET
dpc-4511	137	68	presence	presence	NOUN
dpc-4511	137	69	of	of	ADP
dpc-4511	137	70	certain	certain	ADJ
dpc-4511	137	71	cells	cell	NOUN
dpc-4511	137	72	in	in	ADP
dpc-4511	137	73	the	the	DET
dpc-4511	137	74	dermal	dermal	NOUN
dpc-4511	137	75	/	/	SYM
dpc-4511	137	76	epidermal	epidermal	ADJ
dpc-4511	137	77	layers	layer	NOUN
dpc-4511	137	78	.	.	PUNCT
dpc-4511	138	1	stimulated	stimulate	VERB
dpc-4511	138	2	dendritic	dendritic	ADJ
dpc-4511	138	3	cells	cell	NOUN
dpc-4511	138	4	release	release	VERB
dpc-4511	138	5	il-6	il-6	NOUN
dpc-4511	138	6	,	,	PUNCT
dpc-4511	138	7	which	which	PRON
dpc-4511	138	8	plays	play	VERB
dpc-4511	138	9	a	a	DET
dpc-4511	138	10	role	role	NOUN
dpc-4511	138	11	in	in	ADP
dpc-4511	138	12	inflammation	inflammation	NOUN
dpc-4511	138	13	through	through	ADP
dpc-4511	138	14	immune	immune	ADJ
dpc-4511	138	15	responses	response	NOUN
dpc-4511	138	16	.	.	PUNCT
dpc-4511	139	1	cytokines	cytokine	NOUN
dpc-4511	139	2	released	release	VERB
dpc-4511	139	3	by	by	ADP
dpc-4511	139	4	th-1	th-1	SYM
dpc-4511	139	5	and	and	CCONJ
dpc-4511	139	6	th-17	th-17	NOUN
dpc-4511	139	7	cells	cell	NOUN
dpc-4511	139	8	,	,	PUNCT
dpc-4511	139	9	including	include	VERB
dpc-4511	139	10	tnf	tnf	PROPN
dpc-4511	139	11	-	-	PUNCT
dpc-4511	139	12	α	α	PROPN
dpc-4511	139	13	,	,	PUNCT
dpc-4511	139	14	il-12	il-12	NOUN
dpc-4511	139	15	,	,	PUNCT
dpc-4511	139	16	il-17	il-17	X
dpc-4511	139	17	,	,	PUNCT
dpc-4511	139	18	il-22	il-22	NOUN
dpc-4511	139	19	,	,	PUNCT
dpc-4511	139	20	and	and	CCONJ
dpc-4511	139	21	il-23	il-23	NOUN
dpc-4511	139	22	,	,	PUNCT
dpc-4511	139	23	also	also	ADV
dpc-4511	139	24	contribute	contribute	VERB
dpc-4511	139	25	to	to	ADP
dpc-4511	139	26	the	the	DET
dpc-4511	139	27	development	development	NOUN
dpc-4511	139	28	of	of	ADP
dpc-4511	139	29	psoriasis	psoriasis	NOUN
dpc-4511	139	30	.	.	PUNCT
dpc-4511	140	1	il-22	il-22	NOUN
dpc-4511	140	2	activates	activate	VERB
dpc-4511	140	3	stat-3	stat-3	NUM
dpc-4511	140	4	,	,	PUNCT
dpc-4511	140	5	which	which	PRON
dpc-4511	140	6	causes	cause	VERB
dpc-4511	140	7	the	the	DET
dpc-4511	140	8	epidermal	epidermal	ADJ
dpc-4511	140	9	growth	growth	NOUN
dpc-4511	140	10	seen	see	VERB
dpc-4511	140	11	in	in	ADP
dpc-4511	140	12	psoriatic	psoriatic	ADJ
dpc-4511	140	13	lesions	lesion	NOUN
dpc-4511	140	14	[	[	X
dpc-4511	140	15	15,16	15,16	NUM
dpc-4511	140	16	]	]	PUNCT
dpc-4511	140	17	.	.	PUNCT
dpc-4511	141	1	in	in	ADP
dpc-4511	141	2	addition	addition	NOUN
dpc-4511	141	3	to	to	ADP
dpc-4511	141	4	intrinsic	intrinsic	ADJ
dpc-4511	141	5	factors	factor	NOUN
dpc-4511	141	6	,	,	PUNCT
dpc-4511	141	7	extrinsic	extrinsic	ADJ
dpc-4511	141	8	risk	risk	NOUN
dpc-4511	141	9	factors	factor	NOUN
dpc-4511	141	10	such	such	ADJ
dpc-4511	141	11	as	as	ADP
dpc-4511	141	12	emotional	emotional	ADJ
dpc-4511	141	13	stress	stress	NOUN
dpc-4511	141	14	,	,	PUNCT
dpc-4511	141	15	infections	infection	NOUN
dpc-4511	141	16	,	,	PUNCT
dpc-4511	141	17	physical	physical	ADJ
dpc-4511	141	18	factors	factor	NOUN
dpc-4511	141	19	,	,	PUNCT
dpc-4511	141	20	vaccines	vaccine	NOUN
dpc-4511	141	21	,	,	PUNCT
dpc-4511	141	22	radiotherapy	radiotherapy	NOUN
dpc-4511	141	23	,	,	PUNCT
dpc-4511	141	24	smoking	smoking	NOUN
dpc-4511	141	25	,	,	PUNCT
dpc-4511	141	26	and	and	CCONJ
dpc-4511	141	27	alcohol	alcohol	NOUN
dpc-4511	141	28	can	can	AUX
dpc-4511	141	29	also	also	ADV
dpc-4511	141	30	contribute	contribute	VERB
dpc-4511	141	31	to	to	ADP
dpc-4511	141	32	psoriasis	psoriasis	NOUN
dpc-4511	141	33	.	.	PUNCT
dpc-4511	142	1	these	these	DET
dpc-4511	142	2	risk	risk	NOUN
dpc-4511	142	3	factors	factor	NOUN
dpc-4511	142	4	may	may	AUX
dpc-4511	142	5	be	be	AUX
dpc-4511	142	6	associated	associate	VERB
dpc-4511	142	7	with	with	ADP
dpc-4511	142	8	psoriasis	psoriasis	NOUN
dpc-4511	142	9	-	-	PUNCT
dpc-4511	142	10	related	relate	VERB
dpc-4511	142	11	systemic	systemic	ADJ
dpc-4511	142	12	comorbidities	comorbiditie	NOUN
dpc-4511	142	13	such	such	ADJ
dpc-4511	142	14	as	as	ADP
dpc-4511	142	15	metabolic	metabolic	NOUN
dpc-4511	142	16	syndrome	syndrome	NOUN
dpc-4511	142	17	,	,	PUNCT
dpc-4511	142	18	cardiovascular	cardiovascular	ADJ
dpc-4511	142	19	diseases	disease	NOUN
dpc-4511	142	20	,	,	PUNCT
dpc-4511	142	21	and	and	CCONJ
dpc-4511	142	22	cerebrovascular	cerebrovascular	ADJ
dpc-4511	142	23	events	event	NOUN
dpc-4511	142	24	[	[	X
dpc-4511	142	25	17	17	NUM
dpc-4511	142	26	-	-	SYM
dpc-4511	142	27	22	22	NUM
dpc-4511	142	28	]	]	PUNCT
dpc-4511	142	29	.	.	PUNCT
dpc-4511	143	1	the	the	DET
dpc-4511	143	2	increase	increase	NOUN
dpc-4511	143	3	in	in	ADP
dpc-4511	143	4	these	these	DET
dpc-4511	143	5	comorbidities	comorbiditie	NOUN
dpc-4511	143	6	in	in	ADP
dpc-4511	143	7	the	the	DET
dpc-4511	143	8	geriatric	geriatric	ADJ
dpc-4511	143	9	population	population	NOUN
dpc-4511	143	10	reveals	reveal	VERB
dpc-4511	143	11	the	the	DET
dpc-4511	143	12	need	need	NOUN
dpc-4511	143	13	to	to	PART
dpc-4511	143	14	prioritize	prioritize	VERB
dpc-4511	143	15	and	and	CCONJ
dpc-4511	143	16	manage	manage	VERB
dpc-4511	143	17	not	not	PART
dpc-4511	143	18	only	only	ADV
dpc-4511	143	19	the	the	DET
dpc-4511	143	20	disease	disease	NOUN
dpc-4511	143	21	but	but	CCONJ
dpc-4511	143	22	also	also	ADV
dpc-4511	143	23	its	its	PRON
dpc-4511	143	24	comorbidities	comorbiditie	NOUN
dpc-4511	143	25	in	in	ADP
dpc-4511	143	26	the	the	DET
dpc-4511	143	27	management	management	NOUN
dpc-4511	143	28	of	of	ADP
dpc-4511	143	29	psoriasis	psoriasis	NOUN
dpc-4511	143	30	[	[	X
dpc-4511	143	31	4	4	NUM
dpc-4511	143	32	-	-	SYM
dpc-4511	143	33	6,11,14	6,11,14	NUM
dpc-4511	143	34	]	]	PUNCT
dpc-4511	143	35	.	.	PUNCT
dpc-4511	144	1	we	we	PRON
dpc-4511	144	2	detected	detect	VERB
dpc-4511	144	3	emotional	emotional	ADJ
dpc-4511	144	4	stress	stress	NOUN
dpc-4511	144	5	(	(	PUNCT
dpc-4511	144	6	68.1	68.1	NUM
dpc-4511	144	7	%	%	NOUN
dpc-4511	144	8	)	)	PUNCT
dpc-4511	144	9	as	as	ADP
dpc-4511	144	10	one	one	NUM
dpc-4511	144	11	of	of	ADP
dpc-4511	144	12	the	the	DET
dpc-4511	144	13	most	most	ADV
dpc-4511	144	14	frequently	frequently	ADV
dpc-4511	144	15	detected	detect	VERB
dpc-4511	144	16	triggering	trigger	VERB
dpc-4511	144	17	factors	factor	NOUN
dpc-4511	144	18	at	at	ADP
dpc-4511	144	19	the	the	DET
dpc-4511	144	20	onset	onset	NOUN
dpc-4511	144	21	and	and	CCONJ
dpc-4511	144	22	in	in	ADP
dpc-4511	144	23	the	the	DET
dpc-4511	144	24	course	course	NOUN
dpc-4511	144	25	of	of	ADP
dpc-4511	144	26	the	the	DET
dpc-4511	144	27	disease	disease	NOUN
dpc-4511	144	28	.	.	PUNCT
dpc-4511	145	1	infections	infection	NOUN
dpc-4511	145	2	and	and	CCONJ
dpc-4511	145	3	physical	physical	ADJ
dpc-4511	145	4	factors	factor	NOUN
dpc-4511	145	5	were	be	AUX
dpc-4511	145	6	also	also	ADV
dpc-4511	145	7	among	among	ADP
dpc-4511	145	8	the	the	DET
dpc-4511	145	9	other	other	ADJ
dpc-4511	145	10	detected	detect	VERB
dpc-4511	145	11	triggering	trigger	VERB
dpc-4511	145	12	factors	factor	NOUN
dpc-4511	145	13	.	.	PUNCT
dpc-4511	146	1	also	also	ADV
dpc-4511	146	2	,	,	PUNCT
dpc-4511	146	3	70.6	70.6	NUM
dpc-4511	146	4	%	%	NOUN
dpc-4511	146	5	of	of	ADP
dpc-4511	146	6	patients	patient	NOUN
dpc-4511	146	7	had	have	VERB
dpc-4511	146	8	a	a	DET
dpc-4511	146	9	smoking	smoking	NOUN
dpc-4511	146	10	history	history	NOUN
dpc-4511	146	11	,	,	PUNCT
dpc-4511	146	12	and	and	CCONJ
dpc-4511	146	13	11.9	11.9	NUM
dpc-4511	146	14	%	%	NOUN
dpc-4511	146	15	of	of	ADP
dpc-4511	146	16	the	the	DET
dpc-4511	146	17	patients	patient	NOUN
dpc-4511	146	18	had	have	VERB
dpc-4511	146	19	an	an	DET
dpc-4511	146	20	alcohol	alcohol	NOUN
dpc-4511	146	21	consumption	consumption	NOUN
dpc-4511	146	22	history	history	NOUN
dpc-4511	146	23	.	.	PUNCT
dpc-4511	147	1	psoriasis	psoriasis	NOUN
dpc-4511	147	2	can	can	AUX
dpc-4511	147	3	start	start	VERB
dpc-4511	147	4	at	at	ADP
dpc-4511	147	5	any	any	DET
dpc-4511	147	6	age	age	NOUN
dpc-4511	147	7	,	,	PUNCT
dpc-4511	147	8	but	but	CCONJ
dpc-4511	147	9	it	it	PRON
dpc-4511	147	10	has	have	AUX
dpc-4511	147	11	been	be	AUX
dpc-4511	147	12	found	find	VERB
dpc-4511	147	13	to	to	PART
dpc-4511	147	14	have	have	VERB
dpc-4511	147	15	a	a	DET
dpc-4511	147	16	bimodal	bimodal	NOUN
dpc-4511	147	17	distribution	distribution	NOUN
dpc-4511	147	18	,	,	PUNCT
dpc-4511	147	19	with	with	ADP
dpc-4511	147	20	the	the	DET
dpc-4511	147	21	first	first	ADJ
dpc-4511	147	22	peak	peak	NOUN
dpc-4511	147	23	occurring	occur	VERB
dpc-4511	147	24	in	in	ADP
dpc-4511	147	25	the	the	DET
dpc-4511	147	26	4th	4th	ADJ
dpc-4511	147	27	and	and	CCONJ
dpc-4511	147	28	the	the	DET
dpc-4511	147	29	7th	7th	ADJ
dpc-4511	147	30	decades	decade	NOUN
dpc-4511	148	1	[	[	X
dpc-4511	148	2	1	1	NUM
dpc-4511	148	3	-	-	SYM
dpc-4511	148	4	3	3	NUM
dpc-4511	148	5	]	]	PUNCT
dpc-4511	148	6	.	.	PUNCT
dpc-4511	149	1	psoriasis	psoriasis	NOUN
dpc-4511	149	2	is	be	AUX
dpc-4511	149	3	one	one	NUM
dpc-4511	149	4	of	of	ADP
dpc-4511	149	5	the	the	DET
dpc-4511	149	6	most	most	ADV
dpc-4511	149	7	common	common	ADJ
dpc-4511	149	8	dermatological	dermatological	ADJ
dpc-4511	149	9	diseases	disease	NOUN
dpc-4511	149	10	in	in	ADP
dpc-4511	149	11	the	the	DET
dpc-4511	149	12	geriatric	geriatric	ADJ
dpc-4511	149	13	population	population	NOUN
dpc-4511	149	14	.	.	PUNCT
dpc-4511	150	1	although	although	SCONJ
dpc-4511	150	2	the	the	DET
dpc-4511	150	3	exact	exact	ADJ
dpc-4511	150	4	prevalence	prevalence	NOUN
dpc-4511	150	5	of	of	ADP
dpc-4511	150	6	psoriasis	psoriasis	NOUN
dpc-4511	150	7	in	in	ADP
dpc-4511	150	8	the	the	DET
dpc-4511	150	9	geriatric	geriatric	ADJ
dpc-4511	150	10	population	population	NOUN
dpc-4511	150	11	is	be	AUX
dpc-4511	150	12	unknown	unknown	ADJ
dpc-4511	150	13	,	,	PUNCT
dpc-4511	150	14	studies	study	NOUN
dpc-4511	150	15	have	have	AUX
dpc-4511	150	16	reported	report	VERB
dpc-4511	150	17	rates	rate	NOUN
dpc-4511	150	18	ranging	range	VERB
dpc-4511	150	19	from	from	ADP
dpc-4511	150	20	1	1	NUM
dpc-4511	150	21	%	%	NOUN
dpc-4511	150	22	to	to	PART
dpc-4511	150	23	19	19	NUM
dpc-4511	150	24	%	%	NOUN
dpc-4511	150	25	[	[	X
dpc-4511	150	26	11	11	NUM
dpc-4511	150	27	]	]	PUNCT
dpc-4511	150	28	.	.	PUNCT
dpc-4511	151	1	researchers	researcher	NOUN
dpc-4511	151	2	typically	typically	ADV
dpc-4511	151	3	categorize	categorize	VERB
dpc-4511	151	4	psoriasis	psoriasis	NOUN
dpc-4511	151	5	as	as	ADP
dpc-4511	151	6	eao	eao	PROPN
dpc-4511	151	7	(	(	PUNCT
dpc-4511	151	8	onset	onset	VERB
dpc-4511	151	9	before	before	ADP
dpc-4511	151	10	the	the	DET
dpc-4511	151	11	age	age	NOUN
dpc-4511	151	12	of	of	ADP
dpc-4511	151	13	40	40	NUM
dpc-4511	151	14	years	year	NOUN
dpc-4511	151	15	)	)	PUNCT
dpc-4511	151	16	and	and	CCONJ
dpc-4511	151	17	lateonset	lateonset	NOUN
dpc-4511	151	18	(	(	PUNCT
dpc-4511	151	19	onset	onset	VERB
dpc-4511	151	20	at	at	ADP
dpc-4511	151	21	or	or	CCONJ
dpc-4511	151	22	after	after	ADP
dpc-4511	151	23	the	the	DET
dpc-4511	151	24	age	age	NOUN
dpc-4511	151	25	of	of	ADP
dpc-4511	151	26	40	40	NUM
dpc-4511	151	27	years	year	NOUN
dpc-4511	151	28	)	)	PUNCT
dpc-4511	152	1	[	[	X
dpc-4511	152	2	23	23	NUM
dpc-4511	152	3	]	]	PUNCT
dpc-4511	152	4	.	.	PUNCT
dpc-4511	153	1	however	however	ADV
dpc-4511	153	2	,	,	PUNCT
dpc-4511	153	3	there	there	PRON
dpc-4511	153	4	is	be	VERB
dpc-4511	153	5	an	an	DET
dpc-4511	153	6	overlap	overlap	NOUN
dpc-4511	153	7	in	in	ADP
dpc-4511	153	8	the	the	DET
dpc-4511	153	9	clinical	clinical	ADJ
dpc-4511	153	10	features	feature	NOUN
dpc-4511	153	11	of	of	ADP
dpc-4511	153	12	these	these	DET
dpc-4511	153	13	two	two	NUM
dpc-4511	153	14	groups	group	NOUN
dpc-4511	153	15	.	.	PUNCT
dpc-4511	154	1	recent	recent	ADJ
dpc-4511	154	2	studies	study	NOUN
dpc-4511	154	3	have	have	AUX
dpc-4511	154	4	focused	focus	VERB
dpc-4511	154	5	on	on	ADP
dpc-4511	154	6	the	the	DET
dpc-4511	154	7	eo	eo	PROPN
dpc-4511	154	8	group	group	NOUN
dpc-4511	154	9	,	,	PUNCT
dpc-4511	154	10	which	which	PRON
dpc-4511	154	11	has	have	VERB
dpc-4511	154	12	6	6	NUM
dpc-4511	154	13	original	original	ADJ
dpc-4511	154	14	article	article	NOUN
dpc-4511	154	15	|	|	ADV
dpc-4511	154	16	dermatol	dermatol	ADJ
dpc-4511	154	17	pract	pract	NOUN
dpc-4511	154	18	concept	concept	NOUN
dpc-4511	154	19	.	.	PUNCT
dpc-4511	155	1	2025;15(1):4511	2025;15(1):4511	NUM
dpc-4511	155	2	4	4	NUM
dpc-4511	155	3	.	.	PUNCT
dpc-4511	156	1	tseng	tseng	PROPN
dpc-4511	156	2	il	il	PROPN
dpc-4511	156	3	,	,	PUNCT
dpc-4511	156	4	yang	yang	PROPN
dpc-4511	156	5	cc	cc	PROPN
dpc-4511	156	6	,	,	PUNCT
dpc-4511	156	7	lai	lai	PROPN
dpc-4511	156	8	ec	ec	PROPN
dpc-4511	156	9	,	,	PUNCT
dpc-4511	156	10	lee	lee	PROPN
dpc-4511	156	11	cn	cn	PROPN
dpc-4511	156	12	.	.	PUNCT
dpc-4511	156	13	psoriasis	psoriasis	NOUN
dpc-4511	156	14	in	in	ADP
dpc-4511	156	15	the	the	DET
dpc-4511	156	16	geriatric	geriatric	ADJ
dpc-4511	156	17	population	population	NOUN
dpc-4511	156	18	:	:	PUNCT
dpc-4511	156	19	a	a	DET
dpc-4511	156	20	retrospective	retrospective	ADJ
dpc-4511	156	21	study	study	NOUN
dpc-4511	156	22	in	in	ADP
dpc-4511	156	23	asians	asians	PROPN
dpc-4511	156	24	.	.	PUNCT
dpc-4511	156	25	  	  	SPACE
dpc-4511	157	1	j	j	PROPN
dpc-4511	157	2	dermatol	dermatol	NOUN
dpc-4511	157	3	.	.	PUNCT
dpc-4511	158	1	2021;48(6):818	2021;48(6):818	NUM
dpc-4511	158	2	-	-	SYM
dpc-4511	158	3	824	824	NUM
dpc-4511	158	4	.	.	PUNCT
dpc-4511	159	1	doi:10.1111/1346	doi:10.1111/1346	VERB
dpc-4511	159	2	-	-	PUNCT
dpc-4511	159	3	8138.15737	8138.15737	NUM
dpc-4511	159	4	5	5	NUM
dpc-4511	159	5	.	.	PUNCT
dpc-4511	159	6	balato	balato	NOUN
dpc-4511	159	7	,	,	PUNCT
dpc-4511	159	8	n.	n.	NOUN
dpc-4511	159	9	,	,	PUNCT
dpc-4511	159	10	patruno	patruno	ADJ
dpc-4511	159	11	,	,	PUNCT
dpc-4511	159	12	c.	c.	PROPN
dpc-4511	159	13	,	,	PUNCT
dpc-4511	159	14	napolitano	napolitano	PROPN
dpc-4511	159	15	,	,	PUNCT
dpc-4511	159	16	m.	m.	NOUN
dpc-4511	159	17	  	  	SPACE
dpc-4511	159	18	et	et	PROPN
dpc-4511	159	19	al	al	PROPN
dpc-4511	159	20	.	.	PROPN
dpc-4511	159	21	  	  	SPACE
dpc-4511	159	22	managing	manage	VERB
dpc-4511	159	23	moderate	moderate	ADJ
dpc-4511	159	24	-	-	PUNCT
dpc-4511	159	25	to	to	ADP
dpc-4511	159	26	-	-	PUNCT
dpc-4511	159	27	severe	severe	ADJ
dpc-4511	159	28	psoriasis	psoriasis	NOUN
dpc-4511	159	29	in	in	ADP
dpc-4511	159	30	the	the	DET
dpc-4511	159	31	elderly	elderly	ADJ
dpc-4511	159	32	.	.	PUNCT
dpc-4511	160	1	drugs	drug	NOUN
dpc-4511	160	2	aging	age	VERB
dpc-4511	160	3	  	  	SPACE
dpc-4511	160	4	31	31	NUM
dpc-4511	160	5	,	,	PUNCT
dpc-4511	160	6	233–238	233–238	NUM
dpc-4511	160	7	(	(	PUNCT
dpc-4511	160	8	2014	2014	NUM
dpc-4511	160	9	)	)	PUNCT
dpc-4511	160	10	.	.	PUNCT
dpc-4511	161	1	doi:10.1007	doi:10.1007	VERB
dpc-4511	161	2	/	/	SYM
dpc-4511	161	3	s40266	s40266	NOUN
dpc-4511	161	4	-	-	PUNCT
dpc-4511	161	5	014	014	NUM
dpc-4511	161	6	-	-	PUNCT
dpc-4511	161	7	0156	0156	NUM
dpc-4511	161	8	-	-	SYM
dpc-4511	161	9	6	6	NUM
dpc-4511	161	10	6	6	NUM
dpc-4511	161	11	.	.	PUNCT
dpc-4511	162	1	chen	chen	PROPN
dpc-4511	162	2	c	c	PROPN
dpc-4511	162	3	,	,	PUNCT
dpc-4511	162	4	che	che	PROPN
dpc-4511	162	5	k	k	PROPN
dpc-4511	162	6	,	,	PUNCT
dpc-4511	162	7	guo	guo	PROPN
dpc-4511	162	8	y	y	PROPN
dpc-4511	162	9	,	,	PUNCT
dpc-4511	162	10	huang	huang	PROPN
dpc-4511	162	11	q	q	PROPN
dpc-4511	162	12	,	,	PUNCT
dpc-4511	162	13	hu	hu	PROPN
dpc-4511	162	14	x	x	PROPN
dpc-4511	162	15	,	,	PUNCT
dpc-4511	162	16	yu	yu	PROPN
dpc-4511	162	17	b.	b.	PROPN
dpc-4511	162	18	effect	effect	NOUN
dpc-4511	162	19	of	of	ADP
dpc-4511	162	20	the	the	DET
dpc-4511	162	21	age	age	NOUN
dpc-4511	162	22	of	of	ADP
dpc-4511	162	23	onset	onset	NOUN
dpc-4511	162	24	on	on	ADP
dpc-4511	162	25	epidemiology	epidemiology	NOUN
dpc-4511	162	26	,	,	PUNCT
dpc-4511	162	27	clinical	clinical	ADJ
dpc-4511	162	28	features	feature	NOUN
dpc-4511	162	29	,	,	PUNCT
dpc-4511	162	30	and	and	CCONJ
dpc-4511	162	31	comorbidity	comorbidity	NOUN
dpc-4511	162	32	of	of	ADP
dpc-4511	162	33	geriatric	geriatric	ADJ
dpc-4511	162	34	psoriasis	psoriasis	NOUN
dpc-4511	162	35	[	[	X
dpc-4511	162	36	published	publish	VERB
dpc-4511	162	37	online	online	ADV
dpc-4511	162	38	ahead	ahead	ADV
dpc-4511	162	39	of	of	ADP
dpc-4511	162	40	print	print	NOUN
dpc-4511	162	41	,	,	PUNCT
dpc-4511	162	42	2023	2023	NUM
dpc-4511	162	43	jun	jun	PROPN
dpc-4511	162	44	22	22	NUM
dpc-4511	162	45	]	]	PUNCT
dpc-4511	162	46	.	.	PUNCT
dpc-4511	163	1	j	j	PROPN
dpc-4511	163	2	dermatol	dermatol	NOUN
dpc-4511	163	3	.	.	PUNCT
dpc-4511	164	1	2023;10.1111/1346	2023;10.1111/1346	NUM
dpc-4511	164	2	-	-	PUNCT
dpc-4511	164	3	8138.16856	8138.16856	PROPN
dpc-4511	164	4	.	.	PUNCT
dpc-4511	165	1	doi:10.1111	doi:10.1111	NOUN
dpc-4511	165	2	/1346	/1346	PUNCT
dpc-4511	165	3	-	-	PUNCT
dpc-4511	165	4	8138.16856	8138.16856	PROPN
dpc-4511	165	5	7	7	NUM
dpc-4511	165	6	.	.	PUNCT
dpc-4511	165	7	yamazaki	yamazaki	PROPN
dpc-4511	165	8	f.	f.	PROPN
dpc-4511	165	9	psoriasis	psoriasis	PROPN
dpc-4511	165	10	:	:	PUNCT
dpc-4511	165	11	comorbidities	comorbiditie	NOUN
dpc-4511	165	12	.	.	PUNCT
dpc-4511	165	13	  	  	SPACE
dpc-4511	166	1	j	j	PROPN
dpc-4511	166	2	dermatol	dermatol	NOUN
dpc-4511	166	3	.	.	PUNCT
dpc-4511	167	1	2021;48(6	2021;48(6	NUM
dpc-4511	167	2	):	):	PUNCT
dpc-4511	167	3	732	732	NUM
dpc-4511	167	4	-	-	SYM
dpc-4511	167	5	740	740	NUM
dpc-4511	167	6	.	.	PUNCT
dpc-4511	168	1	doi:10.1111/1346	doi:10.1111/1346	VERB
dpc-4511	168	2	-	-	PUNCT
dpc-4511	168	3	8138.15840	8138.15840	NUM
dpc-4511	168	4	8	8	NUM
dpc-4511	168	5	.	.	PUNCT
dpc-4511	169	1	takeshita	takeshita	PROPN
dpc-4511	169	2	j	j	PROPN
dpc-4511	169	3	,	,	PUNCT
dpc-4511	169	4	grewal	grewal	PROPN
dpc-4511	169	5	s	s	PROPN
dpc-4511	169	6	,	,	PUNCT
dpc-4511	169	7	langan	langan	PROPN
dpc-4511	169	8	sm	sm	PROPN
dpc-4511	169	9	,	,	PUNCT
dpc-4511	169	10	et	et	PROPN
dpc-4511	169	11	al	al	PROPN
dpc-4511	169	12	.	.	PUNCT
dpc-4511	170	1	psoriasis	psoriasis	NOUN
dpc-4511	170	2	and	and	CCONJ
dpc-4511	170	3	comorbid	comorbid	NOUN
dpc-4511	170	4	diseases	disease	NOUN
dpc-4511	170	5	:	:	PUNCT
dpc-4511	170	6	epidemiology	epidemiology	NOUN
dpc-4511	170	7	.	.	PUNCT
dpc-4511	170	8	  	  	SPACE
dpc-4511	171	1	j	j	PROPN
dpc-4511	171	2	am	be	AUX
dpc-4511	171	3	acad	acad	ADJ
dpc-4511	171	4	dermatol	dermatol	NOUN
dpc-4511	171	5	.	.	PUNCT
dpc-4511	172	1	2017;76(3	2017;76(3	NUM
dpc-4511	172	2	):	):	PUNCT
dpc-4511	172	3	377	377	NUM
dpc-4511	172	4	-	-	SYM
dpc-4511	172	5	390	390	NUM
dpc-4511	172	6	.	.	PUNCT
dpc-4511	173	1	doi:10.1016	doi:10.1016	PROPN
dpc-4511	173	2	/	/	SYM
dpc-4511	173	3	j.jaad.2016.07.064	j.jaad.2016.07.064	PROPN
dpc-4511	173	4	9	9	NUM
dpc-4511	173	5	.	.	PUNCT
dpc-4511	173	6	bu	bu	PROPN
dpc-4511	173	7	j	j	PROPN
dpc-4511	173	8	,	,	PUNCT
dpc-4511	173	9	ding	de	VERB
dpc-4511	173	10	r	r	NOUN
dpc-4511	173	11	,	,	PUNCT
dpc-4511	173	12	zhou	zhou	PROPN
dpc-4511	173	13	l	l	PROPN
dpc-4511	173	14	,	,	PUNCT
dpc-4511	173	15	chen	chen	PROPN
dpc-4511	173	16	x	x	PROPN
dpc-4511	173	17	,	,	PUNCT
dpc-4511	173	18	shen	shen	PROPN
dpc-4511	173	19	e.	e.	PROPN
dpc-4511	173	20	epidemiology	epidemiology	PROPN
dpc-4511	173	21	of	of	ADP
dpc-4511	173	22	psoriasis	psoriasis	NOUN
dpc-4511	173	23	and	and	CCONJ
dpc-4511	173	24	comorbid	comorbid	NOUN
dpc-4511	173	25	diseases	disease	NOUN
dpc-4511	173	26	:	:	PUNCT
dpc-4511	173	27	a	a	DET
dpc-4511	173	28	narrative	narrative	NOUN
dpc-4511	173	29	review	review	NOUN
dpc-4511	173	30	.	.	PUNCT
dpc-4511	173	31	  	  	SPACE
dpc-4511	173	32	front	front	ADJ
dpc-4511	173	33	immunol	immunol	NOUN
dpc-4511	173	34	.	.	PUNCT
dpc-4511	174	1	2022;13:880201	2022;13:880201	X
dpc-4511	174	2	.	.	PUNCT
dpc-4511	174	3	published	publish	VERB
dpc-4511	174	4	2022	2022	NUM
dpc-4511	174	5	jun	jun	PROPN
dpc-4511	174	6	10	10	NUM
dpc-4511	174	7	.	.	PUNCT
dpc-4511	175	1	doi:10.3389	doi:10.3389	PROPN
dpc-4511	175	2	/fimmu.2022.880201	/fimmu.2022.880201	PUNCT
dpc-4511	176	1	10	10	NUM
dpc-4511	176	2	.	.	PUNCT
dpc-4511	177	1	reid	reid	PROPN
dpc-4511	177	2	c	c	PROPN
dpc-4511	177	3	,	,	PUNCT
dpc-4511	177	4	griffiths	griffiths	PROPN
dpc-4511	177	5	cem	cem	PROPN
dpc-4511	177	6	.	.	PUNCT
dpc-4511	178	1	psoriasis	psoriasis	NOUN
dpc-4511	178	2	and	and	CCONJ
dpc-4511	178	3	treatment	treatment	NOUN
dpc-4511	178	4	:	:	PUNCT
dpc-4511	178	5	past	past	ADJ
dpc-4511	178	6	,	,	PUNCT
dpc-4511	178	7	present	present	ADJ
dpc-4511	178	8	and	and	CCONJ
dpc-4511	178	9	future	future	ADJ
dpc-4511	178	10	aspects	aspect	NOUN
dpc-4511	178	11	.	.	PUNCT
dpc-4511	178	12	  	  	SPACE
dpc-4511	179	1	acta	acta	PROPN
dpc-4511	179	2	derm	derm	NOUN
dpc-4511	179	3	venereol	venereol	NOUN
dpc-4511	179	4	.	.	PUNCT
dpc-4511	180	1	2020;100(3):adv00032	2020;100(3):adv00032	X
dpc-4511	180	2	.	.	PUNCT
dpc-4511	180	3	published	publish	VERB
dpc-4511	180	4	2020	2020	NUM
dpc-4511	180	5	jan	jan	PROPN
dpc-4511	180	6	30	30	NUM
dpc-4511	180	7	.	.	PUNCT
dpc-4511	181	1	doi:10.2340/00015555	doi:10.2340/00015555	NOUN
dpc-4511	181	2	-	-	PUNCT
dpc-4511	181	3	3386	3386	NUM
dpc-4511	181	4	11	11	NUM
dpc-4511	181	5	.	.	PUNCT
dpc-4511	182	1	van	van	PROPN
dpc-4511	182	2	winden	winden	PROPN
dpc-4511	182	3	mec	mec	PROPN
dpc-4511	182	4	,	,	PUNCT
dpc-4511	182	5	ter	ter	PROPN
dpc-4511	182	6	haar	haar	PROPN
dpc-4511	182	7	elm	elm	PROPN
dpc-4511	182	8	,	,	PUNCT
dpc-4511	182	9	groenewoud	groenewoud	ADJ
dpc-4511	182	10	hmm	hmm	NOUN
dpc-4511	182	11	,	,	PUNCT
dpc-4511	182	12	van	van	PROPN
dpc-4511	182	13	de	de	X
dpc-4511	182	14	kerkhof	kerkhof	PROPN
dpc-4511	182	15	pcm	pcm	PROPN
dpc-4511	182	16	,	,	PUNCT
dpc-4511	182	17	de	de	PROPN
dpc-4511	182	18	jong	jong	PROPN
dpc-4511	182	19	emgj	emgj	PROPN
dpc-4511	182	20	,	,	PUNCT
dpc-4511	182	21	lubeek	lubeek	NOUN
dpc-4511	182	22	sfk	sfk	NOUN
dpc-4511	182	23	.	.	PUNCT
dpc-4511	183	1	disease	disease	NOUN
dpc-4511	183	2	and	and	CCONJ
dpc-4511	183	3	treatment	treatment	NOUN
dpc-4511	183	4	characteristics	characteristic	NOUN
dpc-4511	183	5	in	in	ADP
dpc-4511	183	6	geriatric	geriatric	ADJ
dpc-4511	183	7	psoriasis	psoriasis	NOUN
dpc-4511	183	8	:	:	PUNCT
dpc-4511	183	9	a	a	DET
dpc-4511	183	10	patient	patient	ADJ
dpc-4511	183	11	survey	survey	NOUN
dpc-4511	183	12	comparing	compare	VERB
dpc-4511	183	13	age	age	NOUN
dpc-4511	183	14	groups	group	NOUN
dpc-4511	183	15	.	.	PUNCT
dpc-4511	183	16	 	 	SPACE
dpc-4511	184	1	acta	acta	PROPN
dpc-4511	184	2	derm	derm	PROPN
dpc-4511	184	3	venereol	venereol	NOUN
dpc-4511	184	4	.	.	PUNCT
dpc-4511	185	1	2020;100(14):adv00215	2020;100(14):adv00215	X
dpc-4511	185	2	.	.	PUNCT
dpc-4511	186	1	published	publish	VERB
dpc-4511	186	2	2020	2020	NUM
dpc-4511	186	3	jul	jul	PROPN
dpc-4511	186	4	28	28	NUM
dpc-4511	186	5	.	.	PUNCT
dpc-4511	187	1	doi:10.2340/00015555	doi:10.2340/00015555	NOUN
dpc-4511	187	2	-	-	SYM
dpc-4511	187	3	3569	3569	NUM
dpc-4511	187	4	12	12	NUM
dpc-4511	187	5	.	.	PUNCT
dpc-4511	188	1	megna	megna	PROPN
dpc-4511	188	2	m	m	PROPN
dpc-4511	188	3	,	,	PUNCT
dpc-4511	188	4	camela	camela	ADP
dpc-4511	188	5	e	e	PROPN
dpc-4511	188	6	,	,	PUNCT
dpc-4511	188	7	battista	battista	PROPN
dpc-4511	188	8	t	t	PROPN
dpc-4511	188	9	,	,	PUNCT
dpc-4511	188	10	et	et	PROPN
dpc-4511	188	11	al	al	PROPN
dpc-4511	188	12	.	.	PROPN
dpc-4511	188	13	efficacy	efficacy	NOUN
dpc-4511	188	14	and	and	CCONJ
dpc-4511	188	15	safety	safety	NOUN
dpc-4511	188	16	of	of	ADP
dpc-4511	188	17	biologics	biologic	NOUN
dpc-4511	188	18	and	and	CCONJ
dpc-4511	188	19	small	small	ADJ
dpc-4511	188	20	molecules	molecule	NOUN
dpc-4511	188	21	for	for	ADP
dpc-4511	188	22	psoriasis	psoriasis	NOUN
dpc-4511	188	23	in	in	ADP
dpc-4511	188	24	pediatric	pediatric	ADJ
dpc-4511	188	25	and	and	CCONJ
dpc-4511	188	26	geriatric	geriatric	ADJ
dpc-4511	188	27	populations	population	NOUN
dpc-4511	188	28	.	.	PUNCT
dpc-4511	189	1	part	part	NOUN
dpc-4511	189	2	ii	ii	PROPN
dpc-4511	189	3	:	:	PUNCT
dpc-4511	189	4	focus	focus	VERB
dpc-4511	189	5	on	on	ADP
dpc-4511	189	6	elderly	elderly	ADJ
dpc-4511	189	7	patients	patient	NOUN
dpc-4511	189	8	.	.	PUNCT
dpc-4511	189	9	 	 	SPACE
dpc-4511	190	1	expert	expert	ADJ
dpc-4511	190	2	opin	opin	NOUN
dpc-4511	190	3	drug	drug	NOUN
dpc-4511	190	4	saf	saf	PROPN
dpc-4511	190	5	.	.	PUNCT
dpc-4511	191	1	2023;22(1):43	2023;22(1):43	NUM
dpc-4511	191	2	-	-	SYM
dpc-4511	191	3	58	58	NUM
dpc-4511	191	4	.	.	PUNCT
dpc-4511	192	1	doi:10.1080/14740338.2023.2173171	doi:10.1080/14740338.2023.2173171	PROPN
dpc-4511	192	2	13	13	NUM
dpc-4511	192	3	.	.	PUNCT
dpc-4511	193	1	piaserico	piaserico	PROPN
dpc-4511	193	2	s	s	PART
dpc-4511	193	3	,	,	PUNCT
dpc-4511	193	4	conti	conti	PROPN
dpc-4511	193	5	a	a	X
dpc-4511	193	6	,	,	PUNCT
dpc-4511	193	7	lo	lo	PROPN
dpc-4511	193	8	console	console	PROPN
dpc-4511	193	9	f	f	PROPN
dpc-4511	193	10	,	,	PUNCT
dpc-4511	194	1	et	et	PROPN
dpc-4511	194	2	al	al	PROPN
dpc-4511	194	3	.	.	PROPN
dpc-4511	194	4	efficacy	efficacy	NOUN
dpc-4511	194	5	and	and	CCONJ
dpc-4511	194	6	safety	safety	NOUN
dpc-4511	194	7	of	of	ADP
dpc-4511	194	8	systemic	systemic	ADJ
dpc-4511	194	9	treatments	treatment	NOUN
dpc-4511	194	10	for	for	ADP
dpc-4511	194	11	psoriasis	psoriasis	NOUN
dpc-4511	194	12	in	in	ADP
dpc-4511	194	13	elderly	elderly	ADJ
dpc-4511	194	14	patients	patient	NOUN
dpc-4511	194	15	.	.	PUNCT
dpc-4511	194	16	 	 	SPACE
dpc-4511	195	1	acta	acta	PROPN
dpc-4511	195	2	derm	derm	NOUN
dpc-4511	195	3	venereol	venereol	NOUN
dpc-4511	195	4	.	.	PUNCT
dpc-4511	196	1	2014;94(3):293	2014;94(3):293	NUM
dpc-4511	196	2	-	-	SYM
dpc-4511	196	3	297	297	NUM
dpc-4511	196	4	.	.	PUNCT
dpc-4511	197	1	doi:10.2340/00015555	doi:10.2340/00015555	NOUN
dpc-4511	197	2	-	-	SYM
dpc-4511	197	3	1719	1719	NUM
dpc-4511	197	4	14	14	NUM
dpc-4511	197	5	.	.	PUNCT
dpc-4511	198	1	trettel	trettel	PROPN
dpc-4511	198	2	a	a	PRON
dpc-4511	198	3	,	,	PUNCT
dpc-4511	198	4	spehr	spehr	NOUN
dpc-4511	198	5	c	c	PROPN
dpc-4511	198	6	,	,	PUNCT
dpc-4511	198	7	körber	körber	PROPN
dpc-4511	198	8	a	a	PROPN
dpc-4511	198	9	,	,	PUNCT
dpc-4511	198	10	augustin	augustin	PROPN
dpc-4511	198	11	m.	m.	PROPN
dpc-4511	198	12	the	the	DET
dpc-4511	198	13	impact	impact	NOUN
dpc-4511	198	14	of	of	ADP
dpc-4511	198	15	age	age	NOUN
dpc-4511	198	16	on	on	ADP
dpc-4511	198	17	psoriasis	psoriasis	NOUN
dpc-4511	198	18	health	health	NOUN
dpc-4511	198	19	care	care	NOUN
dpc-4511	198	20	in	in	ADP
dpc-4511	198	21	germany	germany	PROPN
dpc-4511	198	22	.	.	PUNCT
dpc-4511	198	23	 	 	SPACE
dpc-4511	199	1	j	j	PROPN
dpc-4511	199	2	eur	eur	PROPN
dpc-4511	199	3	acad	acad	PROPN
dpc-4511	199	4	dermatol	dermatol	NOUN
dpc-4511	199	5	venereol	venereol	NOUN
dpc-4511	199	6	.	.	PUNCT
dpc-4511	200	1	2017;31(5):870	2017;31(5):870	NUM
dpc-4511	200	2	-	-	SYM
dpc-4511	200	3	875	875	NUM
dpc-4511	200	4	.	.	PUNCT
dpc-4511	201	1	doi:10.1111	doi:10.1111	PROPN
dpc-4511	201	2	/	/	SYM
dpc-4511	201	3	jdv.14115	jdv.14115	PROPN
dpc-4511	201	4	15	15	NUM
dpc-4511	201	5	.	.	PUNCT
dpc-4511	202	1	rendon	rendon	PROPN
dpc-4511	202	2	a	a	PRON
dpc-4511	202	3	,	,	PUNCT
dpc-4511	202	4	schäkel	schäkel	PROPN
dpc-4511	202	5	k.	k.	PROPN
dpc-4511	202	6	psoriasis	psoriasis	NOUN
dpc-4511	202	7	pathogenesis	pathogenesis	NOUN
dpc-4511	202	8	and	and	CCONJ
dpc-4511	202	9	treatment	treatment	NOUN
dpc-4511	202	10	.	.	PUNCT
dpc-4511	202	11	 	 	SPACE
dpc-4511	203	1	int	int	PROPN
dpc-4511	203	2	j	j	PROPN
dpc-4511	203	3	mol	mol	ADP
dpc-4511	203	4	sci	sci	PROPN
dpc-4511	203	5	.	.	PUNCT
dpc-4511	204	1	2019;20(6):1475	2019;20(6):1475	NUM
dpc-4511	204	2	.	.	PUNCT
dpc-4511	205	1	published	publish	VERB
dpc-4511	205	2	2019	2019	NUM
dpc-4511	205	3	mar	mar	PROPN
dpc-4511	205	4	23	23	NUM
dpc-4511	205	5	.	.	PUNCT
dpc-4511	206	1	doi:10.3390	doi:10.3390	NOUN
dpc-4511	206	2	/	/	SYM
dpc-4511	206	3	ijms20061475	ijms20061475	PROPN
dpc-4511	206	4	16	16	NUM
dpc-4511	206	5	.	.	PUNCT
dpc-4511	207	1	sano	sano	PROPN
dpc-4511	207	2	s	s	PROPN
dpc-4511	207	3	,	,	PUNCT
dpc-4511	207	4	chan	chan	PROPN
dpc-4511	207	5	ks	ks	PROPN
dpc-4511	207	6	,	,	PUNCT
dpc-4511	207	7	carbajal	carbajal	PROPN
dpc-4511	207	8	s	s	PART
dpc-4511	207	9	,	,	PUNCT
dpc-4511	207	10	et	et	PROPN
dpc-4511	207	11	al	al	PROPN
dpc-4511	207	12	.	.	PUNCT
dpc-4511	208	1	stat3	stat3	NOUN
dpc-4511	208	2	links	link	NOUN
dpc-4511	208	3	activated	activate	VERB
dpc-4511	208	4	keratinocytes	keratinocyte	NOUN
dpc-4511	208	5	and	and	CCONJ
dpc-4511	208	6	immunocytes	immunocyte	NOUN
dpc-4511	208	7	required	require	VERB
dpc-4511	208	8	for	for	ADP
dpc-4511	208	9	development	development	NOUN
dpc-4511	208	10	of	of	ADP
dpc-4511	208	11	psoriasis	psoriasis	NOUN
dpc-4511	208	12	in	in	ADP
dpc-4511	208	13	a	a	DET
dpc-4511	208	14	novel	novel	ADJ
dpc-4511	208	15	transgenic	transgenic	NOUN
dpc-4511	208	16	mouse	mouse	NOUN
dpc-4511	208	17	model	model	NOUN
dpc-4511	208	18	.	.	PUNCT
dpc-4511	208	19	 	 	SPACE
dpc-4511	209	1	nat	nat	PROPN
dpc-4511	209	2	med	med	PROPN
dpc-4511	209	3	.	.	PUNCT
dpc-4511	210	1	2005;11(1):43	2005;11(1):43	PROPN
dpc-4511	210	2	-	-	SYM
dpc-4511	210	3	49	49	NUM
dpc-4511	210	4	.	.	PUNCT
dpc-4511	211	1	doi:10.1038	doi:10.1038	NOUN
dpc-4511	211	2	/	/	SYM
dpc-4511	211	3	nm1162	nm1162	PROPN
dpc-4511	211	4	17	17	NUM
dpc-4511	211	5	.	.	PUNCT
dpc-4511	211	6	kamiya	kamiya	PROPN
dpc-4511	212	1	k	k	PROPN
dpc-4511	212	2	,	,	PUNCT
dpc-4511	212	3	kishimoto	kishimoto	PROPN
dpc-4511	212	4	m	m	PROPN
dpc-4511	212	5	,	,	PUNCT
dpc-4511	212	6	sugai	sugai	PROPN
dpc-4511	212	7	j	j	PROPN
dpc-4511	212	8	,	,	PUNCT
dpc-4511	212	9	komine	komine	PROPN
dpc-4511	212	10	m	m	PROPN
dpc-4511	212	11	,	,	PUNCT
dpc-4511	212	12	ohtsuki	ohtsuki	ADJ
dpc-4511	212	13	m.	m.	NOUN
dpc-4511	212	14	risk	risk	NOUN
dpc-4511	212	15	factors	factor	NOUN
dpc-4511	212	16	for	for	ADP
dpc-4511	212	17	the	the	DET
dpc-4511	212	18	development	development	NOUN
dpc-4511	212	19	of	of	ADP
dpc-4511	212	20	psoriasis	psoriasis	NOUN
dpc-4511	212	21	.	.	PUNCT
dpc-4511	212	22	  	  	SPACE
dpc-4511	213	1	int	int	PROPN
dpc-4511	213	2	j	j	PROPN
dpc-4511	213	3	mol	mol	ADP
dpc-4511	213	4	sci	sci	PROPN
dpc-4511	213	5	.	.	PUNCT
dpc-4511	214	1	2019;20(18):4347	2019;20(18):4347	X
dpc-4511	214	2	.	.	PUNCT
dpc-4511	214	3	published	publish	VERB
dpc-4511	214	4	2019	2019	NUM
dpc-4511	214	5	sep	sep	NOUN
dpc-4511	214	6	5	5	NUM
dpc-4511	214	7	.	.	PUNCT
dpc-4511	215	1	doi:10.3390	doi:10.3390	PROPN
dpc-4511	215	2	/	/	SYM
dpc-4511	215	3	ijms	ijm	VERB
dpc-4511	215	4	20184347	20184347	NUM
dpc-4511	215	5	18	18	NUM
dpc-4511	215	6	.	.	PUNCT
dpc-4511	216	1	rousset	rousset	PROPN
dpc-4511	216	2	l	l	PROPN
dpc-4511	216	3	,	,	PUNCT
dpc-4511	216	4	halioua	halioua	PROPN
dpc-4511	216	5	b.	b.	PROPN
dpc-4511	216	6	stress	stress	NOUN
dpc-4511	216	7	and	and	CCONJ
dpc-4511	216	8	psoriasis	psoriasis	NOUN
dpc-4511	216	9	.	.	PUNCT
dpc-4511	216	10	  	  	SPACE
dpc-4511	217	1	int	int	PROPN
dpc-4511	217	2	j	j	PROPN
dpc-4511	217	3	dermatol	dermatol	NOUN
dpc-4511	217	4	.	.	PUNCT
dpc-4511	218	1	2018;57(10):1165	2018;57(10):1165	NUM
dpc-4511	218	2	-	-	SYM
dpc-4511	218	3	1172	1172	NUM
dpc-4511	218	4	.	.	PUNCT
dpc-4511	219	1	doi:10.1111	doi:10.1111	NOUN
dpc-4511	219	2	/	/	SYM
dpc-4511	219	3	ijd.14032	ijd.14032	PROPN
dpc-4511	219	4	19	19	NUM
dpc-4511	219	5	.	.	PUNCT
dpc-4511	220	1	zhou	zhou	PROPN
dpc-4511	220	2	s	s	PROPN
dpc-4511	220	3	,	,	PUNCT
dpc-4511	220	4	yao	yao	PROPN
dpc-4511	220	5	z.	z.	PROPN
dpc-4511	220	6	roles	role	NOUN
dpc-4511	220	7	of	of	ADP
dpc-4511	220	8	infection	infection	NOUN
dpc-4511	220	9	in	in	ADP
dpc-4511	220	10	psoriasis	psoriasis	NOUN
dpc-4511	220	11	.	.	PUNCT
dpc-4511	220	12	  	  	SPACE
dpc-4511	221	1	int	int	PROPN
dpc-4511	221	2	j	j	PROPN
dpc-4511	221	3	mol	mol	ADP
dpc-4511	221	4	sci	sci	PROPN
dpc-4511	221	5	.	.	PUNCT
dpc-4511	222	1	2022;23(13):6955	2022;23(13):6955	X
dpc-4511	222	2	.	.	PROPN
dpc-4511	222	3	published	publish	VERB
dpc-4511	222	4	2022	2022	NUM
dpc-4511	222	5	jun	jun	PROPN
dpc-4511	222	6	23	23	NUM
dpc-4511	222	7	.	.	PUNCT
dpc-4511	223	1	doi:10.3390	doi:10.3390	PROPN
dpc-4511	223	2	/	/	SYM
dpc-4511	223	3	ijms	ijm	VERB
dpc-4511	223	4	23136955	23136955	NUM
dpc-4511	223	5	20	20	NUM
dpc-4511	223	6	.	.	PUNCT
dpc-4511	224	1	weatherhead	weatherhead	PROPN
dpc-4511	224	2	sc	sc	PROPN
dpc-4511	224	3	,	,	PUNCT
dpc-4511	224	4	farr	farr	PROPN
dpc-4511	224	5	pm	pm	PROPN
dpc-4511	224	6	,	,	PUNCT
dpc-4511	224	7	jamieson	jamieson	PROPN
dpc-4511	224	8	d	d	PROPN
dpc-4511	224	9	,	,	PUNCT
dpc-4511	224	10	et	et	PROPN
dpc-4511	224	11	al	al	PROPN
dpc-4511	224	12	.	.	PROPN
dpc-4511	224	13	keratinocyte	keratinocyte	PROPN
dpc-4511	224	14	apoptosis	apoptosis	NOUN
dpc-4511	224	15	in	in	ADP
dpc-4511	224	16	epidermal	epidermal	ADJ
dpc-4511	224	17	remodeling	remodeling	NOUN
dpc-4511	224	18	and	and	CCONJ
dpc-4511	224	19	clearance	clearance	NOUN
dpc-4511	224	20	of	of	ADP
dpc-4511	224	21	psoriasis	psoriasis	NOUN
dpc-4511	224	22	induced	induce	VERB
dpc-4511	224	23	by	by	ADP
dpc-4511	224	24	uv	uv	NOUN
dpc-4511	224	25	radiation	radiation	NOUN
dpc-4511	224	26	.	.	PUNCT
dpc-4511	224	27	  	  	SPACE
dpc-4511	225	1	j	j	PROPN
dpc-4511	225	2	invest	invest	VERB
dpc-4511	225	3	dermatol	dermatol	NOUN
dpc-4511	225	4	.	.	PUNCT
dpc-4511	226	1	2011;131(9):1916	2011;131(9):1916	NUM
dpc-4511	226	2	-	-	SYM
dpc-4511	226	3	1926	1926	NUM
dpc-4511	226	4	.	.	PUNCT
dpc-4511	227	1	doi:10.1038	doi:10.1038	NOUN
dpc-4511	227	2	/	/	SYM
dpc-4511	227	3	jid.2011.134	jid.2011.134	PROPN
dpc-4511	227	4	treatment	treatment	NOUN
dpc-4511	227	5	compared	compare	VERB
dpc-4511	227	6	to	to	ADP
dpc-4511	227	7	the	the	DET
dpc-4511	227	8	eo	eo	PROPN
dpc-4511	227	9	group	group	NOUN
dpc-4511	227	10	,	,	PUNCT
dpc-4511	227	11	which	which	PRON
dpc-4511	227	12	may	may	AUX
dpc-4511	227	13	be	be	AUX
dpc-4511	227	14	due	due	ADJ
dpc-4511	227	15	to	to	ADP
dpc-4511	227	16	the	the	DET
dpc-4511	227	17	higher	high	ADJ
dpc-4511	227	18	incidence	incidence	NOUN
dpc-4511	227	19	of	of	ADP
dpc-4511	227	20	comorbidities	comorbiditie	NOUN
dpc-4511	227	21	such	such	ADJ
dpc-4511	227	22	as	as	ADP
dpc-4511	227	23	hypertension	hypertension	NOUN
dpc-4511	227	24	in	in	ADP
dpc-4511	227	25	the	the	DET
dpc-4511	227	26	eo	eo	PROPN
dpc-4511	227	27	group	group	NOUN
dpc-4511	227	28	.	.	PUNCT
dpc-4511	228	1	there	there	PRON
dpc-4511	228	2	were	be	VERB
dpc-4511	228	3	no	no	DET
dpc-4511	228	4	statistically	statistically	ADV
dpc-4511	228	5	significant	significant	ADJ
dpc-4511	228	6	differences	difference	NOUN
dpc-4511	228	7	between	between	ADP
dpc-4511	228	8	the	the	DET
dpc-4511	228	9	two	two	NUM
dpc-4511	228	10	groups	group	NOUN
dpc-4511	228	11	in	in	ADP
dpc-4511	228	12	other	other	ADJ
dpc-4511	228	13	treatments	treatment	NOUN
dpc-4511	228	14	.	.	PUNCT
dpc-4511	229	1	van	van	PROPN
dpc-4511	229	2	winden	winden	PROPN
dpc-4511	229	3	et	et	PROPN
dpc-4511	229	4	al	al	PROPN
dpc-4511	229	5	.	.	PROPN
dpc-4511	229	6	emphasized	emphasize	VERB
dpc-4511	229	7	that	that	SCONJ
dpc-4511	229	8	treatment	treatment	NOUN
dpc-4511	229	9	selection	selection	NOUN
dpc-4511	229	10	in	in	ADP
dpc-4511	229	11	geriatric	geriatric	ADJ
dpc-4511	229	12	psoriasis	psoriasis	NOUN
dpc-4511	229	13	patients	patient	NOUN
dpc-4511	229	14	should	should	AUX
dpc-4511	229	15	not	not	PART
dpc-4511	229	16	consider	consider	VERB
dpc-4511	229	17	the	the	DET
dpc-4511	229	18	patient	patient	NOUN
dpc-4511	229	19	’s	’s	PART
dpc-4511	229	20	age	age	NOUN
dpc-4511	229	21	alone	alone	ADV
dpc-4511	229	22	as	as	ADP
dpc-4511	229	23	a	a	DET
dpc-4511	229	24	limiting	limit	VERB
dpc-4511	229	25	factor	factor	NOUN
dpc-4511	229	26	but	but	CCONJ
dpc-4511	229	27	instead	instead	ADV
dpc-4511	229	28	should	should	AUX
dpc-4511	229	29	apply	apply	VERB
dpc-4511	229	30	personalized	personalized	ADJ
dpc-4511	229	31	treatment	treatment	NOUN
dpc-4511	229	32	by	by	ADP
dpc-4511	229	33	evaluating	evaluate	VERB
dpc-4511	229	34	the	the	DET
dpc-4511	229	35	patient	patient	NOUN
dpc-4511	229	36	’s	’s	PART
dpc-4511	229	37	comorbidities	comorbiditie	NOUN
dpc-4511	229	38	and	and	CCONJ
dpc-4511	229	39	medications	medication	NOUN
dpc-4511	229	40	used	use	VERB
dpc-4511	229	41	[	[	PUNCT
dpc-4511	229	42	11	11	NUM
dpc-4511	229	43	]	]	PUNCT
dpc-4511	229	44	.	.	PUNCT
dpc-4511	230	1	limitations	limitation	VERB
dpc-4511	230	2	the	the	DET
dpc-4511	230	3	retrospective	retrospective	ADJ
dpc-4511	230	4	study	study	NOUN
dpc-4511	230	5	design	design	NOUN
dpc-4511	230	6	and	and	CCONJ
dpc-4511	230	7	being	be	AUX
dpc-4511	230	8	a	a	DET
dpc-4511	230	9	single	single	ADJ
dpc-4511	230	10	-	-	PUNCT
dpc-4511	230	11	center	center	NOUN
dpc-4511	230	12	study	study	NOUN
dpc-4511	230	13	are	be	AUX
dpc-4511	230	14	among	among	ADP
dpc-4511	230	15	the	the	DET
dpc-4511	230	16	limitations	limitation	NOUN
dpc-4511	230	17	of	of	ADP
dpc-4511	230	18	this	this	DET
dpc-4511	230	19	study	study	NOUN
dpc-4511	230	20	.	.	PUNCT
dpc-4511	231	1	conclusion	conclusion	NOUN
dpc-4511	231	2	this	this	DET
dpc-4511	231	3	study	study	NOUN
dpc-4511	231	4	examined	examine	VERB
dpc-4511	231	5	the	the	DET
dpc-4511	231	6	demographics	demographic	NOUN
dpc-4511	231	7	,	,	PUNCT
dpc-4511	231	8	clinical	clinical	ADJ
dpc-4511	231	9	characteristics	characteristic	NOUN
dpc-4511	231	10	,	,	PUNCT
dpc-4511	231	11	treatment	treatment	NOUN
dpc-4511	231	12	features	feature	NOUN
dpc-4511	231	13	,	,	PUNCT
dpc-4511	231	14	and	and	CCONJ
dpc-4511	231	15	treatment	treatment	NOUN
dpc-4511	231	16	responses	response	NOUN
dpc-4511	231	17	of	of	ADP
dpc-4511	231	18	geriatric	geriatric	ADJ
dpc-4511	231	19	psoriasis	psoriasis	NOUN
dpc-4511	231	20	cases	case	NOUN
dpc-4511	231	21	.	.	PUNCT
dpc-4511	232	1	understanding	understand	VERB
dpc-4511	232	2	the	the	DET
dpc-4511	232	3	clinical	clinical	ADJ
dpc-4511	232	4	characteristics	characteristic	NOUN
dpc-4511	232	5	and	and	CCONJ
dpc-4511	232	6	treatment	treatment	NOUN
dpc-4511	232	7	options	option	NOUN
dpc-4511	232	8	for	for	ADP
dpc-4511	232	9	geriatric	geriatric	ADJ
dpc-4511	232	10	psoriasis	psoriasis	NOUN
dpc-4511	232	11	patients	patient	NOUN
dpc-4511	232	12	is	be	AUX
dpc-4511	232	13	crucial	crucial	ADJ
dpc-4511	232	14	due	due	ADP
dpc-4511	232	15	to	to	ADP
dpc-4511	232	16	the	the	DET
dpc-4511	232	17	increasing	increase	VERB
dpc-4511	232	18	incidence	incidence	NOUN
dpc-4511	232	19	of	of	ADP
dpc-4511	232	20	the	the	DET
dpc-4511	232	21	disease	disease	NOUN
dpc-4511	232	22	in	in	ADP
dpc-4511	232	23	this	this	DET
dpc-4511	232	24	population	population	NOUN
dpc-4511	232	25	.	.	PUNCT
dpc-4511	233	1	in	in	ADP
dpc-4511	233	2	this	this	DET
dpc-4511	233	3	study	study	NOUN
dpc-4511	233	4	,	,	PUNCT
dpc-4511	233	5	we	we	PRON
dpc-4511	233	6	evaluated	evaluate	VERB
dpc-4511	233	7	patients	patient	NOUN
dpc-4511	233	8	in	in	ADP
dpc-4511	233	9	two	two	NUM
dpc-4511	233	10	groups	group	NOUN
dpc-4511	233	11	:	:	PUNCT
dpc-4511	234	1	eo	eo	PROPN
dpc-4511	234	2	(	(	PUNCT
dpc-4511	234	3	<	<	X
dpc-4511	234	4	60	60	NUM
dpc-4511	234	5	years	year	NOUN
dpc-4511	234	6	)	)	PUNCT
dpc-4511	234	7	and	and	CCONJ
dpc-4511	234	8	eao	eao	PROPN
dpc-4511	234	9	(	(	PUNCT
dpc-4511	234	10	≥60	≥60	PROPN
dpc-4511	234	11	years	year	NOUN
dpc-4511	234	12	)	)	PUNCT
dpc-4511	234	13	.	.	PUNCT
dpc-4511	235	1	the	the	DET
dpc-4511	235	2	characteristics	characteristic	NOUN
dpc-4511	235	3	of	of	ADP
dpc-4511	235	4	eo	eo	PROPN
dpc-4511	235	5	psoriasis	psoriasis	NOUN
dpc-4511	235	6	differ	differ	VERB
dpc-4511	235	7	from	from	ADP
dpc-4511	235	8	those	those	PRON
dpc-4511	235	9	of	of	ADP
dpc-4511	235	10	eao	eao	ADJ
dpc-4511	235	11	psoriasis	psoriasis	NOUN
dpc-4511	235	12	,	,	PUNCT
dpc-4511	235	13	and	and	CCONJ
dpc-4511	235	14	it	it	PRON
dpc-4511	235	15	may	may	AUX
dpc-4511	235	16	represent	represent	VERB
dpc-4511	235	17	a	a	DET
dpc-4511	235	18	specific	specific	ADJ
dpc-4511	235	19	subtype	subtype	NOUN
dpc-4511	235	20	that	that	PRON
dpc-4511	235	21	requires	require	VERB
dpc-4511	235	22	more	more	ADJ
dpc-4511	235	23	investigation	investigation	NOUN
dpc-4511	235	24	.	.	PUNCT
dpc-4511	236	1	the	the	DET
dpc-4511	236	2	geriatric	geriatric	ADJ
dpc-4511	236	3	population	population	NOUN
dpc-4511	236	4	is	be	AUX
dpc-4511	236	5	associated	associate	VERB
dpc-4511	236	6	with	with	ADP
dpc-4511	236	7	multiple	multiple	ADJ
dpc-4511	236	8	comorbidities	comorbiditie	NOUN
dpc-4511	236	9	and	and	CCONJ
dpc-4511	236	10	polypharmacy	polypharmacy	NOUN
dpc-4511	236	11	,	,	PUNCT
dpc-4511	236	12	highlighting	highlight	VERB
dpc-4511	236	13	the	the	DET
dpc-4511	236	14	importance	importance	NOUN
dpc-4511	236	15	of	of	ADP
dpc-4511	236	16	evaluating	evaluate	VERB
dpc-4511	236	17	patients	patient	NOUN
dpc-4511	236	18	’	'	PUNCT
dpc-4511	236	19	medications	medication	NOUN
dpc-4511	236	20	and	and	CCONJ
dpc-4511	236	21	comorbidities	comorbiditie	NOUN
dpc-4511	236	22	when	when	SCONJ
dpc-4511	236	23	selecting	select	VERB
dpc-4511	236	24	a	a	DET
dpc-4511	236	25	treatment	treatment	NOUN
dpc-4511	236	26	agent	agent	NOUN
dpc-4511	236	27	for	for	ADP
dpc-4511	236	28	psoriasis	psoriasis	NOUN
dpc-4511	236	29	.	.	PUNCT
dpc-4511	237	1	further	furth	ADJ
dpc-4511	237	2	studies	study	NOUN
dpc-4511	237	3	are	be	AUX
dpc-4511	237	4	needed	need	VERB
dpc-4511	237	5	to	to	PART
dpc-4511	237	6	explore	explore	VERB
dpc-4511	237	7	the	the	DET
dpc-4511	237	8	clinical	clinical	ADJ
dpc-4511	237	9	characteristics	characteristic	NOUN
dpc-4511	237	10	of	of	ADP
dpc-4511	237	11	geriatric	geriatric	ADJ
dpc-4511	237	12	psoriasis	psoriasis	NOUN
dpc-4511	237	13	and	and	CCONJ
dpc-4511	237	14	to	to	PART
dpc-4511	237	15	compare	compare	VERB
dpc-4511	237	16	the	the	DET
dpc-4511	237	17	differences	difference	NOUN
dpc-4511	237	18	between	between	ADP
dpc-4511	237	19	eao	eao	ADJ
dpc-4511	237	20	and	and	CCONJ
dpc-4511	237	21	eo	eo	PROPN
dpc-4511	237	22	groups	group	NOUN
dpc-4511	237	23	.	.	PUNCT
dpc-4511	238	1	acknowledgement	acknowledgement	NOUN
dpc-4511	238	2	the	the	DET
dpc-4511	238	3	patients	patient	NOUN
dpc-4511	238	4	in	in	ADP
dpc-4511	238	5	this	this	DET
dpc-4511	238	6	study	study	NOUN
dpc-4511	238	7	gave	give	VERB
dpc-4511	238	8	their	their	PRON
dpc-4511	238	9	written	write	VERB
dpc-4511	238	10	informed	inform	VERB
dpc-4511	238	11	consent	consent	NOUN
dpc-4511	238	12	to	to	ADP
dpc-4511	238	13	the	the	DET
dpc-4511	238	14	publication	publication	NOUN
dpc-4511	238	15	of	of	ADP
dpc-4511	238	16	their	their	PRON
dpc-4511	238	17	case	case	NOUN
dpc-4511	238	18	details	detail	NOUN
dpc-4511	238	19	.	.	PUNCT
dpc-4511	239	1	references	reference	NOUN
dpc-4511	239	2	1	1	NUM
dpc-4511	239	3	.	.	PUNCT
dpc-4511	239	4	greb	greb	PROPN
dpc-4511	239	5	je	je	PROPN
dpc-4511	239	6	,	,	PUNCT
dpc-4511	239	7	goldminz	goldminz	PROPN
dpc-4511	239	8	am	am	NOUN
dpc-4511	239	9	,	,	PUNCT
dpc-4511	239	10	elder	eld	ADJ
dpc-4511	239	11	jt	jt	PROPN
dpc-4511	239	12	,	,	PUNCT
dpc-4511	239	13	et	et	PROPN
dpc-4511	239	14	al	al	PROPN
dpc-4511	239	15	.	.	PUNCT
dpc-4511	239	16	psoriasis	psoriasis	NOUN
dpc-4511	239	17	.	.	PUNCT
dpc-4511	239	18	 	 	SPACE
dpc-4511	240	1	nat	nat	PROPN
dpc-4511	240	2	rev	rev	VERB
dpc-4511	240	3	dis	dis	PROPN
dpc-4511	240	4	primers	primer	NOUN
dpc-4511	240	5	.	.	PUNCT
dpc-4511	241	1	2016;2:16082	2016;2:16082	NUM
dpc-4511	241	2	.	.	PUNCT
dpc-4511	242	1	published	publish	VERB
dpc-4511	242	2	2016	2016	NUM
dpc-4511	242	3	nov	nov	PROPN
dpc-4511	242	4	24	24	NUM
dpc-4511	242	5	.	.	PUNCT
dpc-4511	243	1	doi	doi	NOUN
dpc-4511	243	2	:	:	PUNCT
dpc-4511	243	3	10.1038	10.1038	NUM
dpc-4511	243	4	/nrdp.2016.82	/nrdp.2016.82	SYM
dpc-4511	243	5	2	2	X
dpc-4511	243	6	.	.	X
dpc-4511	243	7	nair	nair	PROPN
dpc-4511	243	8	pa	pa	PROPN
dpc-4511	243	9	,	,	PUNCT
dpc-4511	243	10	badri	badri	ADJ
dpc-4511	243	11	t.	t.	NOUN
dpc-4511	243	12	psoriasis	psoriasis	NOUN
dpc-4511	243	13	.	.	PUNCT
dpc-4511	244	1	in	in	ADP
dpc-4511	244	2	:	:	PUNCT
dpc-4511	244	3	 	 	SPACE
dpc-4511	244	4	statpearls	statpearl	NOUN
dpc-4511	244	5	.	.	PUNCT
dpc-4511	245	1	treasure	treasure	NOUN
dpc-4511	245	2	island	island	NOUN
dpc-4511	245	3	(	(	PUNCT
dpc-4511	245	4	fl	fl	PROPN
dpc-4511	245	5	):	):	PUNCT
dpc-4511	245	6	statpearls	statpearls	PROPN
dpc-4511	245	7	publishing	publishing	NOUN
dpc-4511	245	8	;	;	PUNCT
dpc-4511	245	9	april	april	PROPN
dpc-4511	245	10	3	3	NUM
dpc-4511	245	11	,	,	PUNCT
dpc-4511	245	12	2023	2023	NUM
dpc-4511	245	13	.	.	PUNCT
dpc-4511	246	1	3	3	X
dpc-4511	246	2	.	.	X
dpc-4511	246	3	iskandar	iskandar	PROPN
dpc-4511	246	4	iyk	iyk	PROPN
dpc-4511	246	5	,	,	PUNCT
dpc-4511	246	6	parisi	parisi	PROPN
dpc-4511	246	7	r	r	PROPN
dpc-4511	246	8	,	,	PUNCT
dpc-4511	246	9	griffiths	griffiths	PROPN
dpc-4511	246	10	cem	cem	PROPN
dpc-4511	246	11	,	,	PUNCT
dpc-4511	246	12	ashcroft	ashcroft	PROPN
dpc-4511	246	13	dm	dm	PROPN
dpc-4511	246	14	;	;	PUNCT
dpc-4511	246	15	global	global	ADJ
dpc-4511	246	16	psoriasis	psoriasis	NOUN
dpc-4511	246	17	atlas	atlas	PROPN
dpc-4511	246	18	.	.	PUNCT
dpc-4511	247	1	systematic	systematic	ADJ
dpc-4511	247	2	review	review	NOUN
dpc-4511	247	3	examining	examine	VERB
dpc-4511	247	4	changes	change	NOUN
dpc-4511	247	5	over	over	ADP
dpc-4511	247	6	time	time	NOUN
dpc-4511	247	7	and	and	CCONJ
dpc-4511	247	8	variation	variation	NOUN
dpc-4511	247	9	in	in	ADP
dpc-4511	247	10	the	the	DET
dpc-4511	247	11	incidence	incidence	NOUN
dpc-4511	247	12	and	and	CCONJ
dpc-4511	247	13	prevalence	prevalence	NOUN
dpc-4511	247	14	of	of	ADP
dpc-4511	247	15	psoriasis	psoriasis	NOUN
dpc-4511	247	16	by	by	ADP
dpc-4511	247	17	age	age	NOUN
dpc-4511	247	18	and	and	CCONJ
dpc-4511	247	19	gender	gender	NOUN
dpc-4511	247	20	.	.	PUNCT
dpc-4511	247	21	 	 	SPACE
dpc-4511	248	1	br	br	PROPN
dpc-4511	248	2	j	j	PROPN
dpc-4511	248	3	dermatol	dermatol	NOUN
dpc-4511	248	4	.	.	PUNCT
dpc-4511	249	1	2021;184(2):243	2021;184(2):243	NUM
dpc-4511	249	2	-	-	SYM
dpc-4511	249	3	258	258	NUM
dpc-4511	249	4	.	.	PUNCT
dpc-4511	250	1	doi:10.1111	doi:10.1111	PROPN
dpc-4511	250	2	/bjd.19169	/bjd.19169	ADJ
dpc-4511	250	3	original	original	ADJ
dpc-4511	250	4	article	article	NOUN
dpc-4511	250	5	|	|	ADV
dpc-4511	250	6	dermatol	dermatol	ADJ
dpc-4511	250	7	pract	pract	NOUN
dpc-4511	250	8	concept	concept	NOUN
dpc-4511	250	9	.	.	PUNCT
dpc-4511	251	1	2025;15(1):4511	2025;15(1):4511	NUM
dpc-4511	251	2	7	7	NUM
dpc-4511	251	3	of	of	ADP
dpc-4511	251	4	clinical	clinical	ADJ
dpc-4511	251	5	variables	variable	NOUN
dpc-4511	251	6	,	,	PUNCT
dpc-4511	251	7	comorbidities	comorbiditie	NOUN
dpc-4511	251	8	,	,	PUNCT
dpc-4511	251	9	and	and	CCONJ
dpc-4511	251	10	association	association	NOUN
dpc-4511	251	11	with	with	ADP
dpc-4511	251	12	hla	hla	PROPN
dpc-4511	251	13	cw6	cw6	PROPN
dpc-4511	251	14	in	in	ADP
dpc-4511	251	15	a	a	DET
dpc-4511	251	16	tertiary	tertiary	ADJ
dpc-4511	251	17	care	care	NOUN
dpc-4511	251	18	center	center	NOUN
dpc-4511	251	19	.	.	PUNCT
dpc-4511	251	20	 	 	SPACE
dpc-4511	252	1	indian	indian	PROPN
dpc-4511	252	2	j	j	PROPN
dpc-4511	252	3	dermatol	dermatol	NOUN
dpc-4511	252	4	.	.	PUNCT
dpc-4511	253	1	2021	2021	NUM
dpc-4511	253	2	;	;	PUNCT
dpc-4511	253	3	66(6):705	66(6):705	NUM
dpc-4511	253	4	.	.	PUNCT
dpc-4511	254	1	doi:10.4103	doi:10.4103	ADJ
dpc-4511	254	2	/	/	SYM
dpc-4511	254	3	ijd.ijd_45_21	ijd.ijd_45_21	PROPN
dpc-4511	254	4	24	24	NUM
dpc-4511	254	5	.	.	PUNCT
dpc-4511	255	1	kwon	kwon	PROPN
dpc-4511	255	2	hh	hh	PROPN
dpc-4511	255	3	,	,	PUNCT
dpc-4511	255	4	kwon	kwon	VERB
dpc-4511	255	5	ih	ih	PRON
dpc-4511	255	6	,	,	PUNCT
dpc-4511	255	7	youn	youn	PROPN
dpc-4511	255	8	ji	ji	PROPN
dpc-4511	255	9	.	.	PROPN
dpc-4511	255	10	clinical	clinical	ADJ
dpc-4511	255	11	study	study	NOUN
dpc-4511	255	12	of	of	ADP
dpc-4511	255	13	psoriasis	psoriasis	NOUN
dpc-4511	255	14	occurring	occur	VERB
dpc-4511	255	15	over	over	ADP
dpc-4511	255	16	the	the	DET
dpc-4511	255	17	age	age	NOUN
dpc-4511	255	18	of	of	ADP
dpc-4511	255	19	60	60	NUM
dpc-4511	255	20	years	year	NOUN
dpc-4511	255	21	:	:	PUNCT
dpc-4511	255	22	is	be	AUX
dpc-4511	255	23	elderly	elderly	ADJ
dpc-4511	255	24	-	-	PUNCT
dpc-4511	255	25	onset	onset	VERB
dpc-4511	255	26	psoriasis	psoriasis	NOUN
dpc-4511	255	27	a	a	DET
dpc-4511	255	28	distinct	distinct	ADJ
dpc-4511	255	29	subtype	subtype	NOUN
dpc-4511	255	30	?	?	PUNCT
dpc-4511	255	31	 	 	SPACE
dpc-4511	256	1	int	int	PROPN
dpc-4511	256	2	j	j	PROPN
dpc-4511	256	3	dermatol	dermatol	NOUN
dpc-4511	256	4	.	.	PUNCT
dpc-4511	257	1	2012;51(1):53	2012;51(1):53	NUM
dpc-4511	257	2	-	-	SYM
dpc-4511	257	3	58	58	NUM
dpc-4511	257	4	.	.	PUNCT
dpc-4511	258	1	doi:10.1111	doi:10.1111	NOUN
dpc-4511	258	2	/j.1365	/j.1365	NOUN
dpc-4511	258	3	-	-	PUNCT
dpc-4511	258	4	4632.2011.04979.x	4632.2011.04979.x	NUM
dpc-4511	258	5	21	21	NUM
dpc-4511	258	6	.	.	PUNCT
dpc-4511	259	1	zaiem	zaiem	PROPN
dpc-4511	260	1	a	a	PRON
dpc-4511	260	2	,	,	PUNCT
dpc-4511	260	3	daldoul	daldoul	PROPN
dpc-4511	260	4	m	m	PROPN
dpc-4511	260	5	,	,	PUNCT
dpc-4511	260	6	badri	badri	PROPN
dpc-4511	260	7	t	t	PROPN
dpc-4511	260	8	,	,	PUNCT
dpc-4511	260	9	et	et	PROPN
dpc-4511	260	10	al	al	PROPN
dpc-4511	260	11	.	.	PROPN
dpc-4511	260	12	de	de	PROPN
dpc-4511	260	13	novo	novo	PROPN
dpc-4511	260	14	psoriasis	psoriasis	NOUN
dpc-4511	260	15	induced	induce	VERB
dpc-4511	260	16	by	by	ADP
dpc-4511	260	17	chadox1	chadox1	ADJ
dpc-4511	260	18	-	-	PUNCT
dpc-4511	260	19	s	s	NOUN
dpc-4511	260	20	covid	covid	NOUN
dpc-4511	260	21	19	19	NUM
dpc-4511	260	22	vaccine	vaccine	NOUN
dpc-4511	260	23	.	.	PUNCT
dpc-4511	260	24	 	 	SPACE
dpc-4511	260	25	therapie	therapie	PROPN
dpc-4511	260	26	.	.	PUNCT
dpc-4511	261	1	2023;78(4):446	2023;78(4):446	NUM
dpc-4511	261	2	-	-	SYM
dpc-4511	261	3	447	447	NUM
dpc-4511	261	4	.	.	PUNCT
dpc-4511	261	5	doi:10.1016	doi:10.1016	PROPN
dpc-4511	261	6	/	/	SYM
dpc-4511	261	7	j.therap.2022.07.008	j.therap.2022.07.008	PROPN
dpc-4511	261	8	22	22	NUM
dpc-4511	261	9	.	.	PUNCT
dpc-4511	262	1	adışen	adışen	PROPN
dpc-4511	262	2	e	e	PROPN
dpc-4511	262	3	,	,	PUNCT
dpc-4511	262	4	uzun	uzun	PROPN
dpc-4511	262	5	s	s	PART
dpc-4511	262	6	,	,	PUNCT
dpc-4511	262	7	erduran	erduran	ADJ
dpc-4511	262	8	f	f	NOUN
dpc-4511	262	9	,	,	PUNCT
dpc-4511	262	10	gürer	gürer	PROPN
dpc-4511	262	11	ma	ma	PROPN
dpc-4511	262	12	.	.	PROPN
dpc-4511	262	13	prevalence	prevalence	NOUN
dpc-4511	262	14	of	of	ADP
dpc-4511	262	15	smoking	smoking	NOUN
dpc-4511	262	16	,	,	PUNCT
dpc-4511	262	17	alcohol	alcohol	NOUN
dpc-4511	262	18	consumption	consumption	NOUN
dpc-4511	262	19	and	and	CCONJ
dpc-4511	262	20	metabolic	metabolic	NOUN
dpc-4511	262	21	syndrome	syndrome	NOUN
dpc-4511	262	22	in	in	ADP
dpc-4511	262	23	patients	patient	NOUN
dpc-4511	262	24	with	with	ADP
dpc-4511	262	25	psoriasis	psoriasis	NOUN
dpc-4511	262	26	.	.	PUNCT
dpc-4511	262	27	 	 	SPACE
dpc-4511	263	1	an	an	DET
dpc-4511	263	2	bras	bras	NOUN
dpc-4511	263	3	dermatol	dermatol	NOUN
dpc-4511	263	4	.	.	PUNCT
dpc-4511	264	1	2018;93(2):205	2018;93(2):205	NOUN
dpc-4511	264	2	-	-	PUNCT
dpc-4511	264	3	211	211	NUM
dpc-4511	264	4	.	.	PUNCT
dpc-4511	265	1	doi:10.1590	doi:10.1590	VERB
dpc-4511	265	2	/abd1806	/abd1806	PUNCT
dpc-4511	265	3	-	-	PUNCT
dpc-4511	265	4	4841.20186168	4841.20186168	NUM
dpc-4511	265	5	23	23	NUM
dpc-4511	265	6	.	.	PUNCT
dpc-4511	266	1	fatema	fatema	PROPN
dpc-4511	266	2	f	f	PROPN
dpc-4511	266	3	,	,	PUNCT
dpc-4511	266	4	ghoshal	ghoshal	PROPN
dpc-4511	266	5	l	l	PROPN
dpc-4511	266	6	,	,	PUNCT
dpc-4511	266	7	saha	saha	PROPN
dpc-4511	266	8	a	a	X
dpc-4511	266	9	,	,	PUNCT
dpc-4511	266	10	agarwal	agarwal	PROPN
dpc-4511	266	11	s	s	PART
dpc-4511	266	12	,	,	PUNCT
dpc-4511	266	13	bandyopadhyay	bandyopadhyay	PROPN
dpc-4511	266	14	d.	d.	PROPN
dpc-4511	266	15	early	early	ADJ
dpc-4511	266	16	-	-	PUNCT
dpc-4511	266	17	onset	onset	NOUN
dpc-4511	266	18	versus	versus	ADP
dpc-4511	266	19	late	late	ADJ
dpc-4511	266	20	-	-	PUNCT
dpc-4511	266	21	onset	onset	NOUN
dpc-4511	266	22	psoriasis	psoriasis	NOUN
dpc-4511	266	23	:	:	PUNCT
dpc-4511	266	24	a	a	DET
dpc-4511	266	25	comparative	comparative	ADJ
dpc-4511	266	26	study	study	NOUN